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Within this thesis, the use of anthracene to perform various applications within 
biomolecules is assessed. Anthracene displays two interesting photo properties 
which make it an appealing molecule for incorporation; fluorescence and 
photodimerisation. 
 
Within the first project presented herein, anthracene is incorporated into an 
oligonucleotide to create a probe to sense for single nucleotide polymorphisms 
(SNPs). The intensity of anthracene fluorescence is shown to depend upon the base 
opposite it on a complementary strand of DNA. This intensity displays a linear 
relationship with respect to the amount of each base present at the SNP site, 
allowing for a quantitative assay to be developed. Further to this, the fluorescence 
output was also shown to allow for the identification of the 8-oxoG base 
modification. 
 
The unprecedented use of anthracene photodimerisation within a peptide is also 
explored. It is shown that, within a model system and at low biologically relevant 
micromolar concentrations, the photodimerisation only occurs when the peptide 
units are bound to target DNA, which preorganises the units for 
photodimerisation. Once formed, the photodimer species shows enhanced binding 
affinity for target DNA. 
In addition to this, the photodimerisation properties of anthracene were utilised 
within oligonucleotides, to control the duplex formation and secondary structure 
of sequences. It was shown that anthracene could successfully form photodimers 
when incorporated into oligonucleotides. When this was performed between two 
strands of a three stranded toe-hold system, it resulted in a shift in the equilibrium 
and an effective release of an unmodified strand. This process was shown to be 
both reversible and repeatable, allowing for cycling of the system. When two 
anthracene moieties were incorporated into a quadruplex forming sequence, 
anthracene photodimerisation was achieved between the two units within the 
same strand. This action was shown to alter the folding of the structure, and initial 
studies towards establishing the effect this has on binding to a target protein, 
showed promise.  
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Within this thesis the use of anthracene within biomolecules is assessed, in 
particular within DNA and peptides. This chapter details the biological relevance 
of DNA and proteins, along with modified derivatives which have been utilised 
for many applications. The uses of anthracene are also explored, focussing on the 
current applications of anthracene fluorescence and photodimerisation within the 
literature, particularly within biomolecules. 
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1.2 DNA 
In the last 60 years, since the first proposed correct model of the structure of 
deoxyribose nucleic acid (DNA)1 and the determination of its function,2 
knowledge of the area has greatly expanded. DNA is now understood to be the 
carrier of genetic information for all living organisms and studies on the molecule 
continue due to its potential as a data carrier and a target for therapeutics. 
 
1.2.1 DNA Structure 
DNA is comprised of a sugar-phosphate backbone, from which one of four 
naturally occurring bases protrude. These bases form hydrogen bonds to bases in 
a complementary strand, whilst π-stacking with neighbouring bases, all 
contributing to the stability of the complex, Figure 1.1.  
Figure 1.1 DNA structure showing the sugar-phosphate backbone with thymine (top left) hydrogen bonding to 
adenine (top right) and guanine (bottom right) bonded to cytosine (bottom left). 
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Each unit within the DNA structure is linked to the next via the 3′ carbon on the 
deoxyribose sugar, to the 5′ carbon on the next unit via a phosphate group. Each 
base pair consists of a purine (adenine, A and guanine, G) and a pyrimidine 
(thymine, T and cytosine, C). The A-T pairing is held together by two hydrogen 
bonds whilst the G-C pairing has three (see Figure 1.1). Due to the specific 
nature of the base pairings, hybridisation (the self-assembly of two strands of 
DNA into the duplex structure) usually occurs with a sequence with the correct 
base pairing, the complementary strand. The double stranded DNA (dsDNA) is 
formed in an antiparallel nature, and folds into a helix so as to maximise the 
overlap of the bases and increase π-stacking. This also increases the distance 
between the negatively charged phosphate groups, which experience electrostatic 
repulsion. This effect is also minimised by cations which act as counter ions.3 
 
Double stranded DNA is known to fold into 3 main forms, A-, B- and Z-DNA, 
known as the secondary structure, Figure 1.2. Of these the most common is B-
DNA, which is made of a right-handed helix with approximately 10 base pairs 
per turn, a diameter of 24 Å and a pitch of 35.5 Å. Within this structure, each 
phosphate group is 7 Å apart. In the A-DNA form the phosphate groups are 
closer together (5.9 Å), with the base pairs being tilted with respect to the 
backbone. The diameter of the helix has increased to 25.5 Å, and there are 
approximately 11 base pairs per turn. Z-DNA is considerably different from A- 
and B-DNA, forming a left-handed helix, and is typically found in regions of 
alternating purine-pyrimidine bases where the purine residues adopt a syn 
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configuration. This structure has 12 base pairs per turn, a diameter of 18.4 Å and 
a rise per base of 3.63 Å.4–6 
 
Single stranded DNA can also fold within itself, to form various conformations 
such as hairpins. In addition triplex and quadruplex structures of multiple 
strands are also known. Of particular note are junctions, which form between 
several strands of DNA; G-Quadruplexes, a four stranded structure which forms 
in guanine rich sequences and i-motifs, another four stranded structure which 
forms in cytosine rich sequences.7 
Figure 1.2 Structures of the common forms of DNA. A-DNA (left) is a more compact structure of the most 
common B-DNA structure (middle). B-DNA is a right-handed helix with base pairs perpendicular to the axis of 
the helix. Finally Z-DNA (right) is a left-handed helix with the most base pairs per turn. Figure adapted from 
reference 4. 
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1.2.2 Transcription and Translation 
DNA acts as the genetic blueprint, coding for all proteins and smaller signalling 
peptides within the body. In order for the proteins to be made from the 
information contained within DNA, it must first be copied into ribonucleic acid 
(RNA). RNA is a polymer similar to DNA that consists of ribose sugar units 
rather than deoxyribose as found in DNA. The bases attached to the sugar units 
are identical to those found within DNA, except for thymine which is replaced by 
uridine, which lacks the methyl group on the pyrimidine, Figure 1.3. The two 
main types of RNA which will be referred to within this work are messenger RNA 
(mRNA) and transfer RNA (tRNA). 
Figure 1.3 Comparison of the structure of DNA and RNA. Within RNA the deoxyribose sugar of DNA is replaced 
with ribose. All the bases are the same between the two systems apart from thymine (shown in the structure 
on the left) which is replaced with uracil (right) which lacks the methyl group on the pyrimidine. 
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The process of DNA being copied into RNA, is known as transcription, the rate of 
which is controlled by proteins known as transcription factors which can either 
promote, or inhibit, the transcription process by binding to the DNA strand. 
When an RNA polymerase binds to the DNA, it initially separates the DNA 
duplex to create a region of single stranded DNA (ssDNA). Each base within the 
DNA strand is then paired with the complementary RNA base analogue. As the 
base interactions are formed, the sugar-phosphate backbone is made by joining 
the groups with those of the preceding unit. The hydrogen bonds to the 
complementary DNA are then broken by a helicase enzyme, to produce the single 
stranded RNA (ssRNA) which can be translated into proteins, Figure 1.4. This 
RNA is referred to as messenger RNA (mRNA).8,9 
Figure 1.4 Schematic diagram of the transcription process. A) The region of dsDNA to be transcribed is 
identified and RNA polymerase binds to it. B) The dsDNA is dissociated to expose a region of ssDNA which can 
be paired with complementary RNA bases. As the base pair is formed between the DNA and the new RNA base, 
the sugar-phosphate backbone is made. C) Once the process is completed the new mRNA strand is released 
and the DNA refolds into a double stranded helix. 
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The RNA formed in the translation process is read by the ribosome, an organelle 
within the cell which performs protein synthesis. Each set of three bases, known 
as a codon, details an instruction to either incorporate a specific amino acid or to 
stop the synthesis. A transfer RNA (tRNA) molecule, consisting of a short 
oligonucleotide sequence with an anticodon region (complementary to the codon 
found in mRNA), binds to the codon on the mRNA. The tRNA molecule has the 
selected amino acid bound to the other end, and hence aligns it within the 
sequence, so it can be joined with the preceding amino acid, Figure 1.5. The 




Figure 1.5 A schematic representation of the translation process. The mRNA (green) is read by the ribosome 
(grey). tRNA molecules are matched with each codon by forming complementary base pairs. The amino acids 
attached to them are then synthesised into the protein by the ribosome. 
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1.3 Proteins 
Proteins are polymers formed from building blocks called amino acids. There are 
21 naturally occurring amino acids, all comprising of a carboxylic acid, an amine 
and a side chain. All naturally occurring amino acids are referred to as having L 
stereochemistry (meaning polarised light passed through a solution containing 
them, is rotated in the same direction as a solution containing L-glyceraldehyde). 
Using standard chirality labelling, the chiral amino acids are shown to have S 
chirality, with the exceptions of cysteine and selenocysteine, which are R. Amino 
acids are linked together through the creation of a peptide bond between the 
carboxylic acid of one amino acid with the amine of another, Figure 1.6. The side 





Figure 1.6 The structure of peptide chains. Amino acid units (distinguished by the dashed lines) are linked via 
the amine of one, to the carboxylic acid of the next, to create a peptide bond. Each amino acid has a side chain 
(R) which varies between the amino acids. 
 
Chapter 1 – Introduction – The Use of Anthracene within Biomolecules 
 9 
The amino acid sequence, which a protein is made up of, is known as the primary 
structure. This polymer chain can be folded into a variety of different 
conformations, such as α-helices or β-pleated sheets. This is referred to as the 
secondary structure. A single chain of protein may contain several regions which 
fold into different secondary structures, and how these associate is known as its 
tertiary structure. Finally, several separate protein chains can assemble to form 
large oligomers; this level of assembly is known as the quaternary structure, see 
Figure 1.8. 10,11 
 
Figure 1.7 Structures of the 21 natural occurring amino acids at physiological pH, grouped by property of the 
side chain group. 
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Proteins are responsible for many of the processes within the body, and as such, 
are of great interest for the treatment of diseases and control of processes. As 
well as biomolecules being extensively explored for targeting by therapeutics, 
they are also being used for technologies outside of the body. 
 
1.4 Tagging Biomolecules 
Nature is limited to the naturally occurring bases and amino acids to produce 
DNA, RNA and proteins. In order to widen biomolecule applicability and 
functions, modified derivatives are being created, for example, systems with 
fluorescent labels or responsive features. Various bioconjugation techniques are 
now established and widely used within the field and are described in more 
detailed reviews and summarised in Chapter 5.12,13 In general, the label is 
attached via a reactive group which targets a specific functional group within the 
protein or DNA.  
Figure 1.8 The protein structure is separated into four levels. The amino acid sequence is known as the primary 
structure. This sequence folds into particular conformations and is referred to as secondary structure. The 
separate regions of folded protein can associate with each other to create the tertiary structure. Finally, 
several separate protein chains can associated together to form a quaternary structure. All adapted from PDB 
1ATN.11 
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1.4.1 Modifying DNA 
In addition to the standard techniques used to attach fluorophores and other 
functionalities to DNA, many research groups have worked to modify the natural 
units within the DNA structure, e.g. the backbone or bases, as described below. 
 
1.4.1.1 Modifying the Backbone of DNA 
Modification of the sugar-phosphate backbone of DNA has the potential to 
increase the stability of the structure and make it less susceptible to degradation 
by enzymes, which becomes important when using DNA as a therapeutic or 
probe. The most notable modification in the field, is that of peptide nucleic acid 
(PNA). In this derivative, the backbone of DNA is replaced by a pseudo peptide 
unit, Figure 1.9.14 
 
Figure 1.9 Comparison of the structures of DNA (left), PNA (middle) and LNA (right) showing the modified 
backbone used within PNA, that replaces the sugar-phosphate repeating pattern found in natural DNA and the 
“locked” sugar of LNA. 
 
PNA has been shown to hybridise with both DNA and RNA, resulting in duplexes 
with higher Tm values than the corresponding DNA:DNA and RNA:RNA 
duplexes. It is thought that this is primarily due to the lack of charge on PNA, 
reducing the same charge repulsion found within the natural oligomers. In 
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addition to this, PNA is found to not be degraded by the cellular environment. 
These characteristics make for a very stable “biomolecule”, which has been used 
for many applications.14 Many other backbone derivatives have also been 
developed such as locked nucleic acid (LNA),15 an RNA derivative with a 
connection between the 2′ oxygen and 4′ carbon of the ribose (Figure 1.9);15 and 
ferrocene nucleic acids (FcNA) which incorporates a ferrocene into the backbone, 
replacing two bases.15–17 
 
1.4.1.2 Modifying the Bases of DNA 
In addition to modifying the backbone of DNA, the base attached can also be 
modified, or replaced completely. The majority of these modifications incorporate 
a fluorescent label,18 although other derivatives have also been made, such as 
azobenzene switches19 and metal binding ligands.20 More recently artificial base 
pairs have been made, with the aim of expanding the code that is available to 
researchers. Romesberg and co-workers developed a hydrophobic nucleotide21 and 
later showed that enzymes could successfully replicate DNA containing this 
modification.22 In 2015 Benner and co-workers developed the first unnatural, 
hydrogen bonding bases which, when incorporated into a sequence, increased the 
stability of DNA.23,24 
 
Tucker and co-workers have previously reported on the development of an 
anthracene nucleobase derivative. Within this derivative the natural sugar-
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phosphate backbone is replaced with a theroninol linker; this is attached to 
anthracene via a carbon chain (further detail on the structure can be found in 
Chapter 3.1.4). This derivative has been successfully incorporated into DNA and 
has been shown to give a fluorescent output that is dependent on the nature of 
the surrounding bases.25–28 The design of the nucleobase is explored further in 
Chapter 2, and the use of the fluorescent output, in Chapter 3.  
 
1.4.1.3 Applications of Modified and Tagged DNA 
1.4.1.3.1 DNA Sensing 
An obvious use of DNA, is to use it as a probe to monitor processes based on DNA 
hybridisation, such as diseases and genetic traits within individuals. Many 
sensing assays have been developed which can target specific regions of DNA and 
are detailed in the following chapters. The majority of these use modified DNA 
with a functional group attached that can generate a measureable output, such 
as a fluorophore or redox-active moiety, which can subsequently be detected and 
monitored. 
 
The DNA sensing field was dramatically enhanced by the development of the 
polymerase chain reaction (PCR), allowing for small amounts of DNA material to 
be amplified, making them much easier to detect. Dr Kary Mullis first proposed 
the idea in the early 1980’s.29 He was subsequently awarded a Nobel Prize for the 
work in 1993. The technique works by taking the sample of DNA, and adding in 
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two primers (short oligonucleotides that are complementary to the end section of 
the DNA to be amplified). A primer is used for each of the two DNA strands that 
form the duplex, as shown in Figure 1.10. Upon heating the dsDNA dissociates, 
subsequently lowering the temperature allows for the primers to bind to the 
complementary DNA (known as the template), preventing the reformation of 
dsDNA, and leaving the remainder of the strand as ssDNA. The enzyme, 
typically Taq polymerase, can then extend the primer in a process known as 
elongation, to complete the sequence. By thermal cycling the system, the strands 
dissociate, anneal and elongate several times with the newly made strands 
becoming templates themselves. This results in exponential growth of the DNA 
sequences.30  
 
Figure 1.10 Schematic of the PCR techniques showing the stages of denaturation, annealing and elongation. 
dsDNA (blue) is heated to denature the duplex. Lowering the temperature allows for the primers (red and 
yellow) to bind to the complementary sequence and taq polymerase extends the sequences. 
 
1.4.1.3.2 DNA as a Therapeutic Agent 
Many diseases, such as cystic fibrosis, cancer and neurodegenerative diseases, 
are thought to be partially or wholly caused by a patient’s genes. One can 
imagine that if a gene sequence is changed, the protein the gene codes for will 
also be altered, potentially resulting in disrupted function and disease. By 
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replacing the effected region of the patients DNA, or by supplying the affected 
cells with a “working” DNA sequence, the symptoms can be suppressed and 
potentially the patient cured.31 With the development of these therapeutic 
techniques, there are many ethical and social issues which need to be discussed. 
Although this technology would allow for many diseases to be cured, it could also 
allow for the genetic modification of other traits such as sex, personality and 
physical appearance. Due to this, the currently approved therapeutics do not 
modify any information that is passed on to future generations.32 Another 
potential way to control the production of proteins, is to silence genes. This can 
be done using small fragments of RNA that bind to mRNA and inhibit the 
replication, so called anti-sense therapy.32,33 Due to the RNA binding and 
creating a double stranded section, the replication process is halted and therefore 
the target gene is not expressed. The use of modified DNA derivatives which are 
not as readily broken down in the body as natural DNA or RNA, is now an active 
area of research.34  
 
1.4.1.3.3 DNA Nanostructures and Machines 
DNA use is also being explored outside of the obvious medical uses. Due to the 
highly specific binding of the oligomer, and its ability to hold information, it is 
being used to create nanomachines and build potentially complex 
nanostructures.35 
 
Chapter 1 – Introduction – The Use of Anthracene within Biomolecules 
 16 
The building of nanostructures from DNA is referred to as DNA origami, and was 
pioneered in 1998 by Nadrian Seeman,36 although it wasn’t termed DNA origami 
until later.37 Since then more complex designs have been made, with ever 
increasing functionality incorporated. Work in this area was summarised in a 
recent review by Kuzuya and Ohya.38 
 
Of particular significance to the area, is the work of Turberfield. He has created 
an array of devices utilising DNA as both a nanostructure, but also as a fuel to 
run systems.35,39–42 This technology has been used to make DNA walkers which 
follow specific set routes on a course.42 Nir and co-workers have used the same 
approach to create a bipedal motor which can travel backwards and forwards 
between two DNA “tiles”.43 
 
In 2014, Du and co-workers reported on the use of DNA nanostructures as drug 
delivery vehicles to cancerous tumours.44 Several DNA origami structures were 
made and loaded with an intercalating, anti-cancer drug. The authors found that 
the biodistribution of the nanostructures was dependent upon the shape of the 
DNA origami. In this case, a triangle was found to display the best localisation 
properties for the tumour. The release of the anti-cancer drug was achieved by 
utilising the naturally more acidic environment of the tumour. This increased the 
release by 15% when compared to physiological conditions.44 
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1.4.2 Modifying Proteins 
Proteins are often modified with fluorophores, like DNA, to allow for detection 
within systems. In addition to this, they are routinely reacted with functional 
groups that allow for crosslinking and immobilisation.45,46 These modified 
proteins can then be used to study the association of proteins, control processes 
and develop sensing assays. As with DNA, various routes of modification have 
been developed for proteins. The backbone of the structure, along with the side 
chains of amino acids can be modified, and these are explored below. 
 
1.4.2.1 Side Chain Modifications 
The most widely used route to modify proteins, is to react amine or thiol 
containing amino acids side chain with reactive molecules, which are attached to 
the desired functionality.12 These derivatives comprise of the reactive component, 
which targets the side chain of interest, a linker and the modification to be 
incorporated. Typically, maleimides and idoacetamides are used to target thiols 
and succinimides are used to target amines, Figure 1.11.47 Thiols are particularly 
attractive to target due to their low abundance within proteins. This allows for a 
more controlled incorporation of the derivative of interest. 
Chapter 1 – Introduction – The Use of Anthracene within Biomolecules 
 18 
In addition, unnatural amino acids (UAAs) can be incorporated into structures. 
This has been demonstrated using standard peptide synthesis as well as in 
vitro.48,49 Hundreds of derivatives have been made with side chains that 
incorporate fluorescent groups,50 entities for conjugation51 and redox-active 
groups.52 
 
Crosslinking of proteins is of particular relevance to the work within this thesis. 
This is routinely done using the reactive groups shown in Figure 1.11. Two of the 
reactive groups are joined together and each end is reacted with the protein of 
interest. A common reagent used for this is succinimidyl trans-4-
(maleimidylmethyl)cyclohexane-1-carboxylate (SMCC), Figure 1.12. 
Figure 1.11 Common reactive groups used to derivatise proteins. Maleimides and idoacetamides target thiols 
and succinimides target amines. 
Figure 1.12 Chemdraw structure of SMCC, a crosslinking agent routinely used with proteins. The succinimide 
part of the molecule (left) reacts with amines and the maleimide part (right) reacts with thiols. 
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Aryl azides are an alternative approach. These derivatives, when excited with 
UV light, react with nucleophilic groups in close proximity. In addition, peptide 
stapling can be use. By using modified amino acids, which can react with an 
additional modified residue, the peptide can be “stapled” into a particular 
structure.53 
 
1.4.2.2 Backbone Modifications 
The peptide backbone has also been modified. A whole array of modifications 
have been incorporated with various objectives, including allowing for molecular 
recognition and increasing cell penetration. However, so far, no derivatives have 
become as widely used as those developed for DNA, with many hindered in their 
folding ability compared to natural peptide structures.54–56 
 
Of particular note is the work performed by Horne et al. in 2004. They 
incorporated a triazole amino acid derivative into a peptide, Figure 1.13. It was 
shown that a peptide containing this modification at one site, could still fold into 
the native coiled coil structure. This modification is the same as would be present 
if two groups were joined using click chemistry, and the group therefore proposed 
that this modification could be used to link peptide chains.57 
 
 




Incorporation of anthracene into biomolecules could have many uses, being a 
fluorescent unit and able to dimerise upon irradiation with UV light. Other 
fluorophores are available, many of which emit at more biologically compatible 
wavelengths and that have higher quantum yields.58,59 However, anthracene is 
the only molecule that displays fluorescence within the visible spectrum that can 
also dimerise upon irradiation, making it a useful tool for incorporation. 
 
Anthracene is an organic molecule comprised of three benzene rings fused in a 
planar structure, Figure 1.14A. It is a fluorescent molecule that emits in the blue 
region. Examples of absorption and emission spectra are shown in Figure 1.14B. 
Figure 1.13 The triazole derivative (B) used in the work of Horne et al. to modify the peptide backbone shown 
with the comparative unmodified linkage (A). 
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In addition to this property, anthracene is known to form photodimers when 
irradiated with UV light (around 365 nm), Figure 1.15. This process forms a 
mixture of head-to-head (H-H) and head-to-tail (H-T) orientations. The 
photodimer product can be reverted to the monomers, by heating or irradiation 
with light < 300 nm.60–62 
Tracking of photodimer formation can be easily achieved by monitoring the 
absorbance and fluorescence bands shown in Figure 1.14B. These bands arise 
from the π  π* transitions of the extended conjugated system. Upon photodimer 
Figure 1.15 A) Chemdraw structure of anthracene and B) its characteristic absorbance (between 300 – 400 nm, 
black) and fluorescence (between 400 – 500 nm, grey) spectra in 100 mM sodium phosphate buffer at pH 7. 
 
Figure 1.14 Anthracene undergoes a 4π+4π pericyclic addition upon excitation with UV light to form 
photodimer products with either head-to-head or head-to-tail conformations. The dimer species can be 
reverted to monomers, by heating or irradiation with a shorter wavelength of light. 
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formation this conjugation is reduced and therefore the characteristic anthracene 
bands are no longer observed. 
 
1.5.1 Uses of Anthracene within Supramolecular Chemistry 
The photochemical properties of anthracene have been utilised extensively within 
the supramolecular community. Beyeler et al. described the development of a 
molecular switch using anthracene units as the “switching” entity and a metal 
binding centre as a fluorescence output. In the monomer forms, the anthracene 
units quench fluorescence from the bipyridine-metal complex, Figure 1.16. Upon 
photodimerisation the extended π system is removed and therefore the quenching 
pathway is no longer available and fluorescence is observed.63 
Figure 1.16 Molecular switch developed by Beyeler et al. comprised of anthracene units attached to a 
bipyridine metal binding ligand. Upon irradiation the photodimer product forms, removing the quenching 
pathway and fluorescence is observed.  
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Jin demonstrated the use of anthracene to control Na+ transport across a 
phospholipid bilayer in 2000.64 A calix[4]arene ester, a known carrier of Na+ 
across membranes, was modified with anthracene units. Prior to exposure to UV 
light, it was shown that the modified derivative was still able to transport the 
sodium ion across the membrane, however, upon photodimerisation this was 
inhibited. McSkimming et al. demonstrated a similar principle using an aza-
crown ether.65,66 
 
The Tucker group have also utilised an anthracene photo-switch within a 
Hamilton receptor.67,68 As with the above examples, prior to photodimerisation 
the guest molecule can bind to the host, however, upon irradiation, the 
photodimer forms and the guest can no longer bind, Figure 1.17A. This system 
has also been show to work on a gold surface which will enable a reusable sensor 
to be developed.69 Of particular note in these examples, is that the anthracene 
photodimer formation closes the ring structure. The group has gone on to utilise 
this property to form a rotaxane by closing the ring using anthracene 
photodimerisation, Figure 1.17B.70 The system utilises the Hamilton receptor, 
with the barbiturate guest acting to preorganise the “thread” within the 
rotaxane. Bulky groups incorporated onto the thread prevent the rotaxane 
“slipping off”. The group were able to demonstrate cycling of the system with a 
recovery rate of over 80% per cycle. 
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1.5.2 Uses of Anthracene within Polymers 
In addition to small molecule work, anthracene has been utilised within polymer 
systems. Goldbach et al. first demonstrated the potential use of anthracene 
photodimerisation in polymers in 2002.71 They incorporated an anthracene 
derivative on to two polymer building blocks. These units could then be linked 
together by irradiation with UV light to make a “diblock”. Subsequent thermal 
release by heating to cause the reversion of the anthracene photodimer was 
achieved, demonstrating the potential polymer breakdown that the system could 
be utilised for. Unfortunately it was considered that this system could not be 
Figure 1.17 Supramolecular systems using anthracene photodimerisation. A) A Hamilton receptor incorporating 
anthracene moieties. Upon photodimerisation the guest molecule is released. B) Anthracene 
photodimerisation has been used to form a rotaxane from a Hamilton receptor formed around a thread 
molecule, which is held in place by a barbiturate guest. Adapted with permission from Tron et al., J. Org. Chem., 
2015, 80, 988-96. Copyright 2015 American Chemical Society. 
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cycled due to the formation of homodimer products upon irradiation of the 
samples.71 
 
A potential use of these systems was demonstrated by Wells et al. in 2011.72 The 
group utilised a hydrogel, which had anthracene moieties appended to the 
polymer structure. The gel was soaked in a solution containing a model 
compound, which was absorbed into the gel structure. The samples were then 
exposed to UV light to induce the photodimer formation of anthracene, which 
resulted in the release of the compound from the gel. Although the compound was 
successfully released, the additional amount released when compared to samples 
not exposed to light, is modest. However, the group proposed this technology 
could be used to release drug molecules at specifically irradiated sites.72 
 
In recent years, more elegant work has been performed to produce photo-patterns 
using anthracene modified polymers.73 By shielding the polymer with a metal 
template, only certain regions of the sample are exposed to UV irradiation and, 
therefore, only these regions form the photodimer product. This was then 
visualised using polarised light, which showed the difference between the 
amorphous photodimer and the ordered unirradiated phase, Figure 1.18. 
Subsequent heating to 220 °C reverted the photodimer to monomer species and 
the sample returned to its crystalline state. This process was found to be 
repeatable over several cycles.73 
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Prior to these examples, anthracene had been incorporated into polymer systems 
as a fluorescent reporter. The groups of Pekcan, Winnik and Nuyken used the 
fluorescence of anthracene to monitor changes in polymer structure and swelling 
under particular conditions.74–76 Wang et al. utilised the fluorescence output to 
monitor the structure of a gel which could be changed using anthracene 
photodimerisation.77 Although in the system used, a gel also formed prior to 
irradiation, the group were able to show that photodimer formation resulted in a 
change to the polymer structure, and was accompanied by a decrease in 
fluorescence as the photodimer product formed.77 
Figure 1.18 Examples of the photo-patterns that can be achieved using anthracene photodimerisation to 
crosslink polymers. The metal templates (left) are placed over the polymer sample, shielding areas from 
irradiation which therefore do not form photodimer species. Upon imaging with polarised light (right) the 
regions where photodimer has formed are easily distinguished from the crystalline monomer species. 
Reprinted with permission from Kihara et al., ACS Appl. Mater. Interfaces, 2013, 5, 2650-7. Copyright 2013 
American Chemical Society. 
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1.5.3 Uses of Anthracene within Biomolecules 
Anthracene has also been incorporated into biomolecules to utilise its 
photochemical properties. It was first incorporated into phospholipids in 1984 to 
study the distribution of lipids in a bilayer. By using the photodimerisation 
properties of anthracene it could be established which phospholipids were in close 
proximity to one another in a liposome. The group also used anthracene 
fluorescence, to monitor the formation of the liposomes from the phospholipids.78 
They subsequently went on to demonstrate the use of the system in live 
bacteria.79 More recently, anthracene has been utilised within an alginate system 
to create a photosensitiser, which the authors believe could find applications in 
sensitising organic reactions and in the development of sensors.80 
 
1.5.3.1 Anthracene within DNA 
Anthracene was first incorporated into DNA by Nakano and co-workers in 1995. 
The group attached an anthracene unit onto the 2 position of the sugar of a 
uridine phosphoramidite. Incorporation into an oligonucleotide allowed the group 
to show that duplex formation was still possible with the modification, and this 
was accompanied by an increase in anthracene fluorescence intensity.81 
Mortensen and co-workers reported on the synthesis of a unit in which the base 
of the phosphoramidite was replaced with anthracene, however, they did not go 
on to incorporate this into DNA.82 
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Jyo and colleagues took an alternative approach, attaching anthracene 
derivatives onto the ends of two short oligonucleotides. They then utilised the 
photodimerisation properties of anthracene, to link the oligonucleotides together. 
Upon binding to a template strand of DNA (comprised of complementary bases of 
the two oligonucleotides), the anthracene units were placed in close proximity to 
one another and UV irradiation afforded the linked product, Figure 1.19.83,84 This 
strategy has also been used within locked nucleic acid (LNA) systems.85 
By incorporating the anthracene moieties into the same strand of DNA, Arslan et 
al. were able to “lock” DNA into a circular structure. The strand was first 
preorganised on a template so as to place the anthracene moieties into close 
proximity. This was done using a triplex forming sequence, Figure 1.20.86 
 
 
Figure 1.19 Work by Jyo and co-workers has focussed on linking two short oligonucleotides together using 
anthracene photodimerisation. The short oligonucleotides are preorganised on a template strand of DNA. 
Irradiation with UV light affords the crosslinked product. Adapted with permission from Mukae et al., Org. 
Biomol. Chem., 2009, 7, 1349-54. Copyright 2009 Royal Society of Chemistry. 
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Tucker and co-workers utilised a similar approach to the early examples of 
anthracene incorporation, by replacing a base in the oligonucleotide sequence 
with an anthracene derivative. Anthracene was attached via a carbon chain 
linker to a serinol and phosphate backbone unit, which could be incorporated into 
DNA.25 Later developments replaced serinol with threoninol to allow for control 
over the stereochemistry of the unit. These derivatives have been utilised as 
fluorescent sensors within DNA, as discussed in detail in Chapter 3. 26,87 
 
In addition to using anthracene fluorescence, the group have also utilised the 
photodimerisation properties of anthracene. Two anthracene moieties were 
incorporated into the same strand of DNA and, upon irradiation, the photodimer 
product was shown to bend the DNA and prevent binding to a complementary 
strand. However, duplex formation to the complementary strand prior to 
irradiation, prevented the photodimer formation and therefore a gated 
photochromic system was developed, Figure 1.21.88 
Figure 1.20 Schematic diagram of the formation of circular DNA using anthracene photodimerisation. The 
anthracene tagged strand is preorganised onto a template strand. Upon irradiation an anthracene photodimer 
is formed. Reprinted with permission from Arslan et al., Org. Biomol. Chem., 2010, 8, 4843-8. Copyright 2010 
Royal Society of Chemistry. 
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Saito et al. have also worked to utilise anthracene fluorescence by attaching 
anthracene to uridine (Figure 1.22). On incorporation in DNA, they demonstrated 
the use of the fluorescence output to identify errors in a complementary sequence 
of DNA. This is discussed in more detail in Chapter 3.89 Brown and co-workers 
adopted a similar approach using a thymine base.90 
 
Figure 1.21 Anthracene units were incorporated into an oligonucleotide. Upon photodimer formation, a 
change in conformation of the DNA was induced which prevented duplex formation with a complementary 
strand of DNA. However, prior duplex formation prevented the reaction of the anthracene units, revealing a 
gated photochromic system. Adapted with permission from Manchester et al., J. Am. Chem. Soc., 2012, 134, 
10791-4. Copyright 2012 American Chemical Society. 
  
Figure 1.22 Chemical structure of the anthracene unit incorporated into DNA by Saito et al. for the detection of 
errors in DNA sequences. 
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1.5.3.2 Anthracene within Proteins 
The use of anthracene within proteins and peptides has been very limited. There 
are a few examples that use the fluorescent output of small anthracene 
derivatives to study proteins.13,91–94 However, to the best of my knowledge, there 
is only one example in the literature to attach an anthracene unit to a peptidic 
structure.95 Within this example 9-carboxylic acid anthracene was coupled to the 
side chain of a lysine residue within a peptide expected to bind to DNA in an α 
helical conformation.95 The group went on to assess the effect of adding PNA 
bases to the end of the peptide in the hope that this will increase the DNA 
binding affinity. The anthracene moieties acted as reporter groups, displaying 
changes in absorbance, fluorescence and CD signals upon binding to DNA.95 
 
1.6 Project Aims 
The work presented in this thesis aims to explore the use of anthracene within 
biomolecules, utilising both the fluorescence and photodimerisation properties it 
possess. 
 
Anthracene fluorescence has previously been shown to allow for the detection of 
base identity at a SNP site.25,87 This technique is to be further explored within a 
sequence associated with Alzheimer’s disease. Several different anthracene 
probes will be synthesised and the fluorescence properties analysed. The optimal 
stereochemistry and linker length will then be used to assess the application of 
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the assay to quantify ratios of two possible bases at a SNP site. This assay would 
allow for quantitative determination of the bases that are present within a 
sample. In addition to this, the probes will be analysed in a different sequence to 
establish if they can be used to distinguish between guanine and the 8-oxoG 
modified base. 
 
Anthracene will also be incorporated into a transcription factor that is known to 
bind to DNA as a homodimer. The incorporation will be made so as to replace the 
natural dimerisation region within the protein. The affect this incorporation has 
upon DNA binding will be assessed, utilising anthracene fluorescence amongst 
other techniques. Upon irradiation, the anthracene units are proposed to 
dimerise, but only when bound to the target DNA sequence and therefore 
brought into close proximity. The photodimerisation will in turn increase the 
DNA binding affinity. The reversibility of the system will also be analysed in 
order to develop a photo-switched peptide binding system. 
 
Anthracene photodimerisation will be further explored within DNA structures. 
By incorporating anthracene units within a sequence capable of forming a 
hairpin structure, dimerisation is expected to induce the hairpin formation, and 
release the complementary strand of DNA. Several systems will be explored in 
order to optimise the amount of release achieved and the reversibility of the 
systems assessed. Incorporation of anthracene into a G-quadruplex is also 
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reported within the thrombin binding aptamer (TBA). Incorporations of two 
anthracene entities at various positions on the aptamer will, upon 
photodimerisation, stabilise or destabilise the structure depending upon where 
the incorporations are made. This will affect the folding of the structure and also 
the binding to the target protein. The reversibility of the process will be assessed 
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Within this chapter the techniques used during the course of this work are 
presented. These will include solid-phase oligonucleotide synthesis, detailing 
anthracene incorporation and solid-phase peptide synthesis, followed by the 
purification and characterisation of these, as well as analytical techniques; 
ultraviolet-visible spectroscopy (UV-Vis), fluorescence spectroscopy, circular 
dichroism spectroscopy (CD), high performance liquid chromatography (HPLC), 
mass spectrometry (MS) and gel electrophoresis. 
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2.2 Oligonucleotide Synthesis 
Over the past 60 years oligonucleotide synthesis has progressed from using 
standard organic chemistry techniques to using automated synthesisers that can 
produce long sequences of DNA.1,2 The advancement in the methodology was 
pioneered by Caruthers and co-workers, utilising a reactive phosphoramidite to 
build the oligonucleotide chain in a series of steps; deprotecting the previous unit, 
coupling the new monomer, oxidising the phosphate group and repeating.1,3,4 By 
ensuring all side chains are protected, and the main chain is protected until it 
needs to be coupled, the sequence can be made with a high specificity. The main 
chain is protected using an acid labile group, whilst the bases are protected with 
base labile groups. This ensures the removal of the correct groups and is known 
as orthogonal protection. The amine on the base is protected with benzoyl on 
adenine, an acetyl on cytosine and an isobutyryl on guanine (thymine is not 
protected as it does not have a primary amine group). The alcohol group on the 5′ 
of the sugar is protected with a dimethoxytrityl (DMT) group. 
 
Oligonucleotides are synthesised in the 3′ to the 5′ direction. The synthesis is 
performed using a solid support which normally incorporates the initial base, 
typically using a controlled pore glass (CPG) bead. In the first step of the 
synthesis, the DMT protecting group is removed to expose the primary alcohol 
using trichloroacetic acid (Figure 2.1, step 1). The DMT cation liberated in this 
step is orange in colour and by measuring the absorbance at 498 nm, an 
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indication of the deprotection efficiency can be determined, which in turn can be 
an indication of the yield of the synthesis, allowing for step-by-step tracking of 
individual coupling yields. The next step is to attach the subsequent base in the 
sequence. The base is activated with 5-(ethylthio)-1H-tetrazole (ETT) and coupled 
to the available alcohol (Figure 2.1, steps 2 and 3). Any unreacted sequences are 
then capped with an acetyl group (Figure 2.1, step 4), to prevent sequences with 
deleted bases being synthesised, allowing for greater ease of subsequent 
purification. Finally, the phosphite is oxidised to a phosphate using iodine. The 
whole cycle is then repeated with the next base in the sequence and continues 
until the desired oligonucleotide sequence is complete. It can then be cleaved 
from the resin with aqueous ammonia and the protecting groups on the bases are 
then removed by heating in the same solution. The cleaved and deprotected 
oligonucleotides are purified by reversed-phase high performance liquid 
chromatography (RP-HPLC) which is described in Section 2.5.5,6  
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Figure 2.1 Solid-phase oligonucleotide synthesis cycle. Step 1 – removal of the DMT protecting group of the 
alcohol, Step 2 – Activation of the phosphoramidite for coupling, Step 3 – Coupling of the new phosphoramidite 
to the chain via the newly exposed alcohol, Step 4 – Capping of any unreacted alcohol groups, Step 5 – 
oxidation of the phosphite group. These 5 steps are repeated until the desired sequence has been made. The 
oligonucleotide can then be cleaved from the resin and the side chains deprotected (Step 6). 
 
 
2.3 Anthracene Incorporation into Oligonucleotides 
Phosphoramidites with an anthracene moiety in the place of the DNA base have 
been synthesised and successfully incorporated into oligonucleotides within the 
literature. A full discussion of the development of the synthetic procedures has 
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been previously reported;7,8 a description of the currently used method is outlined 
below. 
 
The anthracene is incorporated via the oligonucleotide backbone so as to replace 
one base (Figure 2.2). A variety of linker lengths to the anthracene, as well as L- 
and D-stereochemistries, have previously been made. Within these studies, 
linkers of 1 and 3-7 carbons were used with both L- and D-stereochemistries.  
 
The synthesis starts from anthrone, which is reacted with a bromo ethyl ester, 
this specifies the length of the carbon chain, and reacts with the anthrone via a 
base-induced nucleophilic substitution, Figure 2.3. Subsequent saponification 
yields the carboxylic acid, which can then be reacted with threoninol to form an 
amide bond with activation from N,N,N′,N′-tetramethyl-O-(1H-benzotriazol-1-
yl)uronium hexafluorophosphate (HBTU) and N, N-diisopropylethylamine 
(DIPEA). The threoninol linkage is chosen with the stereochemistry desired for 
the final product. The primary alcohol is then protected with a DMT protecting 
Figure 2.2 Comparison of the Tucker group probe (right) to natural DNA (left). Anthracene is incorporated into 
the oligonucleotide to replace one base. A threoninol linker (green) is used to control the stereochemistry and 
the length of the carbon linker (red) can be altered to control the position of the anthracene (orange). 
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group and the secondary alcohol is phosphytilated ready for solid-phase 
oligonucleotide synthesis, as discussed in Section 2.1. Full experimental 
conditions and characterisation have been previously reported7,8 and can also be 
found in the experimental section (Chapter 8.2). 
 
2.4 Peptide Synthesis 
As with oligonucleotide synthesis, peptide synthesis is currently performed on a 
solid-support using chemistry initially developed by Merrifield.9 Within these 
studies rink amide 4-methylbenzhydrylamine (MBHA) resin was used, although 
many alternatives are available. The peptide is synthesised from the C-terminus 
towards the N-terminus. The resin is first deprotected to remove the 
fluorenylmethyloxycarbonyl (Fmoc) group on the amine using piperidine (Figure 
2.4, step 1). The first amino acid in the sequence can then be coupled. This amino 
Figure 2.3 Synthesis of anthracene phosphoramidites for subsequent incorporation into DNA. 
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acid contains an Fmoc protected amine, as well as side chains protected with acid 
labile groups where appropriate, and is coupled upon activation from HBTU and 
DIPEA (Figure 2.4, step 2). The cycle can then be repeated by removing the Fmoc 
group from the coupled amino acid, followed by coupling the subsequent amino 
acid in the sequence. This cycle is repeated until the desired sequence has been 
completed. It is important to completely rinse the resin between each step so as 
to ensure that the previous reagents have been removed, for the step-by-step 
synthesis to work efficiently. Following Fmoc deprotection, the N-terminus is 
then capped with an acetyl group and the peptide cleaved from the resin with 
trifluoroacetic acid (TFA). The acid concomitantly deprotects the side chains of 
the amino acids. The peptides are then purified using RP-HPLC (Section 2.5).10,11 
 
Figure 2.4 Solid-phase peptide synthesis (SPPS) cycle showing the deprotection of the main chain amine (step 
1) followed by the coupling of the subsequent amino acid (step 2). These are repeated until the desired peptide 
has been made. The exposed amine is then capped (step 3) and the peptide cleaved from the resin (step 4). 
Side chain deprotection is also achieved in this step. 
 
Within these studies anthracene is incorporated into the peptide via a lysine side 
chain. Details of this can be found in Chapter 4.4.1. 
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2.5 Reversed-Phase High Performance Liquid Chromatography 
High performance liquid chromatography (HPLC) is a technique used to separate 
molecules according to their interaction with a solid-phase and a mobile phase. 
Traditionally a polar stationary phase (i.e. silica), which is packed into a column, 
is used with a non-polar mobile phase (i.e. chloroform). High pressure is applied 
to the column, forcing the mobile phase, and the dissolved compounds being 
analysed, to move through and the latter to separate according to the affinity 
they have with the stationary phase. Non-polar compounds interact with the 
stationary phase the least and hence are eluted first. The eluent is monitored by 
recording its optical properties (i.e. UV-Vis absorbance or fluorescence) and peaks 
can be seen when an analyte, which absorbs at the monitored wavelength, elutes. 
The technique can be used on a preparative or an analytical scale, dependent 
upon the size of the column used and the amount of material being loaded.12,13 
 
With RP-HPLC the stationary phase is made to be non-polar by coating the silica 
particles with hydrocarbons. A polar mobile phase is then used (i.e. water). This 
method is well suited for more hydrophilic molecules such as oligonucleotides and 
peptides, and typically results in the most hydrophilic molecules being eluted 
first, although size can also play a factor. Since pH can alter the hydrophobic 
character of the compounds being analysed, the pH of the mobile phase is 
controlled. The work reported herein uses 0.1 M triethylammonium acetate 
(TEAA) at pH 7 to separate oligonucleotides and 0.05% trifluoroacetic acid at pH 
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2 to separate peptides, using a water and acetonitrile mobile phase. The 
separation can be performed using either an isocratic method (i.e. the eluting 
solvent is kept constant throughout the separation) or a gradient method in 
which the amount of polar solvent is increased during the run. Combinations of 
these two methods can also be used, to achieve optimum separation.13,14 
 
2.6 Mass Spectrometry 
Mass spectrometry is the technique used to determine the molecular weight of 
components within a sample and is the primary characterisation technique used 
for peptides and oligonucleotides. The technique works by ionising the sample 
and then detecting the ions formed, by separation according to their mass to 
charge ratio. All studies reported herein used a time of flight (TOF) detector. In 
this detection method, all ions are accelerated so that they all have the same 
kinetic energy. The time taken for the ions to reach the detector is then recorded, 
with lower mass species reaching the detector first.15 A variety of techniques for 
ionising the compounds are available, however, within these studies electrospray 
(ESI) and matrix assisted laser desorption ionisation (MALDI) were used. 
 
The ESI technique uses a fine nozzle with an electrical current supplied over it. 
The analyte is sprayed through the nozzle causing an aerosol to form and the 
compounds to be ionised. This technique is a soft ionisation method and typically 
gives multiply charged species for large biomolecules.15 The fragmentation can be 
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controlled using the cone voltage, an increase in this results in more 
fragmentation.16 
 
MALDI is an ionisation technique predominantly used for biomolecules. It works 
by firing a laser at the sample which is co-crystallised with a matrix. The matrix 
compounds are typically charged acids, which are strongly absorbing in the UV 
region to efficiently absorb the energy from the laser and transfer ionisation to 
the sample. The matrix is ionised by the laser and causes secondary ionisation of 
the sample. This technique gives rise to singly charged ions of the analyte, with 
very little fragmentation, making it an ideal technique for large biomolecules.15,16 
 
2.7 Ultraviolet Visible Spectroscopy 
Ultraviolet visible (UV-Vis) spectroscopy is an optical technique used to 
determine the absorbance profile of a compound. Upon light irradiation, electrons 
within a molecule can absorb the energy and become excited, moving from the 
highest occupied molecular orbital (HOMO) to a higher unoccupied molecular 
orbital. The extent of light absorbed at different wavelengths is recorded by the 
spectrophotometer to give an absorbance value as described in equation 2.1. 
𝐴 =  𝑙𝑜𝑔 (
𝐼0
𝐼
)                                                             𝐸𝑞 2.1 
Where A is absorbance, I0 is the intensity of incidence light and I is the intensity 
of light transmitted to the detector. 
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For a given compound, the absorbance is related to the concentration of the 
compound in the solution being measured, the pathlength the light needs to 
travel through the solution, and the extinction coefficient of the compound at a 
specific wavelength, as described by the Beer Lambert Law, shown in equation 
2.2.  
𝐴 = 𝜀𝑙𝑐                                                                  𝐸𝑞 2.2 
Where A is absorbance, Ɛ is the extinction coefficient of the compound in a 
specific solvent, l is the sample path length and c is the concentration of the 
compound in solution.17 
 
For peptides and oligonucleotides, the above relationship between concentration 
and absorbance is routinely used to determine an accurate concentration of 
solutions. Classical methods of weighing the material and dissolving in a known 
volume are not adopted herein, due to the small quantities of compound used and 
the tendency of the compounds to contain salts and water, making the theoretical 
molecular weight unreliable for use in concentration calculation. Within this 
study a variety of ways to determine the concentration optically were used and 
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2.7.1 Oligonucleotide Concentration Determination 
The concentration of oligonucleotides are routinely determined at 260 nm where 
the bases π  π* transition is observed. The most commonly accepted method for 
determining the extinction coefficient at this wavelength is the nearest-neighbour 
model, which takes into account the effect of the neighbouring bases upon one 
another.18,19  
 
Anthracene is known to absorb at 260 nm and hence contributes to the 
absorbance value obtained. Duprey has previously calculated the extinction 
coefficient for the anthracene molecules used herein to be 51 444 M-1 cm-1 at 260 
nm in aqueous solution at pH 7.8 In order to accurately determine the extinction 
coefficient of anthracene containing sequences, the extinction coefficient of the 
flanking regions of the anthracene were calculated independently of one another 
and the total calculated by the sum of all three components.  
 
2.7.2 Peptide Concentration Determination using Anthracene 
Unmodified peptides are usually quantified using the absorbance of aromatic 
amino acids such as tryptophan, tyrosine and phenylalanine.20 Free thiols on 
cysteine residues can also be quantified and the peptide concentration 
determined from this. The latter can be performed using an Ellman’s assay.21 A 
solution of 5,5’-dithiobis-(2-nitrobenzoic acid) (DTNB) reacts with free accessible 
thiols in a 1:1 ratio to produce 2-nitro-5-thiobenzoate, which is a yellow molecule 
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with known absorbance properties (Ɛ412 nm = 14 150 M-1 cm-1).22 The absorbance is 
measured and hence the concentration determined. Due to the exposed thiol on 
the peptide reacting with DTNB, this method is sacrificial. 
 
The peptide used in these studies does not contain the standard amino acids used 
for quantification, however, it is possible to take advantage of the absorbance 
properties of the anthracene that has been attached. Anthracene has a strong 
absorbance at 253 nm and weaker absorbance’s between 300 – 400 nm, as 
discussed in Chapter 1.5. Due to a slight absorbance of the peptide within the 253 
nm region it was decided that the peptide concentration would be determined at 
375 nm for more accuracy, using the extinction coefficient of 6 300 M-1 cm-1 for 
free anthracene in aqueous solutions pH 7.23 
 
2.7.3 Thermal Melting of DNA 
A routine method for the measurement of the relative stability of duplex DNA 
and folding of single stranded DNA is thermal melting analysis to deduce the 
melting temperature (Tm), typically tracked by measuring the change in UV-Vis 
absorbance as a function of temperature. DNA bases are known to display a 
stronger absorbance when in the single stranded form, compared to a double 
stranded system.24,25 This is referred to as the hyperchromic effect and has been 
attributed to several causes, which have recently been summarised in a book by 
McLaren and Shugar.26 By measuring the increase in absorbance as a sample is 
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heated, the transition from double stranded to single stranded DNA can be 
monitored, Figure 2.5. This transition occurs at a higher temperature for more 
stable duplexes i.e. those with more base pairs, and for more G-C rich sequences, 
due to the larger number of hydrogen bonds they contain. The Tm value is taken 
as the temperature at which the first derivative of the absorbance signal displays 
its maximum intensity. 
 
Within the studies presented herein, 5 ramps are performed for each Tm 
measurement. Ramps 1, 3 and 5 are dissociation ramps, i.e. heating, and ramps 2 
and 4 are annealing, i.e. cooling. The Tm value is only taken from the dissociation 
ramp data, while a temperature of association, Ta can be obtained from the 
association ramps. These values normally display slight differences due to the 
mechanisms of annealing and denaturing. 
 
Figure 2.5 Schematic of a thermal melting curve showing the increase in absorbance as a function of 
temperature (___), the first derivative (…..) and the point at which the Tm value would be taken. 
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The Tm of an oligonucleotide is heavily dependent upon the sequence of the DNA, 
as this is directly correlated to the hydrogen bonds formed and the π-stacking of 
the system. Due to this, systems are also affected by mismatches in the DNA 
sequence and intercalation between the bases.27,28 
 
Furthermore, thermal melting transitions are influenced significantly by the 
salts within the sample. Hard cations within the solution are known to stabilise 
the DNA duplex, by acting as a counter ion for the negative phosphate backbone. 
Altering the concentration or type of ions will alter the Tm value obtained. A 
change in the pH can also alter the Tm, as this will alter the hydrogen bonding 
propensity of the base pairs. For these reasons values are only directly 
comparable to samples performed under the same buffer and salt conditions.29 
 
2.8 Fluorescence Spectroscopy 
In fluorescence spectroscopy, light of a particular wavelength is used to excite 
electrons in the molecule into a higher energy electronic state. As these electrons 
relax back to the ground state, light can be emitted (Figure 2.6) and this emission 
of light is recorded within the technique. The term fluorescence only applies to 
light emitted resulting from an electron returning to the ground state from an 
excited singlet state. It is also possible for a similar process to occur from an 
excited triplet state, termed phosphorescence, which is not relevant to these 
studies.23 
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Several values can be determined from fluorescence data, including quantum 
yields, a measure of how many of the excited molecules decay by fluorescence; 
and lifetimes of fluorescence, which can indicate quenching pathways of the 
excited state.23 
 
2.9 Circular Dichroism Spectroscopy 
Circular dichroism (CD) spectroscopy is a technique widely used to study the 
secondary structure of biomolecules. It works by measuring the difference in 
absorbance of left handed and right handed circularly polarised light, to give an 
ellipticity value. Chiral molecules, by their nature, will absorb the different 
helices of light by varying amounts, allowing them to be studied.30 In addition to 
Figure 2.6 Jablonski diagram displaying the electronic excitation of an electron from the ground state (S0) to an 
excited singlet state (S1). As the electron returns to the ground state, light of a lower energy (higher 
wavelength) is emitted which is termed fluorescence. 
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chiral centres, DNA and proteins fold into organised structures which can also 
absorb a preferential direction of polarised light at various wavelengths. 
 
It is known that B-DNA displays a characteristic CD signal of a positive band 
centred at ~275 nm and a negative band ~240 nm. A-DNA, a more compacted 
version of B-DNA in which the bases are more tilted, is shown by a positive 
signal centred at 260 nm and a negative band centred at 210 nm. Z-DNA, a left 
handed helix, is characterised by a weak negative band at 290 nm, a weak 
positive band at 280 nm and a large negative band between 220-280 nm.30,31 
Examples of these spectra are shown in Figure 2.7. 
Figure 2.7 Schematic representation of the CD signals displayed by B-, Z- and A-DNA. Reprinted with permission 
from Dodero et al., Front. Biosci., 2011, 16, 61-73. Copyright 2011 Frontiers in Bioscience.  
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Proteins and peptides can also be studied using this method, and the transitions 
displayed from them are much better understood than with DNA. As with DNA, 
characteristic bands are displayed for the secondary structures found within 
proteins, Figure 2.8.30,32 The ellipticity values that are obtained are routinely 
converted to molar ellipticity values per residue (Equation 2.3) to allow for easier 
comparison between systems.33 
𝜃𝑚 =  
𝜃
10 ×  𝑙 ×  𝑐 ×  𝑁𝑎
                                                         𝐸𝑞 2.3 
Where θm is the molar ellipticity value, θ is the measured ellipticity, l is the 
pathlength of the sample in cm, c is the concentration in M and Na is the number 
of amino acids present. 
Figure 2.8 Schematic representation of the CD profiles obtained from various protein structures, α-helix (____), 
β-sheet (__ __ __), β-turn (……...) and random coil (-----). Reprinted with permission from Johnson et al., Proteins., 
1990, 7, 205-14. Copyright 1990 Wiley-Liss, Inc. 
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In addition to this qualitative evaluation, quantitative information can be 
obtained from CD measurements of proteins. For α-helical systems the 
percentage folding can be obtained using Equation 2.4.34–36 
 
% 𝑓𝑜𝑙𝑑𝑖𝑛𝑔 =  (
𝜃𝑚 − 𝜃𝑐
𝜃ℎ − 𝜃𝑐
) × 100                                          𝐸𝑞 2.4 
Where θc is the mean residue ellipticity of a random coil (+640 deg cm2 dmol-1) 
and θh is the mean residue ellipticity of a complete helix as described by Equation 
2.5.  
𝜃ℎ = −42500 × (1 − (
3
𝑛
))                                                𝐸𝑞 2.5 
Where n is the number of amino acid residues. 
 
2.10 Gel Electrophoresis 
Gel Electrophoresis is a technique used to study biomolecules, which separates 
species dependent upon their size, shape and charge. A gel is made with either 
polyacrylamide or agarose, and an electrical current is applied across the gel. 
Molecules move through the gel towards the positive electrode, separating 
depending upon their size, fold and charge. Highly charged molecules move faster 
through the gel due to the increased attraction to the electrode. Small molecules 
also move faster, as they are more freely able to move through the small pores in 
the gel. Once the run is complete the molecules can be visualised by various 
techniques and the gel imaged.37,38 
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A variety of techniques have been developed to study proteins, DNA and the 
interactions of molecules with DNA. Those used within these studies are 
discussed below. 
 
2.10.1 DNA Gel Electrophoresis 
DNA is a highly charged molecule, making it amenable to gel electrophoresis 
studies. Samples can be loaded onto the gel and, due to the highly negatively 
charged backbone of DNA, the species migrate towards the positive electrode. As 
oligonucleotides are considerably smaller than typically analysed DNA 
fragments, adaptions have to be made to the method to allow the smaller species 
to be successfully separated and analysed. This is achieved by increasing the 
percentage of acrylamide used in the gel and hence decreasing the pore size and 
restricting the flow of the molecules through the gel. 
 
There are two types of gel used within these studies to analyse oligonucleotides; 
native and denaturing. A native gel maintains secondary structure and 
interactions between DNA strands, allowing for the interactions of 
oligonucleotides to be studied and for example the duplex DNA structure to be 
retained. Denaturing gels disrupt the secondary structure and interactions 
between strands, using formamide and urea, allowing the size of ssDNA to be 
more closely analysed and any covalently induced interactions to be assessed.37 
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DNA gels can be imaged via several techniques. The simplest is UV shadow. A 
thin layer chromatography (TLC) plate is placed under a UV lamp with the gel on 
top. The silica on the TLC plate fluoresces upon excitation at 254 nm, however, 
where the DNA bands are, the excitation light is absorbed and a shadow is seen 
on the TLC plate which can then be imaged. Although this is the cheapest and 
safest way to visualise gels, large quantities of sample need to be loaded on to the 
gel in order for the bands to be visualised. To overcome this problem many 
fluorescent dyes have been developed that fluoresce upon binding to DNA, 
typically through intercalation, such as ethidium bromide and SYBR Gold®. 
Although these dyes offer lower detection limits than UV shadow, they are toxic 
and care has to be taken in their use. They also limit the extraction of the DNA 
from the gel. In addition to these visualisation techniques, radio labelling of the 
DNA can also be used. This uses an enzyme to attach a 32P to the DNA which can 
then be imaged.14 The DNA can also be labelled with a fluorophore and 
subsequently imaged. 
 
2.10.2 Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) is the 
standard technique used to analyse proteins. Unlike DNA, proteins and peptides 
are less highly charged. In addition to this they can be positive, negative or 
neutral making them harder to analyse via gel electrophoresis. In order to 
overcome this issue, all proteins are run using sodium dodecyl sulphate (SDS), a 
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chemical denaturant that is negatively charged. This results in all proteins 
having a similar charge and therefore separating solely dependent upon their 
size. As with DNA, due to the smaller nature of peptides compared with proteins, 
they are run using gels containing a higher percentage of acrylamide gel. Once 
run, protein gels can be imaged by a variety of techniques including silver 
staining, fluorescent dyes or Coomassie staining.33,38 
 
2.10.3 Electrophoretic Mobility Shift Assay 
In order to analyse binding of a molecule to DNA, a gel electrophoretic mobility 
shift assay (EMSA) is used. As before, the DNA is loaded onto the gel and 
migrates towards the positive electrode. In each well of the gel, an increasing 
amount of the binding molecule of interest is added, and as this is a native 
technique, the interactions with the DNA are maintained during the running of 
the gel. The binding of this molecule increases the effective size of the DNA, 
retarding its movement through the gel, resulting in a new band appearing. As 
the concentration of the molecule increases, the original DNA band in the gel 
disappears and eventually the only band that can be seen is that of the higher 
molecular weight species, corresponding to the bound DNA. The gel is imaged 
using the same techniques as discussed in Section 2.10.1.39,40 
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Within this chapter the use of anthracene as a fluorescent single nucleotide 
polymorphism (SNP) reporter probe is explored. SNPs are the primary source of 
genetic diversity and it is thought that many may be indicators of a susceptibility 
to disease. As such they are currently the focus point of much research. 
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3.1.1 Single Nucleotide Polymorphisms 
Over recent years the understanding of the human genome has increased 
significantly. This has led to the discovery of regions of DNA that are thought to 
be responsible for diseases. 90% of the differences in these regions are down to a 
single nucleotide polymorphism (SNP), where just one base is changed in the 
sequence, making them the most common form of genetic variation.1–3 Within each 
coding region of a gene, there are an average of four SNPs; half of these result in 
mutations in the proteins the gene codes for.3 This property arises from the DNA 
being read in codons (Chapter 1.2.2). If the SNP occurs at a particular position 
within the codon, the amino acid selected remains the same, resulting in no change 
to the protein, despite a SNP being present. These are referred to as synonymous 
or silent SNPs.4 However, if the SNP does affect the amino acid coded for, a non-
synonymous SNP, then the protein function can be altered. SNPs are known to be 
responsible for cystic fibrosis and sickle-cell anaemia. 
 
3.1.2 Present Detection Methods 
One of the most popular and established methods to identify the base at a SNP 
site, is the commercially available Taqman assay, which works by amplifying DNA 
using the polymerase chain reaction (PCR), Chapter 1.4.1.3.1. The probe consists 
of a DNA oligonucleotide with a fluorophore attached, typically to its 5′ end, and a 
quencher attached to its 3′ end. When the target DNA strand is present, a duplex 
is formed with the probe. As the PCR process replicates the DNA, taq polymerase 
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degrades the complementary strand, in this case the probe, from the 5′ to the 3′ 
end, releasing the fluorophore and associated quencher, thereby resulting in 
fluorescence being observed, Figure 3.1.5 This technique relies upon the 
mismatched strand not binding, and hence not being degraded. Therefore, a 
difference in the binding affinities between the fully complementary and one base 
mismatch are required, in order for the system to work. As a consequence of this 
fine balance, the assay is performed at a slightly elevated temperature, typically 
50-60 °C. If the temperature is too low, the probe will bind to both strands; if it is 
too high, neither will bind. Due to the elevated temperatures used and the need for 
PCR, this assay is unsuitable for use in live cellular environments. 
Figure 3.1 Schematic diagram illustrating the principle behind the Taqman assay. The probe containing a FRET 
pair of fluorophores binds to the target DNA (top). PCR is performed and the complementary strand is produced 
(middle). As the polymerase approaches the probe, it is digested and the fluorophores are released from close 
proximity, removing the FRET pathway and hence fluorescence occurs (bottom). 
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 Another popular method is the use of molecular beacons.6 These use a DNA 
hairpin structure in which the ends of the DNA probe sequence complement each 
other, Figure 3.2. Rather like the Taqman System, at one end of the probe is a 
fluorophore and at the other end is a quencher. In the hairpin form any 
fluorescence from the probe is quenched due to the close proximity of the quencher 
group and the fluorescent label. In the presence of target DNA, the probe unfolds 
to hybridise with the target, due to the presence of more complementary bases 
compared to the stem. Upon target binding and duplex formation, the fluorophore 
and quencher become separated and fluorescence is observed. As with the Taqman 
probe, this process is temperature dependent, since it relies upon a difference in 
binding affinity for target sequences with different SNP identities. 
 
Scorpion probes have recently been developed which combine the molecular beacon 
concept with a PCR reaction. These probes contain the primer for the PCR reaction 
joined to a molecular beacon, the loop of which is the same sequence as the target 
site (i.e. complementary to the PCR product being formed). Upon extension of the 
Figure 3.2 Schematic diagram illustrating the process of SNP sensing using a Molecular Beacon. In the stem loop 
form the fluorophore and quencher are in close proximity and FRET occurs (left). Upon hybridising with the target 
strand, the stem loop unfolds, separating the quencher from the fluorophore and fluorescence is observed 
(right). 
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primer, the molecular beacon unfolds with the loop region binding to the newly 
formed PCR product, leading to a structural rearrangement spatially, 
repositioning fluorophore and quencher, resulting in fluorescence, Figure 3.3. Due 
to the molecular beacon region being covalently attached to the PCR product, the 
annealing process is intramolecular and therefore faster and able to give more 
reliable results than the Taqman assay.7 
 
3.1.3. Limitations of Present Methods 
The Taqman, molecular beacon and scorpion probe methods all have the same 
limitation, they rely upon a difference in binding affinity of the probe to strands 
containing different SNP identities. As discussed above, this means that the assays 
have to be performed at an elevated temperature and more importantly, in a well-
defined temperature range that is difficult to optimise and is never the same for 
any two SNPs. Another limitation is that the above methods are only able to 
identify the presence or absence of the base they are designed to. It would instead 
be more useful if a probe could be developed that could identify the base that is 
present, thus determining the sequence of DNA. This could enable biologists to 
Figure 3.3 Schematic representation of the Scorpion Probe process. A primer is attached to a stem loop forming 
sequence in which a fluorophore and quencher are held in close proximity (left). PCR is performed, extending 
the primer, this extended sequence is complementary to that in the loop region of the stem loop (middle). Upon 
the next cycle of PCR, the target is released and the stem loop opens to hybridise with the newly formed 
sequence. This increases the distance between the fluorophore and quencher and hence fluorescence is 
observed (right). 
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establish whether the SNP will have an effect on the amino acid that is coded for, 
and therefore an effect on phenotype. 
 
3.1.4. Base-discriminating Fluorescent Nucleotides 
By replacing a base within an oligonucleotide with a fluorescent molecule, the base 
that is opposite, or next to the probe can potentially be identified by the changes 
that are observed in fluorescence upon hybridisation. Seitz and co-workers have 
recently used a Peptide Nucleic Acid (PNA) with a thiazole orange fluorophore 
incorporated as a SNP sensor. The PNA binds to the DNA target, with the thiazole 
orange tag intercalating with the DNA bases. When a matched DNA base pair is 
present next to the tag, it is forced into a coplanar arrangement and fluorescence 
is observed. However, when a mismatch is present, the tag can move more freely 
and undergo torsional motions, depleting the fluorescence observed. This is shown 
schematically in Figure 3.4.8,9 
Figure 3.4 Schematic of the probe used by Seitz and co-workers to probe for SNPs within a DNA sequence. A) The 
FIT-PNA probe is hybridised with target DNA. If a fully matched sequence is formed, the thiazole orange tag is 
held in the coplanar conformation (B, top) and fluorescence is observed. However, when a mismatch is present 
in the sequence, the thiazole orange moiety can form the perpendicular arrangement (B, bottom) and 
fluorescence is depleted. Reprinted with permission from Socher et al., Anal. Biochem., 2008, 375, 318-30. 
Copyright 2008 Elsevier, Inc. 
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The same group have also used a pyrene moiety attached to an adenine derivative 
to identify when a thymine base was opposite the probe, Figure 3.5.10 When 
thymine is present the adenine forms a Watson-Crick base pair with it, forcing the 
pyrene into solution and fluorescence occurs. However, when thymine is not 
present (i.e. a SNP) there is no base pair formed and the pyrene moiety 
intercalates. In this arrangement the fluorescence is quenched by the surrounding 
DNA bases and hence no fluorescence is observed.10,11 
 
 
Another recent SNP detection method made use of a cyclodextrin tagged DNA 
sequence.12 This binds to the complementary sequence of DNA up to the point of 
the SNP. A nucleobase specific fluorescent probe is then added. This molecule is 
made up of the nucleotide binding region, designed to only bind to a specific base, 
which is attached to a dansyl group. If the corresponding base is present, the probe 
binds, placing the dansyl group inside the cyclodextrin resulting in fluorescence, 
Figure 3.5 Pyrene phosphoramidite tag for incorporation into DNA probe. The pyrene moiety is attached to an 
adenine base to allow for the sensing of thymine on the complementary strand. 
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Figure 3.6. Although the group has so far only made a probe to bind to guanine, 




Previous work within the Tucker group has focused on developing and utilising an 
anthracene tag, for incorporation into DNA as a fluorescent probe, briefly described 
in Chapter 2.3. The anthracene tag has been shown previously to display 
significantly different fluorescence intensities when placed opposite all four 
possible bases in a target DNA sequence.13–15 The anthracene tag incorporates a 
carbon chain linker, the length of which can be varied, and a threoninol unit which 
allows for control of the stereochemistry, Figure 3.7. Both of these properties can 




Figure 3.6 Schematic representation of cyclodextrin tagged DNA for SNP detection. An oligonucleotide with a 
cyclodextrin moiety attached, is bound up to the SNP site. A small molecule specific for the base of interest is 
introduced. If the complementary base is present, it binds and places a dansyl group within the cyclodextrin, 
resulting in fluorescence. Reprinted with permission from Ihara et al., J. Am. Chem. Soc., 2009, 131, 1386-7. 
Copyright 2009 American Chemical Society. 
 




More recently Saito et al. have used anthracene incorporated into the DNA via 
uridine, which allows for the detection of adenine when located directly opposite 
the probe. In contrast, when other bases are located opposite, a quenching in the 
anthracene fluorescence is observed.16 
 
The approach used within base discriminating fluorescent nucleotides (BDF’s), 
removes the problem of working at a particular elevated temperature window, as 
needed with the popular Taqman assay, due to the probe sequence binding to the 
target strand irrespective of the SNP site base identity. Within the Tucker group 
probe, the change in fluorescence arises from the differences in intercalation of the 
anthracene, and any interactions it has with the adjacent and opposite bases. The 
research is now moving towards targeting relevant sequences known to be 
associated with diseases such as prostate cancer and Alzheimer’s disease.17 
 
Figure 3.7 Comparison of the Tucker group probe (right) to natural DNA (left). The anthracene probe can be 
altered by varying the length of the carbon chain connecting the anthracene to the DNA backbone (n, in red) and 
the stereochemistry of the threoninol unit (green) to provide optimum differences between the various bases. 
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3.2 Project Aims 
Within this chapter the use of an anthracene SNP detection probe is assessed 
within a sequence of DNA thought to be associated with Alzheimer’s disease. 
Various stereochemistry and linker length combinations are incorporated into a 
sequence of DNA complementary to the SNP site, with the anthracene 
incorporation being made directly opposite the base that is expected to change. The 
fluorescence of anthracene is then measured and tracked upon duplexing with the 
complementary DNA. Increases in fluorescence intensity are observed for some 
bases but decreases for other, Figure 3.8, allowing the base identity to be 
determined. Further to this, analysing a mixture of two bases is expected to give a 
fluorescence output proportional to the amount of each base present allowing for 
quantitative determination of the bases present. 
 
 
Figure 3.8 Anthracene is incorporated into a strand of DNA complementary to the strand of interest. Upon duplex 
formation a change in the intensity of fluorescence is observed depending on the base that is present. 
 
In addition, the use of the anthracene probe to detect the base modification 8-oxoG 
will be assessed. 
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3.3. Anthracene SNP Sensing 
3.3.1. Alzheimer’s SNP Sensing Sequences 
To further prove the applicability of the technique, it was decided that a sequence 
associated with Alzheimer’s disease (rs1801270) should be investigated.18,19 The 
target sequence is one of several SNP sites thought to be prevalent in Alzheimer’s 
disease. The native sequence contains a C base which is altered to an A with a 
higher rate in Alzheimer’s patients (Table 3.1). This causes a mutation of a serine 
to an alanine in the protein that the gene codes for, resulting in complications in 
the neuron cell cycle and fibril formation. An anthracene monomer was 
incorporated into a complementary probe strand directly opposite the site of the 
SNP. Anthracene probes of stereochemistries L and D and linker lengths of 1, 3-7 
were synthesised as described in Chapter 2.3. A linker length of 2 was not used as 
it was previously established within the group that upon saponification to the 
carboxylic acid, a competing, faster elimination reaction yielded anthraquinone 
instead of the desired product.20 Probe and target strands were synthesised using 
standard solid-phase oligonucleotide synthesis, purified by RP-HPLC and 
characterised by ESI-MS (Chapter 2). This was performed by Dr Zheng-Yun Zhao 
on some strands and these are indicated in the appendix. 
Table 3.1 Sequences synthesised for SNP detection trials on Alzheimer’s associated mutation. Probes labelled 
according to the linker length (n) and stereochemistry of the threoninol unit (L/D). 
 Name Sequence 5′ – 3′ 
Probe Alz-Pr(nL/D) AGT CGC  GXC  TCA GCT 
Target Alz-TarA/C AGC TGA GA/CC GCG ACT 
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3.3.2. Fluorescence Spectroscopy Studies 
Fluorescence spectra of the probe alone were recorded between 370 – 570 nm in 
the absence and presence of target strands, containing either SNP identity. After 
addition of each target strand, a change in the intensity of the fluorescence was 
observed, Figure 3.9. 
 
In order to compare the fluorescence response between various probes, the 
percentage change in fluorescence at 426 nm was plotted as a function of increasing 
equivalence of target strand (Figure 3.10). It was found that after additions 
exceeded 1 molar equivalent of target to probe, there was little change in 
fluorescence, indicating that a 1:1 duplex had been formed.  
 
Figure 3.9 Fluorescence spectra of Alz-Pr(5L) (dot) in the presence of Alz-TarC (grey) and Alz-TarA (black), 
performed at 1 µM probe with 1.5 µM target, where applicable, in 10 mM sodium phosphate buffer pH 7 and 
100 mM NaCl, λex 350 nm, 293 K. 
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Titrations were performed in triplicate for all probe and target combinations, the 
results of which are summarised in Figure 3.11. It was found that in all the longer 
linker length probes (3-7) there is an increase in the fluorescence intensity upon 
addition of Alz-TarA, and a decrease with Alz-TarC. The Alz-Pr(1L) and Alz-Pr(1D) 
probes show little discrimination between the two targets. These results are in 
good agreement with those for a model system studied extensively by the group.21 
It is proposed that the 1L and 1D linkers are too short for the anthracene to fully 
interact within the duplex. However, the longer linkers allow for intercalation of 
the anthracene, and an interaction with the base opposite as well as those 
upstream of the incorporation site. It is thought that the change in fluorescence is 
caused by a combination of quenching from neighbouring bases, the amount of 
intercalation and photo-induced electron transfer (PET) to the bases. Interestingly, 
Alz-Pr(5L) shows a significantly larger increase in fluorescence when forming a 
Figure 3.10 Fluorescence titration of Alz-Pr(5L) with Alz-TarC (grey) and Alz-TarA (black) performed at 1 µM 
probe in 10 mM sodium phosphate buffer pH 7 and 100 mM NaCl, λex 350 nm, 293 K. Error bars correspond to 1 
standard deviation. 
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duplex with Alz-TarA than any of the other probes. The changes in fluorescence 
intensity observed are not as large as those found with other BDF’s.9,11 Despite 
this, they are significant and can easily be detected. In addition to this, the probes 
used within these studies can distinguish all bases,21 a property that other BDF’s 
do not possess. 
 
3.3.3. Thermal Melting Studies 
Thermal melting studies (as described in Chapter 2.7.3), were performed on the 
strands to ensure they were duplexes at room temperature, and to determine the 
extent of any differences seen in binding strength. It was found that all systems 
formed stable duplexes, with recorded Tm values being above both room and at the 
Figure 3.11 Fluorescence titration of all Alz-Pr probes with Alz-TarC (black) and Alz-TarA (grey) performed at 1 
µM probe in 10 mM sodium phosphate buffer pH 7 and 100 mM NaCl, ʎex 350 nm, 293 K. Values taken after 
addition of 1.5 µM target and are the average of three repeat runs. Error bars correspond to 1 standard deviation. 
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biological relevant temperature 37.5°C, Table 3.2. This confirmed that the systems 
studied by fluorescence were fully hybridised at the temperature used (293 K, 
20°C). In all cases there is a reduction in Tm upon replacement of a base with the 
anthracene probe. This is expected due to the removal of the stabilising hydrogen 
bonds provided by the base that has been removed. However, the anthracene is 
able to intercalate (depending upon the linker length and stereochemistry allowing 
the correct orientation) with the neighbouring bases, resulting in higher Tm values 
than would be expected for the complete removal of a base, based on work 
previously performed within the group.21  
Table 3.2 Tm values (°C) for duplexes formed between Alz-Pr and Alz-Tar. Values are compared to unmodified 
target (UM) in which a G or T base replaces the anthracene probe when the C or A target is used, respectively. 
Studies are performed at 5 µM duplex oligonucleotide in 10 mM sodium phosphate buffer pH 7 and 100 mM 
NaCl. All values are an average of at least 3 repeat runs and are reported to the closest 0.5 °C due to the limits of 
instrument error. 
 Probe Alz-Pr 
Target UM 1L 1D 3L 3D 4L 4D 5L 5D 6L 6D 7L 7D 
Alz-
TarA 
67.0  58.5  58.0  61.0  62.5  59.0  61.5  60.0  59.0  59.0  61.5  59.0  61.5  
Alz-
TarC 
73.0  57.5  55.0  62.0  61.0  63.0  61.5  63.0  60.5  61.5  63.0  62.5  62.0  
 
Notwithstanding the closeness of the values, in the majority of cases, the duplex 
formed with Alz-TarC has a higher Tm than that formed with Alz-TarA, indicating 
that a more stable duplex is formed in these cases. A potential explanation for this 
is the relative sizes of cytosine, a pyrimidine, and adenine, a purine. The smaller 
pyrimidine increases the cavity size in the duplex, allowing for the anthracene to 
fully intercalate, and the duplex to assemble into a more natural DNA 
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conformation. However, the larger purine could disrupt the local environment 
more, disrupting the bases surrounding the anthracene site, resulting in a 
reduction in the Tm. This observation is consistent with the fluorescence data for 
the longer linker length probes; it is possible that when the anthracene is able to 
intercalate more, it could interact with the upstream bases more, leading to 
fluorescence quenching as seen in Figure 3.10. 
 
The increase in fluorescence observed in the case of the adenine target, could be 
due to the anthracene being removed from a solvent exposed environment upon 
duplex formation, restricting the quenching pathway that water offers. However, 
despite some degree of intercalation, in this system the anthracene cannot stack 
effectively with the bases upstream due to the limited space afforded by the 
adenine base, resulting in less quenching compared to the cytosine case and 
consequently a slightly lower Tm and a relative increase in the fluorescence. 
Molecular modelling of a control system has been performed previously and 
showed an intricate relationship between the anthracene unit, the base upstream 
of it and the bases directly opposite.21 
 
The Tm values of the duplexes formed with Alz-Pr(1L) and Alz-Pr(1D) are 
considerably lower than those with the longer linker lengths. This is proposed to 
be due to the relative rigidity of these linkers not allowing for the intercalation of 
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the anthracene and therefore the systems do not benefit from the favourable 
stacking interactions formed between anthracene and the bases. 
 
 3.3.4. Circular Dichroism Studies 
Circular dichroism (CD) studies were performed to evaluate the secondary 
structure of the duplexes formed between the anthracene probe and the DNA 
targets. Previous studies on a model system showed that all duplexes formed a B-
DNA structure, with some showing an induced signal from the anthracene at 254 
nm.21 As expected, the duplexes studied herein all formed B-DNA structures with 
a positive band centred ~275 nm and a negative band centred ~240 nm, Figure 
3.12 and 3.13. 
 
Studies on the single stranded probes for linker lengths of 3 and above, showed 
them to be well folded, with an induced anthracene peak at 254 nm, the intensity 
of which varies between probes. It is expected that secondary structure is forming 
out of the single strand so as to remove anthracene from the polar water 
environment. CD spectra of single stranded probes showed the Alz-Pr(1L) and Alz-
Pr(1D) to be similar to the expected signal for unmodified single stranded DNA, 
with no induced anthracene peak at 254 nm. This is expected to be due to the short 
linker being more rigid and restricting the amount of folding that can occur in 
order for the bases to stack with the anthracene. A comparison to the unmodified 
ssDNA and dsDNA strands can be found in the appendix (Chapter 9.1).  




Figure 3.12 Circular Dichroism spectra of all Alz-Pr and Alz-Tar combinations, probe alone (___), with Alz-TarC 
(…..) and with Alz-TarA (----). All spectra shown are recorded with 1 µM probe and target, where applicable, in 
10 mM sodium phosphate buffer pH 7 and 100 mM NaCl at 293 K. 




Figure 3.13 Circular Dichroism spectra of all Alz-Pr and Alz-Tar combinations, probe alone (___), with Alz-TarC 
(…..) and with Alz-TarA (----). All spectra shown are recorded with 1 µM probe and target, where applicable, in 
10 mM sodium phosphate buffer pH 7 and 100 mM NaCl at 293 K. 
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Upon addition of target DNA, an increase in the intensities of the positive band 
around 280 nm and the negative band around 245 nm was noted. This would be 
expected due to the formation of duplex B-DNA between the target and probe. It 
was also found that the anthracene induced signal present in the spectrum for the 
single stranded probes, was not visible upon duplex formation. This is possibly 
caused by the anthracene no longer being able to lay at the optimum angle (45º in 
relation to the base pair long axis) for an induced signal to occur, and therefore the 
signal is reduced.21,22 
 
In general, the duplex formed with Alz-TarA shows a blue shift of the negative 
band at ~250 nm in comparison to the duplex formed with Alz-TarC. The positive 
band shows little change in position but some change in intensity with the Alz-
TarA duplex displaying a higher intensity. Of particular interest is the case of Alz-
Pr(5L) with Alz-TarA; this is the only duplex to show a marked increase in 
intensity of the negative band in relation to the duplex formed with Alz-TarC and 
a significant increase in the fluorescence intensity upon duplex formation with the 
Alz-TarA target. Within this region, signals from the B-DNA structure as well as 
induced signals from the anthracene are known to contribute, making assigning 
the change to a particular conformation of DNA, or orientation of the anthracene, 
quite difficult. 23,24 
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3.4. Anthracene Heterozygous SNP sensing 
3.4.1. Heterozygous SNP sensing 
So far the studies presented herein have focussed on the identification on samples 
with homozygous SNP sites, i.e. with only one of the bases present. Of increasing 
interest to medical professionals is the study of heterozygous SNPs. These arise as 
a result of everyone having two copies of the same gene, one paternal and one 
maternal. These copies vary in their sequence and therefore different base 
identities may be present in one and not the other, Figure 3.14. 
 
Previously the possibility of sensing the presence of heterozygous DNA using the 
anthracene probe has been explored with a prostate cancer SNP.17 In this case a 
T/A SNP site was analysed with a mixture of 50% T base and 50% A base. It was 
found that the intensity of the anthracene fluorescence was in between the results 
obtained for the homozygous samples. 
 
Figure 3.14 Schematic representation of the possible base combinations at a C/A SNP site with paternal DNA 
shown in blue and maternal DNA in pink. The two DNA strands can contain the same base, homozygous as seen 
on the left, or have different bases, heterozygous as seen on the right. 
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During the transcription process (Chapter 1.2.2), the DNA is converted into mRNA 
and, in heterozygous cases, this process may result in one allele being transcribed 
in preference to the other. This therefore alters the effect seen within a patient due 
to the SNP. Unusual allelic ratios of mRNA may be a marker for disease 
progression or susceptibility. Therefore the ability to assess how much one copy of 
a gene is transcribed compared to another, would be beneficial. 
 
The SNP determination examples discussed in Section 3.1.2, the Taqman assay, 
molecular beacons and scorpion probes, can be made into systems that can study 
heterozygous cases. Two probes can be used, one for each allele, which contain 
different fluorophores. The probe that displays the highest binding (i.e. the one 
with the correct sequence) will bind and display fluorescence, the wavelength of 
which corresponds to the base that is present. The wavelength can then be read 
out and hence the base determined. These methods are limited by their need for a 
specific temperature window restricting their use in cellular environments. 
 
In addition to this, there are a few methods currently available specifically 
designed for heterozygous sample determination. Firstly, PCR-based methods 
relying on complex design utilising SNPs that are present in restriction sites, 
followed by gel electrophoresis analysis of the PCR fragments.25,26 An enzyme is 
used that cuts the DNA at a specific sequence, the restriction site. If this site is 
altered by the presence of an alternative base, then the enzyme does not recognise 
Chapter 3 – SNP Detection Using and Anthracene Probe 
 
 84 
the site and hence does not cut the DNA and it remains the full length. The 
fragments are then analysed by gel electrophoresis and according to the size of the 
DNA, either cut or full length, the SNP ratio can be deduced. This method cannot 
be applied in all cases due to the need for SNP sites to be in a restriction site. 
Furthermore, the quantification of the separated fragments can be inaccurate. 
 
A second method is the commercially available SNaPshot system (Applied 
Biosystems Ltd.) which is based upon the dideoxy single base extension 
technique.27–29 This method uses single-base extension of a primer. The primer is 
made to be complementary up to the SNP site, this primer is then extended by 
enzymes using fluorescently labelled bases. Upon incorporation into the sequence 
the fluorophore emission is read, with the wavelength of the fluorescence being 
specific to the base that has been incorporated, allowing for the read-out of the 
base present and the relative quantities of each base.30 
 
Pyrosequencing has also been used for the quantification of allele expression.31 In 
this technique single stranded DNA is tethered to a surface and forms a template 
for DNA polymerase to form the complementary strand. Upon incorporation of a 
base, pyrophosphate is released which is converted into adenosine triphosphate 
(ATP) by ATP sulfurylase. The amount of ATP is then quantitatively determined 
using the fluorescence produced by the firefly luciferase, upon consumption of ATP. 
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By repeating the process in cycles, using one base in turn, the sequence of DNA 
can be determined.32 
 
All the techniques described above rely on either the PCR reaction, elevated 
temperatures or the DNA being analysed being tethered to a surface, meaning that 
they cannot be used in cellular environments. In many cases the technologies are 
also limited by the sequences they work on. If the assay developed by the Tucker 
group could be used to quantify the amounts of each base present at a SNP site, 
the technology could potentially be used in situations where the other assays fail 
or as an alternative. This could allow for real time tracking of allele specific 
expression within biological systems. 
 
3.4.2. Heterozygous SNP Sensing using an Anthracene Probe 
In order to evaluate whether the Tucker group probe could be used for this 
application, several target samples with varying ratios of wild type and SNP DNA 
present, were prepared. In order to maximise the sensitivity of the assay, the probe 
showing the largest difference between the C/A bases used in the Alzheimer’s SNP 
sensing was used, Alz-Pr(5L). The fluorescence intensity of the probe was 
monitored followed by addition of 1.5 equivalents of target mixture. The 
fluorescence intensity was then re-measured and the percentage change in 
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intensity at 426 nm calculated. It was determined that there was a linear trend 
between the ratio of base concentrations and fluorescence intensity, Figure 3.15.  
Figure 3.15 Calibration of heterozygous SNP quantification, where remaining percentage of base on x-axis is 
made up with A base. Performed on 1 mL samples with 1 µM probe and 1.5 µM target in 10 mM sodium 
phosphate buffer pH 7 and 100 mM NaCl, ʎex 350 nm, excitation and emission slit widths were 3 and 5 nm 
respectively, performed at 293 K. Data shown is the average of three repeat runs. Error bars correspond to 1 
standard deviation. 
 
Using the calibration in Figure 3.15, blind heterozygous samples of Alz-TarA and 
Alz-TarC were analysed to determine the percentage of C/A base present. The 
results were calculated using the equation of the linear trend line: 
𝑦 = −1.7711𝑥 + 138.64 
The y value was obtained by calculating the percentage change in fluorescence at 
426 nm in relation to the probe alone fluorescence. The results of this trial can be 
seen in Table 3.3 and are shown to be very close to the actual values of the blind 
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samples. The results obtained when no target is present, highlights an important 
limitation of this assay. As the calibration crosses the x-axis, at this point you 
would be unable to tell if the assay was working or if there was ~80% of target with 
C base and 20% with A base present. This issue could be circumvented by running 
an identical assay with a different anthracene linker length, and/or 
stereochemistry, which would cross the x-axis at a different value. This would also 
give a double verification of the results obtained. 
Table 3.3 Trial of anthracene probe heterozygous SNP sensing using the calibration shown in Figure 3.14. All 
samples run at 1 µM probe in 10 mM sodium phosphate buffer pH 7 and 100 mM NaCl. ʎex 350 nm, 293 K. 
Percentage Change in 
Fluorescence at 426 nm (%) 
Calculated Percentage 
of C base present (%) 
Actual Percentage of C 
base present (%) 
+28 62 60 
-37 99 100 
+34 59 55 
0 78 No target 
 
Using the above calibration, quantities of allelic ratios in unknown samples would 
be able to be determined. However, in order for the assay to be biologically 
compatible, even with PCR amplification, the amount of target required would 
need to be reduced. Subsequently the volume was reduced to 50 µL in an ultramicro 
quartz cuvette and analysis was performed on a more sensitive fluorimeter 
(Edinburgh FLSP920 fluorescence spectrometer). A longer excitation wavelength 
of 370 nm was also used as the anthracene probe shows a higher absorbance at 
this wavelength and hence the fluorescence output should be increased. The slit 
widths used were also increased to allow more light to irradiate the sample and 
reach the detector. This results in a reduction in the resolution of the fluorescence 
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spectra obtained, but it was deemed more important to increase the intensity of 
the signals observed. As detailed previously, a calibration graph was produced 
which closely matches that shown in Figure 3.15. Due to the lower volume cuvette 
increasing the scatter within the instrument, the errors found in this case were 
much higher, Figure 3.16. 
Figure 3.16 Calibration of heterozygous SNP quantification where remaining percentage of base on x-axis is made 
up with A base. Performed on 50 µL samples with 1 µM probe and 1.5 µM target in 10 mM sodium phosphate 
buffer pH 7 and 100 mM NaCl, ʎex 370 nm fitted with 375 nm long pass filter, excitation and emission slit widths 
were 8 nm, performed at 293 K. Data shown is the average of three repeat runs. Error bars correspond to 1 
standard deviation. 
 
Using the calibration in Figure 3.16, unknown heterozygous samples of Alz-TarA 
and Alz-TarC were analysed as done previously, using the new equation of the 
linear trend line: 
𝑦 = −1.8056𝑥 + 140.76 
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The results of this trial can be seen in Table 3.4 and, although reasonably accurate, 
do show a greater error than that found when studying larger volumes. This is an 
inherent problem of using a smaller volume cuvette that increases the scatter of 
light. By optimising the fluorescence output of the probe, larger volumes at lower 
concentrations could be used. This would maintain the amount of material needed 
but decrease the scatter seen and hence decrease the error. 
Table 3.4 Trial of anthracene probe heterozygous SNP sensing using the calibration shown in Figure 3.15. All 
samples run at 1 µM probe in 10 mM sodium phosphate buffer pH 7 and 100 mM NaCl, 50 µL. ʎex 370 nm fitted 
with 375 nm long pass filter, 293 K. 
Percentage Change in 
Fluorescence at 426 nm (%) 
Calculated Percentage 
of C base present (%) 
Actual Percentage of C 
base present (%) 
+34 59 50 
+76 36 25 
+14 70 60 
-20 89 90 
+13 71 75 
+9 73 80 
+59 45 50 
+60 45 40 
 
These results are extremely promising and demonstrate for the first time that a 
BDF can be used to quantitatively determine the ratio of bases at a SNP site. This 
could offer a solution to study DNA sequences in situations where the currently 
used methods are unable to be used, for example within cells or in G-C rich 
sequences which cannot be easily amplified. 
 
Further optimisation of the assay is continuing in the group, with the aim of testing 
true biological samples and reducing the amount of target that is needed to make 
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the assay more applicable to the standard biological concentrations. Potential 
routes being explored use asymmetric PCR or Förster Resonance Energy Transfer 
(FRET), to display the relative anthracene fluorescence via a different 
fluorophore.33  
 
3.5 Preliminary Studies: Identifying Base Modifications using an Anthracene 
Probe 
3.5.1 Base Modifications 
DNA is also known to alter by chemical changes to the base rather than a complete 
base change. This is known as an epigenetic change. In these situations the 
sequence of DNA is unchanged, rather a chemical alteration to the base occurs 
which could potentially lead to a change in gene expression. Examples of this are 
8-oxoG and 5-MeC, which occur as a result of metabolic processes, Figure 3.17A.34 
The occurrence of 8-oxoG, a product of oxidative stress, results in the guanine being 
able to pair with either a thymine or adenine via Hoogsteen base-pairing, due to 
the additional hydrogen bond that can be formed. This confuses the usual pairing 
system, shown in Figure 3.17B.35,36 
 
With 5-MeC a methyl group is added to the 5-position on the cytosine. This is of 
interest as there is evidence that unusual methylation patterns are associated with 
cancer development.37 Therefore identification of these modifications would also be 
beneficial and is being addressed using Tucker group probes. We have previously 
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reported its use in identifying 5Me-C modifications,14 within this thesis the 
possible sensing of 8-oxoG is explored. 
 
3.5.2 Current Detection Methods 
3.5.2.1. Global Analysis 
The level of 8-oxoG in cells is a direct measure of the oxidative damage experienced 
and is hence extremely interesting to medics.38 This has resulted in several assays 
being developed that examine the overall level of 8-oxoG within a system. 
 
Figure 3.17 A) The structures of the base modifications 8-oxoG compared to guanine (left) and 5-MeC compared 
to cytosine (right). B) The possible binding modes of 8-oxoG to guanine’s usual hydrogen bonding partner, 
cytosine (left) and through a Hoogsteen base-pair with an adenine (right). 
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A common method used that is applicable to many base modifications, is enzymatic 
digestion followed by HPLC separation of the products. The DNA is broken down 
into the monomer constituents and subsequently analysed to determine the bases 
present. For 8-oxoG, electrochemistry can be used for its detection along with MS. 
This is a sensitive method that can detect oxidation of one base in every 10 000, 
however relatively large amounts of material are required.39,40 Alternatively GC-
MS can be utilised in a similar manner.40,41 
 
Recently, fluorescent aptamers have been synthesised that allow for the detection 
of 8-oxoG, which could be utilised after an enzymatic digestion. It is envisioned 
that this will allow for quicker and cheaper determination compared to HPLC and 
MS.42,43 Other less established methods for determination have included 
monitoring the electrochemical properties of strands containing 8-oxoG44,45 and ion 
mobility through a nanopore.46 
 
Alternative approaches use antibodies to bind 8-oxoG sites followed by a 
competitive enzyme-linked immunosorbent assay (ELISA) to determine the 
modification,47 or use of an enzyme that binds to the modification which can 
subsequently be detected by gel electrophoresis.48 One of the main problems with 
these detection methods is that during the extraction of samples, guanine can be 
oxidised giving false positive results.49 In order to circumvent this problem and 
allow for the cell by cell determination of oxidation, imaging techniques have 
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subsequently been developed. Persinger et al. have summarised this work in a 
comprehensive review.50  
 
3.5.2.2 Site Specific Detection 
The above examples focus on determining the overall amount of oxidation within 
a sample. Assays that can deduce a specific site of oxidation could help in the 
research of this field to evaluate the affect oxidation has on the patient and also 
the factors affecting where the oxidation occurs.  
 
The use of fluorescent DNA probes, in a similar manner to the approach already 
described in this work, is currently the only reported successful technique to 
perform site specific identification of 8-oxoG. Tor and co-workers have developed a 
fluorescently labelled cytosine adduct that can successfully distinguish between G, 
8-oxoG and T bases. By incorporating the furan labelled cytosine opposite the site 
of interest in a complementary strand of DNA, the fluorescence intensity could be 
used to determine the identity of the base present.51 
 
Sasaki and colleagues have also developed a fluorescent assay using 1, 3-
diazaphenoxazine labelled nucleotides. Initially the group made a probe that would 
detect the presence of 8-oxoG without distinguishing its position within the DNA 
sequence.52–54 They then further developed this assay by incorporating the group 
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onto adenine and, when placed opposite a site for a potential 8-oxoG ligand, this 
fluorescent nucleobase analogue showed a dramatic decrease in fluorescence when 
8-oxoG was present.55 
 
3.5.3. Strand Design – 8-oxoG Sensing 
In order to prove the applicability of the Tucker probe system in sensing 8-oxo-G, 
a sequence was analysed that was recommended by Nik Hodges, University of 
Birmingham. The sequence is used within the studies of the Hodges group and the 
probe could have applications within their research. In addition to this, strands of 
the control system routinely used within the Tucker group were also assessed. This 
sequence has been extensively researched and will act to help understand any 
trends seen.  The control system strands had previously been synthesised, purified 
and characterised by fellow members of the group.21 The sequences used are shown 
within Table 3.4. Probes were synthesised with the same scope of linker length and 
stereochemistry possibilities as were used in Section 3.3. The strands were 
subsequently purified and characterised as described in the experimental section. 
This was performed by Dr Zheng-Yun Zhao on some strands and these are 
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Table 3.4 Sequences synthesised for base modification detection trials. Probes labelled according to the linker 
length (n) and stereochemistry of the threoninol until (L/D) 
 Name Sequence 5′ – 3′ 
Control Probe ConBM-Pr(nL/D) TGG ACT CXC TCA ATG 
Control Target ConBM-TarG/oxo-G CAT TGA GG/oxoGG AGT CCA 
Probe BM-Pr(nL/D) GGG GAT XAC TAG TTC 
Target BM-TarG/oxo-G GAA CTA GTG/oxoG ATC CCC 
 
3.5.4. Base Modification Fluorescence Studies 
As with the SNP sensing in Section 3.3.5, fluorescence spectra of all probes 
(ConBM-Pr’s and BM-Pr’s) were recorded in the absence and presence of both 
targets, ConBM-TarG and ConBM-TaroxoG, and BM-TarG and BM-TaroxoG, 
respectively. Percentage changes in the intensity of the fluorescence in relation to 
the probe alone were calculated and are shown in Figure 3.18. 
 
Within the model system, the longer linker length probes (ConBM-Pr(3-7)) can all 
distinguish between the 8-oxo-G and G bases, whilst ConBM-Pr(1L) and ConBM-
Pr(1D) fail to discriminate between the two bases. As with the SNP identification 
in Section 3.3.2, this can be ascribed to the lack of flexibility resulting from the 
shorter linker length arm, restricting the intercalation of the anthracene moiety. 
With the longer linker lengths, anthracene can intercalate and stack with the 
neighbouring bases. The resulting decrease in fluorescence seen when 8-oxo-G is 
present, could be explained one of two ways. Firstly, due to the increase in size of 
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8-oxoG compared to G because of the extra oxygen atom. This could restrict the 
intercalation of the anthracene, resulting in a significant amount of quenching by 
water. Secondly, 8-oxo-G is known to have a lower oxidation potential compared to 
G,56–58 which would allow for more effective PET to the base and therefore 
fluorescence quenching as Tor and co-workers reported with their work.51 In order 
to establish which of these routes is responsible, or if indeed both play a role, more 
in depth studies analysing the lifetimes of fluorescence and computational 
modelling of the systems would need to be performed.  
 
In comparison, the BM-Pr system displayed different effects, with all the longer 
linker lengths exhibiting a decrease in fluorescence upon duplex formation, 
independent of the base opposite. In all cases, hybridisation with BM-TaroxoG 
resulted in less of a reduction than that with BM-TarG, indicating that the above 
hypothesis to explain the trends could still hold true. 
 




The overall difference in the trends seen is thought to be as a consequence of the 
bases flanking the anthracene. Within ConBM-Pr systems, a C is upstream of the 
anthracene and within BM-Pr systems a T is in this position. It has been noted 
Figure 3.18 Percentage changes in fluorescence intensity upon addition of ConBM-TaroxoG (light grey) and 
ConBM-TarG (dark grey) with all ConBM-Pr configurations, top and BM-TaroxoG (light grey) and BM-TarG (dark 
grey) with all BM-Pr configurations, bottom. All performed at 1 µM probe in 10 mM sodium phosphate buffer 
pH 7 and 100 mM NaCl at 293 K. ʎex 350 nm. Values taken after addition of 1.5 µM target. 
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previously that the anthracene is affected by the upstream base and that, upon 
duplex formation, the identity of this base can alter the fluorescence.21 This is 
expected to arise as a result of the PET to the upstream base with which it stacks. 
It has been previously calculated that C would be a more efficient quencher of 
anthracene fluorescence than T.21 It can therefore be hypothesised that in the 
ConBM-Pr systems, the initial quenching by the upstream C is reduced upon 
duplex formation with ConBM-TarG, resulting in a relative increase in the 
fluorescence. However, when duplexed with ConBM-TaroxoG, the 8-oxoG can 
quench by PET and a decrease in fluorescence is observed. In the case of the BM-
Pr system, the initial quenching is not as significant due to the inefficient 
quenching of the T upstream. Upon duplex formation the change in fluorescence is 
therefore smaller and is seen as a slight decrease in both cases. Measurements of 
quantum yields of the single stranded probes would be able to confirm this. 
 
An alternative explanation is that the 8-oxoG base lies in its preferred syn 
configuration (Figure 3.19), which does not allow the anthracene to intercalate as 
readily as a G base does. This would result in the anthracene being outside of the 
DNA duplex and hence exposed to the water environment, which is known to 
quench anthracene fluorescence.15 These hypotheses could be investigated using 
CD, Tm and fluorescence quantum yield studies. Obtaining crystal structures and 
performing molecular dynamic simulations on the systems, could offer greater 
insight. 




Figure 3.19 Anti and Syn conformations of 8-oxoG. In the preferred anti conformation, 8-oxoG forms hydrogen 
bonds with cytosine (left). When in the syn conformation it can form a Hoogsteen base pair with adenine (right). 
 
 
The data shows that the best probe for further optimisation in the sequence of 
interest would be BM-Pr(1L), as this probe shows the largest fluorescence 
differences between the two targets, BM-TaroxoG and BM-TarG. This is expected 
to be due to the constrained nature of the shorter linker length, restricting the 
optimal intercalation of the anthracene. This would affect the fluorescence when 
in the single stranded form, as well as when duplexed. In order to evaluate the 
causes of this, CD and Tm analysis should be performed, along with lifetime and 
fluorescence quantum yield studies. These would give an insight into the stability 
of the duplex structures and give an insight into the nature of the anthracene 
environment, enabling the system to be further understood. 
 
In due course, it would be expected that this base modification identification 
technique could be developed into a quantitative method for 8-oxoG determination, 
in a similar way to that detailed with the SNP sensing in Section 3.4.2. 
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3.6 Conclusions and Future Work 
The use of anthracene as a fluorescent SNP and base modification reporter 
molecule, has been presented. Within an Alzheimer’s SNP sequence the 
fluorescence intensity of the anthracene has been shown to be sensitive to the 
nature of the base located directly opposite in the complementary strand. The 
change in this intensity is shown to display a linear relationship with respect to 
the ratios of base present at a SNP site, allowing for the technique to be used for 
quantitative determination of the DNA present. Future work will focus on the 
detection of RNA as this would be the target molecule for cellular studies. The RNA 
work has been performed by Rosemary Bamford and will be published at a later 
date.33 In addition to this, samples extracted from patients are also to be analysed 
to establish the reliability of the assay when used on much longer sequences of 
DNA. Further studies on the origin of the trends seen, should be performed by 
assessing the lifetimes of the fluorescence and molecular modelling of systems. 
 
The anthracene probe has also been shown to be an effective 8-oxoG sensor, 
although the influence that the surrounding bases have on the output has been 
identified to be a significant issue. Further work in this area to understand the 
systems further, could be performed using CD, Tm analysis, lifetime measurements 
and molecular modelling. It would also be of interest to assess whether sensing the 
base modification, displays the same linear trend to that seen in the related SNP 
system. 
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Photodimerization within peptides: Light Induced, Sequence-Selective DNA 
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4.1 Introduction 
The vast majority of biological processes rely upon several separate entities 
associating together. For instance DNA transcription relies upon the double 
stranded nature of the DNA, an enzyme binding to the DNA and the enzyme itself 
often comprises of several domains or even separate proteins.1 Therefore, 
controlling oligomerisation could prove beneficial for a variety of applications. 
Within this chapter the first reported use of anthracene to control the 
oligomerisation of a peptidic structure is explored. A summary of this work has 
recently been published.2 
 
4.1.1 Protein Crosslinking 
Within nature there are known to be several ways in which proteins interact with 
one another, including hydrophobic interactions, hydrogen bonds, salt bridges and 
electrostatic interactions.3 In addition to these they can also be covalently 
crosslinked, the most well-known being disulphide bond formation between two 
cysteine residues, but recently many more amino acids have been found to be 
capable of crosslinking such as tyrosines.4 Chemists and biologists have spent 
many years working on ways to mimic and control the crosslinking of proteins to 
enable them to study the localisation of proteins, allowing for deduction of protein 
relationships and elucidation of the proteins function. In addition to this, 
crosslinking will allow the evaluation of the processes that oligomerisation is key 
for.5–8 
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The traditional way to induce oligomerisation, is to chemically link the entities. 
This is typically done using crosslinking reagents, many of which are commercially 
available and summarised in The Molecular Probes Handbook by Invitrogen.9 The 
majority of these utilise an exposed thiol, typically from a cysteine residue, or an 
amine and can be used with either hetero- or homo- bifunctionality to link 
multiples of the same protein or attach different entities. This is done utilising 
reactive groups such as maleimides, succinimidyl esters or iodoacetamides (Figure 
1.11), as well as many other derivatives which have been used. The vast array 
available are explored in the comprehensive Bioconjugate Techniques text book by 
Hermanson.10 
 
4.1.2 Controlling Protein Crosslinking using Light 
The use of light to control oligomerisation would have several advantages over the 
chemical alternatives. Notably it would offer increased control of the reaction by 
adjustments in the intensity and wavelength of the irradiation light used, small 
focussed areas of irradiation, and the advantage of no chemical activators being 
required. A recent review by Preston and Wilson covers techniques in this area.11 
 
In recent years the Photo Induced Crosslinking of Unmodified Proteins (PICUP) 
technique has been developed which allows for the crosslinking of proteins via 
tyrosine residues.12,13 This technique, although photo activated, requires the 
addition of a ruthenium complex and ammonium persulphate (APS) in order to 
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proceed. The tris-bipyridylruthenium (II) complex undergoes brief photolysis upon 
excitation with visible light when in the presence of APS, to generate Ru(III) and 
a sulphate radical. It is thought that the reaction proceeds via oxidation of a 
tyrosine residue by Ru(III), the resultant radical can then react either with another 
tyrosine residue or a nucleophilic cysteine or lysine side chain. Kodadek and co-
workers have published proposed mechanisms for these two pathways, Figure 
4.1,12 and the technique has been applied to a variety of systems within the 
literature.14–20 
Figure 4.1 Proposed mechanism of the PICUP technique showing the two possible reaction routes with tyrosine 
(right) and cysteine (left).12 
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A limitation of the PICUP technique, along with the requirement for the use of 
APS and the ruthenium complex, is that the crosslinking is not site specific, i.e. 
you cannot direct the crosslinking to a particular protein or amino acid. This can 
be seen as an advantage to some, as it allows for the determination of protein 
oligomerisation within cells due to the ability to crosslink proteins in close 
proximity. However, for some applications there is a need to specifically control the 
site at which crosslinking occurs. In order to overcome this issue, several photo 
reactive alternatives have been developed, some of which are now commercially 
available, which allow for a more targeted crosslinking approach.9 
 
Firstly, aryl azides have been utilised that, upon irradiation with UV-light, react 
with nucleophilic groups in the vicinity. The aryl azide can be coupled to a variety 
of chemical crosslinking reagents (as described in Section 4.1.1) to allow for 
coupling to the protein of interest. The crosslinker is first coupled to the protein 
and then, upon irradiation, the aryl azide will react with a nucleophilic group in 
close proximity to form the crosslinking. This technique has been applied to the 
photocrosslinking of proteins with both DNA as well as other proteins.21,22 
 
Photo reactive amino acids have recently been reported which contain diazirine 
rings which, upon UV-light activation, form crosslinks with nearby amino acid side 
chains and protein backbones.23 Methionine and leucine derivatives have been 
made commercially available, Figure 4.2, and it has been shown that these 
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modified amino acids can be incorporated endogenously into protein sequences, 
allowing for easy addition within cells.23 
 
The currently available methods allow for site specific incorporation of a 
photoreactive group into one protein, however, upon light activation, the 
modification reacts indiscriminately with several different amino acid side chains, 
as well as the peptide backbone, and the specific site of crosslinking cannot be 
controlled. However, those that crosslink with thiols are often used in a moderately 
selective manner due to the rarity of the cysteine residue, especially on the protein 
surface.10 
 
4.1.3 Anthracene for Photocrosslinking 
Anthracene is known to form photodimers upon UV-light irradiation (Chapter 
1.5).24–26 Incorporation of anthracene moieties at specific points in protein 
sequences could therefore allow for site specific crosslinking on both proteins. 
Figure 4.2 Structure of commercially available photoreactive amino acids (bottom) compared to the naturally 
occurring amino acids (top), methionine (left) and leucine (right). 
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Many anthracene derivatives are commercially available and could potentially be 
coupled to a variety of amino acid side chains. In order to evaluate the feasibility 
of photo-induced anthracene dimerisation within proteins, a model system based 
on the GCN4 transcription factor was investigated. This was chosen due to the fact 
that strong DNA binding is associated with protein dimerisation and its extensive 
study in the literature. This represents, to the best of my knowledge, the first time 
that anthracene photodimerisation has been used within a peptide or protein 
structure to control oligomerisation. 
 
4.2 GCN4 Transcription Factor 
The yeast transcription factor GCN4 is known to comprise of a homodimer 
protein,27 the monomer of which displays weak binding to target site DNA.28 The 
proteins are held together by a leucine zipper region towards the C-terminus of the 
protein,27 which has been studied extensively in the literature and found to be 
essential for dimerisation and subsequent DNA binding. The leucine zipper is 
made of two α-helical regions held together by hydrophobic interactions between 
the two chains. The DNA binding residues are found in the basic region of the 
GCN4 structure, Figure 4.3.29 
 
The native GCN4 transcription factor is known to bind to the AP1 site of DNA 
(ATGACTCAT), however, it is also found to bind to the similar CRE site 
(ATGACGTCAT), which differs in only a single base pair, and has been used 
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extensively for binding studies.30 Both of these sequences contain two binding 
sites, one for each strand of GCN4 within the homodimer, separated by one base 
in the case of AP1 and two bases in the case of CRE. These sites are shown in the 
above sequences in bold. 
 
 
4.2.1 Controlling DNA Binding using the Coiled Coil Region 
The DNA binding of GCN4 is known to be a cooperative process with the dimer 
species displaying a higher DNA binding affinity.28 Due to this, an interesting 
approach to control DNA binding, is to control dimerisation of the GCN4 units. 
This can be done using the natural dimerisation domain, the coiled coil. Controlling 
Figure 4.3 Pymol representation of the C-terminus of the GCN4 homodimer bound to target DNA (based on PDB 
2DGC).29 The coiled coil region (red) holds the protein together as a homodimer, which is joined to the basic 
region (green) via a linker region (blue). Towards the N-terminus is a capping region (purple). 
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the secondary structure of the peptide in this region has the potential to disrupt 
the coiled coil, controlling the association of the GCN4 units and hence the DNA 
binding.  
 
Futaki and co-workers reported a GCN4-bZIP modified peptide with iminodiacetic 
acid groups attached on the exterior of the coiled coil region. Upon chelation of 
Co(II) by iminodiacetic acid residues, the α-helical structure is disrupted resulting 
in disruption to the coiled coil, Figure 4.4. The monomer peptides that are formed 
are shown to display a much weaker DNA binding affinity consistent with other 
GCN4 monomer reports.31 
 
Light has also been used to disrupt the folding of the protein, and hence the DNA 
binding. In work by Woolley and colleagues, the DNA binding residues of GCN4 
were grafted onto the sequence of the photo-activated yellow protein (PYP). In the 
native form of PYP, the DNA binding residues were not in the right arrangement 
Figure 4.4 The iminodiacetic acid tagged GCN4-bZIP derivative shows the expected DNA binding (left) in the 
absence of a metal ion. However, upon addition of Co(II), the iminodiacetic acid groups chelate the Co(II), 
disrupting the α-helix and hence the coiled coil, resulting in monomer formation and reduced DNA binding (right). 
Reprinted with permission from Azuma et al., Angew. Int. Ed. Engl., 2009, 48, 6853-6. Copyright 2009 WILEY-VCH 
GmbH & Co. 
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Figure 4.6 GCN4-bZIP with azobenzene attached in the coiled coil domain. In the trans configuration the protein 
cannot fold into an α-helix and DNA binding is disrupted. Upon light excitation the cis conformer is produced 
which allows for the α-helix and coiled coil formation, and hence DNA binding Reprinted with permission from 
Woolley et al., Biochemistry, 2006, 45, 6075-84. Copyright 2006 American Chemical Society. 
to form interactions with the DNA and hence bind. However, upon irradiation, the 
protein conformation changes, exposing the DNA binding residues, and binding to 
target DNA is achieved, Figure 4.5.32 
Zhang et al. utilised the trans-cis isomerisation properties that azobenzene 
displays upon UV-light irradiation to control coiled coil formation within the 
leucine zipper region of GCN4. They attached azobenzene to amino acid residues 
seven units apart within the α-helices of the zipper region. In the trans form a bend 
is induced disrupting the α-helix and coiled coil formation. Upon light irradiation 
the cis form of azobenzene is formed, which allows for the coiled coil to form and 
hence DNA binding to be achieved, Figure 4.6.33 
 
 
Figure 4.5 The DNA binding residues of the GCN4 transcription factor are grafted onto the photoactive yellow 
protein. In its native form the DNA binding residues are not exposed (left), but upon irradiation with 446 nm light 
the protein changes conformation, exposing the DNA binding residues and allowing for DNA binding. Adapted 
with permission from Morgan et al., J. Mol. Biol., 2010, 399, 94-112. Copyright 2010 Elsevier Ltd. 
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4.2.2 Controlling DNA Binding using the Dimerisation of Short Peptides 
An alternative approach is to use short readily synthesised peptides and control 
the dimerisation of these. Kim and co-workers were the first to demonstrate this 
approach within the GCN4 system. They replaced the coiled coil region with a 
single cysteine which could subsequently form a disulphide linkage with another 
chain. It was shown that the monomer version did not retain strong DNA binding, 
however, upon dimer formation, DNA binding was recovered.34 
 
A few years later, a more elegant approach utilising non-covalent interactions was 
demonstrated by Ueno et al. utilising a cyclodextrin and guest compound to control 
dimerisation.35 To one unit of the GCN4 binding domain, a cyclodextrin moiety was 
attached, with a 1-adamantaneacetic acid unit attached to the other. Upon 
addition of these two modified strands to target DNA, increased affinity for the 
DNA strand is observed in relation to the monomer peptide species when studied 
individually.35 The group went on to study whether non-covalent interactions, such 
as that of the 1-adamantaneacetic acid with cyclodextrin, displayed the same DNA 
binding properties as covalent dimerisation techniques. They concluded that, 
although the covalently linked peptide displayed a slightly higher affinity for DNA, 
the non-covalent versions displayed enhanced selectivity.36 It is thought that this 
is due to the monomer GCN4 units binding weakly to the DNA and pre-organising 
the dimerisation entities. 
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4.2.3 Controlling DNA Binding with Basic Domain Orientation 
In order to display strong DNA binding, the basic domain of the protein not only 
needs to be dimerised, but also has to be held in the correct orientation. This 
property has also been utilised to control DNA binding. 
 
Schepartz and co-workers attached the binding residues to iron complexes to allow 
for the control of the orientation and distance between the binding regions.37 
Peacock and Oheix took this further, developing a reversible metal based system 
to allow for control of the orientation and hence DNA binding. A terpyridine 
linkage between the two peptidic binding domains displayed weak DNA binding in 
the apo form, however, upon addition of Cu(II) or Zn(II), the terpyridine chelates 
to the metal and the resultant cis orientation of the peptide chains promotes DNA 
binding.38 
 
Mascareñas and colleagues appended the DNA binding region of GCN4 to an 
azobenzene linker with the aim of using the cis-trans isomerisation properties of 
azobenzene to control DNA binding. They established that when the azobenzene 
linker was in the trans conformation, poor DNA binding was observed. Upon light 
excitation the azobenzene unit converted to the cis conformation, shortening the 
distance between the two DNA binding domains and resulting in an increase in 
DNA binding, Figure 4.7.39 
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These approaches offer the advantage of using relatively short peptides, which are 
more readily synthesised than those that include the leucine zipper region of 
GCN4. Work has also shown that both dimerisation and orientation of the strands, 
can be used to control the sequence to which the peptide structure binds. By linking 
the peptide chains at the N-terminus as oppose to the natural C-terminus, the 
target site can be reversed.40 
 
Most recently, Mascareñas and co-workers published work that utilised the 
different DNA sequence selectivity when dimerised at the C- or N- terminus. The 
C-terminus of the GCN4 DNA binding domain contained a Ni(II) dependent 
dimerisation unit. However, the N- terminus could be dimerised via a cysteine 
residue introduced for disulphide formation. Dimerisation through the natural C- 
terminus was shown to maintain selectivity for the natural DNA target site, whilst 
dimerisation through the N- terminus displayed selective binding for a reversed 
target site.41 
Figure 4.7 Schematic representation of azobenzene linked basic regions of GCN4. In the trans form there is a 
large distance between the chains (left) and no DNA binding is observed. Upon isomerisation, the cis form binds 
to the target site of DNA. Reprinted with permission from Caamaño et al., Angew. Int. Ed. Engl., 2000, 39, 3104-
7. Copyright 2000 WILEY-VCH GmbH & Co. 
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4.3 Project Aims 
Within this project anthracene will be incorporated on the terminus of the GCN4 
transcription factor, in place of the natural dimerisation unit, the coiled coil. It is 
thought that this incorporation will not disrupt the ability of the peptide to bind to 
a specific sequence of DNA and the anthracene unit can be utilised to assess this 
by monitoring the fluorescence output in a similar fashion to Chapter 3. When the 
peptide binds to target site DNA, the anthracene units will be arranged in a close 
proximity to one another and, upon irradiation, they will form a photodimer which 
will result in an increased binding affinity for the target site, Figure 4.8. In the 
absence of the specific sequence, the anthracene units will not be arranged in close 







Figure 4.8 Schematic representation of the anthracene tagged peptide binding to target site DNA. Upon binding, 
the anthracene units are placed in close proximity and will form the photodimer upon irradiation. 
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4.4 Anthracene Tagged Peptide for Dimerisation Control 
4.4.1 Anthracene Tagged Peptide Design 
All essential residues for specific DNA binding29,42 were maintained within the 
design (shown in bold), along with the linker region which is known to enhance the 
thermal stability of the protein-DNA complex (underlined).43 A lysine was 
incorporated towards the C- terminus with a labile protecting group on the side 
chain, to allow for the preferential deprotection of this group, for the subsequent 
incorporation of the anthracene moiety (highlighted in black). Three additional 
residues, not essential to DNA binding, that form part of the natural GCN4 
sequence were retained at the N- terminus to help maintain the α-helical nature 
of the peptide within the DNA binding region. A glycine was incorporated at the 
C- terminus to aid in the synthesis of the peptide. The final sequence is shown 
below: 
 
Ac -A L K R A R N T E A A R R S R A R K L Q R M K Q K G - NH2 
 
A methyltrityl (Mtt) protecting group was chosen to protect the lysine at which the 
anthracene was to be incorporated and was selectively removed in mild acid, 
maintaining other side chain protecting groups and the bond between the resin 
and the peptide. The removal of the Mtt group was tracked using the Kaiser test.44 
It was found that three cycles of 3% TFA in DCM for 10 minutes were required so 
as to ensure complete deprotection. A carboxylic acid derivative of anthracene was 
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subsequently coupled via the side chain amine using standard coupling conditions 
for 15 hours.45 The peptide sequence was then completed and the peptide cleaved, 
deprotected and purified using standard conditions.46  
 
The initial anthracene derivative chosen for coupling was the carboxylic acid 
intermediate, formed during the synthesis of anthracene phosphoramidites for 
incorporation into DNA (Chapter 2.3), Figure 4.9. However, it was identified by 
MS that this derivative did not survive the peptide synthesis conditions. A mass 
which could be attributed to cleavage of the anthracene at the ester bond was 
observed and hence this derivative could not be used. Instead anthracene 9-
carboxylic acid was successfully incorporated as desired. 
4.4.2 DNA Sequences used within this Study 
In order to study the DNA sequence selectivity, three strands of DNA were 
assessed, target site (CRE), a strand containing half the target site (half CRE) and 
a non-specific (NS) sequence.  
Figure 4.9 Structure of anthracene derivatives used in this study. A) 6-(anthracene-9-yloxy) hexanoic acid 
incorporation was unsuccessful. B) Anthracene 9-carboxylic acid was successfully incorporated. 
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           Table 4.1 DNA sequences used within the study with target sites shown in bold. 
Name Sequence 
CRE 1 5′-ACG AGA TGA CGT CAT CTC CA-3′ 
 
CRE 2 3′-TGC TCT ACT GCA GTA GAG GT-5′ 
 
Half CRE 1 5′-TGG AGA TGA CGT TGT CTC GT-3′ 
 
Half CRE 2 3′-ACC TCT ACT GCA ACA GAG CA-5′ 
 
NS 1 5′-TGG AGT ATG CGT CGA TTC GT-3′ 
 
NS 2 3′-ACC TCA TAC GCA GCT AAG CA-5′ 
 
 
The NS sequence contains the same number and type of bases as CRE and half 
CRE, but in a scrambled order. It is expected that the peptide will display some 
affinity for NS DNA due to favourable electrostatics between the positive peptide 
and the negative DNA. In addition to this, the hydrophobic, planar anthracene is 
expected to intercalate into the DNA so as to be shielded from the water 
environment. With the half CRE system, there is a binding site for only one peptide 
strand. It is expected that one peptide may fold into an α-helix and bind weakly to 
the DNA at the target site, whilst the other peptide will bind in a non-specific 
manner. Finally, with the CRE site, two peptides are proposed to be able to bind 
in a specific nature, forming contacts with the bases in the DNA sequence. This 
conformation preorganises the anthracene moieties to allow them to photodimerise 
upon irradiation. It is proposed that in the other systems, due to the anthracene 
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groups not being in close proximity, no photodimerisation will be observed, Figure 
4.10. 
 
Figure 4.10 The peptide is expected to be unfolded in solution (A), upon addition of NS DNA the peptide will 
associate in a non-specific manner (B); with half CRE DNA one peptide can fold and form specific interactions (C); 
whilst with CRE DNA two peptides can bind (D); upon irradiation no photodimerisation is expected with no DNA 
present (E); when associated with NS DNA (F) or with half CRE DNA (G); when irradiated whilst preorganised with 
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4.5 DNA Binding of Anthracene Tagged Peptide 
4.5.1 Fluorescence and UV-Vis Tracked Binding 
The fluorescence of anthracene is known to be quenched by DNA bases and hence 
a reduction in fluorescence is expected upon DNA binding.47,48 It was observed 
that, upon addition of NS DNA, there was a slight reduction in fluorescence 
intensity, this is accompanied by a small (2 nm) bathochromic shift in the λmax and 
could be attributed to intercalation of the anthracene.49 With the addition of half 
CRE a greater reduction is seen and a further decrease is seen with the addition 
of CRE (Figure 4.11). Both of these systems show no bathochromic shift possibly 
indicating a different binding mode in these systems.48,50 
In an attempt to quantify the binding affinity and stoichiometry, binding fits were 
performed on the above fluorescence titrations for CRE and NS DNA, Figure 4.12, 
using Dynafit software (Biokin Ltd., Massachusetts, USA).51 This software uses 
the Newton-Raphson algorithm for computing the composition of the reactants of 
the equilibrium process. The binding curves are then obtained using the Livermore 
Figure 4.11 Fluorescence spectra of anthracene tagged peptide (2 µM) in 10 mM sodium phosphate buffer pH 
7 and 100 mM NaCl, in the presence of increasing concentrations (0-3 µM) of duplex A) NS, B) Half CRE or C) 
CRE DNA at 293 K. λex = 325 nm. 
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solver and a Levenberg-Marquardt least squares regression algorithm.51 In both 
cases a 1:1 stoichiometry of peptide:DNA showed poor fitting. However, 2:1 and 3:1 
peptide:DNA fits were comparable and could not be used to unambiguously assign 
DNA binding ratios. This is expected to be as a result of multiple binding modes 
occurring, such as electrostatics and intercalation of anthracene. Using a 
stoichiometry of 4:1 and 5:1 displayed poor fits. A similar study was performed 
using UV-Vis spectroscopy to track DNA binding, Figure 4.13, which displayed 
similar trends to above. 
 
Figure 4.13 Fittings of UV-Vis titrations of CRE (A) and NS (B) DNA into 2 µM anthracene tagged peptide using 
a 1:1 (solid), 2:1 (dash) and 3:1 (dotted) peptide:DNA binding model. Performed in 100 mM NaCl and 10 mM 
sodium phosphate buffer pH 7 at 293 K. 
Figure 4.12 Fittings of fluorescence titrations of CRE (A) and NS DNA (B) into 2 µM anthracene tagged peptide 
using a 1:1 (solid), 2:1 (dash) and 3:1 (dotted) peptide:DNA binding model. Performed in 100 mM NaCl and 10 
mM sodium phosphate buffer pH 7 at 293 K. 
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Dissociation constants were calculated using the fits shown in Figures 4.12 and 
4.13, Table 4.2. The binding constants obtained are all within the micromolar 
range, which is comparable to binding of dimer systems reported in the 
literature.52–54 Monomer systems have been reported and are typically an order of 
magnitude weaker.28 Binding to NS DNA is not commonly reported due to the 
weaker binding affinity. Within our system, the similarity between the two DNA 
systems is proposed to be an indication of the relatively high binding affinity the 
anthracene moiety contributes due to intercalation, in combination with 
favourable electrostatic interactions between the positive peptide and negative 
DNA backbone. 
Table 4.2 Dissociation constants calculated from fitting fluorescence and UV-Vis titrations of CRE and NS DNA 
into peptide. All performed using Dynafit software (Biokin Ltd., Massachusetts, USA). 
System Fluorescence logKD UV-Vis logKD 
CRE 2:1 -6.1 -6.7 
CRE 3:1 -5.8 -6.2 
NS 2:1 -5.9 -6.0 
NS 3:1 -5.6 -5.9 
 
Job plots were also attempted on the system (Appendix, Figure 8.4). Upon 
changing the concentration of the peptide, the anthracene signals change in 
intensity due to the concentration of the chromophore also changing. This was 
accounted for by completing an identical “Job plot” in the absence of DNA. 
However, when data was corrected for this, there was a large amount of variation 
in the points and the stoichiometry could not be deduced. 
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4.5.2 Circular Dichroism Tracked Binding 
Circular dichroism (CD) has also been used to assess if the miniature peptide still 
recognises the natural DNA binding site. Anthracene tagged peptide monomer was 
shown to be relatively unfolded (38% ± 1) in the absence of DNA. Upon addition of 
1:2 NS DNA to anthracene tagged peptide monomer, very little change to the 
folding of the peptide (40% ± 2) is observed, Figure 4.14A. This would be expected 
due to the lack of a binding site, and the formation of only non-specific interactions 
between the peptide and the DNA, Figure 4.10B. However, the analogous 
experiment performed with half CRE DNA, lead to an increase in the α-helical 
content of the peptide (57% ± 2). A further increase is seen upon addition of CRE 
DNA (75% ± 1), Figures 4.14B and C, respectively. In order to bind, the peptide 
needs to form specific bonds to the DNA bases and in order to do this the peptide 
needs to be folded into an α-helix. Upon addition of CRE DNA, two peptides can 
fold to bind the two target sites present (Figure 4.10D) and this is shown by an 
increase in the α-helical content from 38  75%. In the presence of half CRE, only 
one peptide can bind as an α-helix (Figure 4.10C) and hence results in half the 
increase of that seen with CRE DNA. 
Figure 4.14 CD tracked addition of DNA (1 µM) to peptide (2 µM) in 100 mM NaCl and 10 mM sodium phosphate 
buffer pH 7 at 293 K. Peptide (____) and with DNA (-----) for NS (A), half CRE (B) and CRE DNA (C). DNA signals have 
been subtracted from all spectra. 
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In all cases changes in the 250-300 nm region of the spectra are observed. These 
have been attributed to a combination of effects from the anthracene induced 
signal and changes to the DNA backbone.55,56 
 
4.5.3 Thermal Melting Analysis of DNA 
It is known that when molecules bind to DNA, by intercalation or via groove 
binding, that the Tm of the DNA can change.57 As such the Tm values of CRE and 
NS DNA in the absence and presence of anthracene tagged peptide were measured, 
Table 4.3. Values are reported to the nearest 0.5°C, although the repeats show 
error lower than this value, the instrumental error is 0.5°C and therefore the 
values cannot be reported to more accuracy. It can be seen that with both DNA 
sequences there is an increase upon addition of anthracene tagged peptide. This 
agrees with the observations from earlier studies, as both intercalation (in the case 
of NS DNA),50,58 but also with major groove binding (in the case of CRE DNA) is 
expected to be associated with an increase.57 
Table 4.3 Tm values obtained for CRE and NS DNA (1 µM) in the absence and presence of anthracene tagged 
peptide (2 µM). All performed in 100 mM NaCl and 10 mM sodium phosphate buffer pH 7. All values are average 
of 2 repeat runs and are reported to the closest 0.5 °C due to the limits of experimental error. 
DNA Strand Tm without peptide (°C) Tm with peptide (°C) 
CRE 65.5 68.0 
NS 65.5 69.0 
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4.6 Formation of Anthracene Tagged Peptide Photodimer – Long Irradiation 
4.6.1 UV-Vis and Fluorescence Tracking 
Initial studies into the photodimerisation of the anthracene tagged peptide were 
performed by irradiating at 365 nm until the anthracene band in fluorescence and 
UV-Vis had fully disappeared, as would be expected upon dimer formation. It was 
found that this occurred over 90 minutes and that with CRE and NS DNA strands, 
a similar rate of reduction was seen, Figures 4.15 and 4.16. 
Figure 4.16 UV-Vis tracked irradiation of anthracene tagged peptide with NS (A) and CRE (B) DNA. Peptide (2 µM) 
shown prior to addition of DNA (…….) and after addition of 1 µM DNA (____) followed by irradiation with 365 nm 
light for 15, 30, 45, 60, 75 and 90 minutes. Performed in 100 mM NaCl, 10 mM sodium phosphate buffer pH 7 at 
293 K. 
Figure 4.15 Fluorescence tracked irradiation of anthracene tagged peptide with NS (A) and CRE (B) DNA. Peptide 
(2 µM) shown prior to addition of DNA (…….) and after addition of 1 µM DNA (____) followed by irradiation with 
365 nm light for 15, 30, 45, 60, 75 and 90 minutes. Performed in 100 mM NaCl, 10 mM sodium phosphate buffer 
pH 7 at 293 K. λex = 325 nm. 
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This would not have been predicted as it was expected that only the CRE DNA 
would allow for the preorganisation of the anthracene moieties, which is proposed 
to be a requirement for photodimerisation to occur under these experimental 
conditions, Figure 4.10D.  
 
4.6.2 Monitoring Photodimer Formation using SDS-PAGE 
In order to evaluate if these events are associated with photodimer formation, the 
irradiated samples were subsequently analysed via SDS-PAGE, Figure 4.17. It can 
be seen that in the samples that were irradiated in the presence of NS DNA, there 
is only a very weak band at higher molecular weight, indicating that very little 
photodimerised anthracene tagged peptide is present. In the samples irradiated in 
the presence of CRE DNA, a higher molecular weight species is identified, however 
over the course of the extended irradiation there appears to be no further increase 




Figure 4.17 SDS-PAGE of 2 µM peptide in the presence of either 1 µM NS (lanes 1-7) or 1 µM CRE (lanes 8-14) 
DNA in 10 mM sodium phosphate buffer pH 7 and 100 mM NaCl irradiated with 365 nm light at 293 K. Aliquots 
taken prior to irradiation and at 15, 30, 45, 60, 75 and 90 minutes. Visualised using Coomassie brilliant blue R-
250 protein stain. 
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4.6.3 Monitoring Photodimer Formation with Mass Spectrometry 
Irradiated samples were analysed by mass spectrometry, to assess whether the 
new higher molecular weight species is a dimer product and to provide insight into 
the origin of the decrease in the anthracene bands (not associated with photodimer 
formation) in the presence of NS DNA. It was found to be problematic to obtain 
mass spectra for samples which had been irradiated in buffer (and in the presence 
of salt) and subsequently desalted. In order to overcome this, samples were 
irradiated in water and analysed by Dr Andrew Jones. The results indicated the 
presence of several species with the most prevalent corresponding to masses of 
3137.8, 3341.9 and 6683.8 Da. Peptide prior to irradiation was run using the same 
method and gave the expected mass of 3325.9 Da. 
 
A mass of 3341.9 Da species is consistent with the addition of an oxygen atom to 
the peptide. The corresponding dimer of this would have a mass of 6683.8 Da which 
is also detected. If we assume the mass of 3137.8 Da is also from an oxidised 
species, the reduction in relation to 3341.9 Da of 204.1 Da could correspond to the 
loss of the anthracene and the carbonyl group used to attach it, with the addition 
of one proton. However, there is no further experimental evidence to support this 
hypothesis, although the loss of anthracene could account for the loss in 
fluorescence and UV-Vis signals. 
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4.6.4 Peptide Irradiated Alone – UV-Vis and MS Analysis 
In order to understand the system further, anthracene tagged peptide was 
irradiated in the absence of DNA and the anthracene band tracked by UV-Vis 
spectrometry, Figure 4.18. This also indicated a significant reduction in 
absorbance over the course of two hours. 
Analysis of the sample by MS indicated the major species to be of mass 3340.89 
Da, a +16 Da species, along with a small amount of 3162.81 Da, corresponding to 
loss of 162 Da, and no dimer formation. It is proposed that the +16 Da species is 
the result of oxidation. Subsequent MS fragmentation studies, performed by Dr 
Cleidiane Zampronio, indicated this to be the case with oxidation of methionine 
identified, Figure 4.19. Oxidation of methionine is known to occur during light 
exposure over extended periods of time.59,60 Interestingly, irradiation of a control 
peptide (Ac-ALKRARNTEAARRSRARKLQRMKQCG-NH2) prepared previously 
in the group by Xun Zhong,61 which lacks our anthracene unit, but which contains 
the same methionine residue, showed no oxidation. It is therefore proposed that 
the anthracene moiety is enhancing the oxidation of the methionine residue. 
Figure 4.18 UV-Vis tracked irradiation of anthracene tagged peptide (2 µM) shown prior to irradiation (black) 
and after 1 hour (dark grey) and 2 hour (light grey) irradiation with 365 nm light. Performed in 100 mM NaCl, 
10 mM sodium phosphate buffer pH 7 at 293 K. 
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However, this observation does not account for the reduction in the anthracene 
signals seen in the UV-Vis and fluorescence spectra recorded after irradiation. If 
oxidation is occurring on the methionine, then it is assumed that the anthracene 
it is not being chemically altered, and a decrease in the optical spectra would not 
be expected. 
Figure 4.19 ESI-MS of irradiated peptide (top) with fragmentation of the 3340.89 Da peak showing oxidation of 
methionine (bottom). Experiments performed by Cleidiane Zampronio. Residues shown in red are found to have 
modifications, alanine is acetylated and glycine amidated as part of the peptide synthesis, the lysine is modified 
with the anthracene moiety and methionine with the oxygen species being investigated. 
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It should be noted that mass spectrometry probes the molecules in the gaseous 
state and it is therefore results are not always indicative of the molecules that are 
in solution. This could account for the unexplained behaviour observed. 
 
4.6.5 Small Molecule Irradiation 
In an attempt to determine the cause of the reduction in UV-Vis and fluorescence 
signals, small molecule anthracene derivatives were subsequently irradiated and 
investigated. These studies were performed at low micromolar concentrations to 
mimic the conditions used in the peptide system, and where possible, in aqueous 
solvent. This proved difficult and experiments were hindered by precipitation over 
time. However, MS and NMR of dilute samples of anthracene-9-carboxylic acid 
were obtained prior to and following, irradiation. The spectra taken after 
irradiation indicated the complete conversion to anthraquinone, a known product 
of anthracene irradiation in an oxygen rich environment (Figure 4.20).62,63 If we 
apply the same reaction scheme for the formation of anthraquinone proposed by 
Mallakin and co-workers to our system, it would result in detachment of the 
anthracene from the peptide. Within the mass spectrum presented in Section 4.6.4, 
a species of mass 3162.82 Da was detected which could correspond to loss of the 
anthracene and an additional proton if the methionine is also oxidised. The 
fragmentation studies reported would also be consistent with this scenario. 
Figure 4.20 Chemical structure of anthraquinone, a known oxidation product of anthracene. 
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The formation of anthraquinone would be consistent with the reduction in the 
fluorescence and UV-Vis spectra, as was observed upon irradiation of the 
anthracene tagged peptide. However, the MS studies on the samples indicate that 
not all of the peptide is degraded, despite the spectral studies indicating no 
remaining characteristic anthracene bands. 
 
4.6.6 Degassing Trials 
It was known from previous studies64 that the anthracene moiety used in the DNA 
work did not display the same degradation problems. A trial was performed 
irradiating an anthracene tagged oligonucleotide system with and without 
degassing the sample to monitor the effect, Figure 4.21. Degassing the sample will 
removed oxygen and therefore decrease the oxidation products formed. This 
showed a stark difference between the two systems, with no reduction in 
fluorescence signal when irradiation was performed after degassing. 
Figure 4.21 Fluorescence tracked irradiation of anthracene tagged oligonucleotide BM-Pr(3L) in 100 mM NaCl 
and 10 mM sodium phosphate buffer pH 7 at 293 K. Scans taken at 0, 30, 60, 90 and 120 minutes with no prior 
degassing (A) and with degassing for 10 minutes prior to irradiation and then continued degassing during (B). 
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In order to minimise the amount of oxidative damage caused with the anthracene 
tagged peptide, samples were degassed to remove the oxygen as above. Comparison 
of the degassed sample to one which was subject to no degassing, Figure 4.22, 
showed the opposite trend to above. The degassed sample showed a greater 
reduction in the anthracene fluorescence over the course of 30 minutes irradiation. 
In order to conclude that the degassing was not causing this effect due to mixing 
of the sample rather than the oxygen displacement, a similar experiment was 
performed with a sample with air being bubbled through, Figure 4.23. This sample 
displayed the same reduction in fluorescence as that which had not been degassed, 
confirming the difference is due to the reduction in dissolved gases and not a result 
of agitation of the sample. 
Figure 4.22 Fluorescence tracked irradiation of anthracene tagged peptide without degassing (grey) and with 
argon degassing (black), prior to irradiation (solid) and after 30 minutes irradiation with 365 nm light (dot). All 
performed on 2 µM peptide in 100 mM NaCl and 10 mM sodium phosphate buffer pH 7 at 293 K. 
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These observations are contradictory to the proposed anthraquinone formation, 
(Section 4.6.3) which would be reduced upon removal of oxygen from the 
irradiation environment. Further studies need to be performed to analyse the 
systems further. Possible studies could look to alter the sequence by removing the 
methionine, and monitoring the influence on irradiation. This could indicate 
whether this particular residue located close to the anthracene, is problematic. In 
addition to this it could be helpful to perform NMR studies on the irradiated 
peptide and compare any changes. Due to the large amounts of material required 
to do this, it could not be performed at this time. However, this could provide 
insight in to the site of oxidation and the reduction in the anthracene signals. 
 
4.7 Shorter Irradiations 
Subsequent irradiations were performed over shorter time frames (10 minutes). It 
was hypothesised that this would reduce the amount of photo side products formed. 
Figure 4.23 Fluorescence tracked irradiation of anthracene tagged peptide without agitation (grey) and with air 
bubbling (black), prior to irradiation (solid) and after 30 minutes irradiation with 365 nm light (dot). All performed 
on 2 µM peptide in 100 mM NaCl and 10 mM sodium phosphate buffer pH 7 at 293 K. 
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Analysis of photodimer formation over a period of 30 minutes showed that within 
10 minutes photodimer species had formed and the yield (qualitatively by SDS-
PAGE) did not increase upon further irradiation, Figure 4.24. The gel was 
performed with a control covalently linked dimer (GCN4bd1)2Pyr which had 
previously been synthesised within the group.65 This displayed similar mobility 
through the gel as the higher molecular weight species present, when the 
anthracene tagged peptide is irradiated in the presence of CRE DNA, strongly 
suggesting that this species is the dimer product. Due to these observations 




4.7.1 Fluorescence, UV-Vis and CD Tracked Irradiation 
Formation of the photodimer species was performed with irradiation with 365 nm 
light for 10 minutes and monitored by UV-Vis and fluorescence spectroscopy, 
Figures 4.25 and 4.26. Using this shorter irradiation time, a clear difference can 
be seen when the anthracene tagged peptide is irradiated with CRE DNA. In both 
Figure 4.24 SDS-PAGE tracking photodimer formation of 2 µM anthracene tagged peptide with 1 µM DNA where 
applicable. Lane 1 – anthracene tagged peptide, 2 – (GCN4bd1)2Pyr covalent dimer control, 3 – peptide alone 
irradiated for 10 minutes, 4 – peptide alone irradiated for 20 minutes, 5 – peptide alone irradiated for 30 minutes, 
6 – peptide with CRE DNA irradiated for 10 minutes, 7 – peptide with CRE DNA irradiated for 20 minutes, 8 – 
peptide with CRE DNA irradiated for 30 minutes, 9 – peptide with NS DNA irradiated for 10 minutes, 10 – peptide 
with NS DNA irradiated for 20 minutes and 11 – peptide with NS DNA irradiated for 30 minutes. Gel visualised 
using Coomassie brilliant blue R-250 protein stain. 
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the fluorescence and UV-Vis spectra, a greater reduction is seen in this sample 
than any of the other systems.  
Figure 4.25 Fluorescence tracked irradiation of anthracene tagged peptide (2 µM). Peptide alone (_____), with DNA 
where applicable (----) and after 10 minute irradiation with 365 nm light (……..). A) Peptide in the absence of DNA, 
B) with NS, C) with half CRE and D) with CRE DNA. All performed in 100 mM NaCl and 10 mM sodium phosphate 
buffer pH 7 at 293 K. λex = 325 nm. 
 
Figure 4.26 UV-Vis tracked irradiation of anthracene tagged peptide (2 µM). Peptide alone (_____), with DNA where 
applicable (----) and after 10 minute irradiation with 365 nm light (……..). A) Peptide in the absence of DNA, B) with 
NS, C) with half CRE and D) with CRE DNA. All performed in 100 mM NaCl and 10 mM sodium phosphate buffer 
pH 7 at 293 K. 
 
Tracking of the irradiation via CD also indicates a difference in the four cases, 
Figure 4.27. The only system which displays a change upon irradiation is the 
sample irradiated with CRE DNA present, which displays a further increase in the 
α-helical content.  
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Figure 4.27 CD tracked irradiation of anthracene tagged peptide (2 µM). Peptide alone (_____), with DNA where 
applicable (----) and after 10 minute irradiation with 365 nm light (……..). A) Peptide in the absence of DNA, B) with 
NS, C) with half CRE and D) with CRE DNA. All performed in 100 mM NaCl and 10 mM sodium phosphate buffer 
pH 7 at 293 K. 
 
 
4.7.2 Summary of Photodimer Formation 
In order to have a more quantitative evaluation of the results, the percentage 
changes in the signals, shown in the above results, were calculated. All values are 
relative to those of the peptide recorded in the presence of DNA, prior to irradiation 
(signals are known to change upon DNA addition as discussed at the beginning of 
this chapter, Figures 4.12, 4.13 and 4.14), Table 4.4. 
Table 4.4 Percentage changes in relative absorbance at 364 nm, fluorescence intensity at 426 nm and percentage 
folding values from ellipticity at 222 nm after 10 minute irradiation with 365 nm with error calculated as standard 
deviation. All relative to initial value taken after DNA addition and average of 3 repeats. 
Sample % change in 
absorbance at 
364 nm (%) 
% change in 
fluorescence 





% folded after 
irradiation 
(%) 
No DNA -8 ± 3 -7 ± 2 38 ± 1 36 ± 1 
NS DNA -9 ± 2 -8 ± 3 40 ± 2 40 ± 1 
Half CRE DNA -6 ± 2 -4 ± 3 57 ± 2 56 ± 2 
CRE DNA -27 ± 1 -20 ± 1 75 ± 1 84 ± 1 
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Reductions in the fluorescence intensity and absorbance, of the anthracene tagged 
peptide, when irradiated alone or in the presence of half CRE or NS DNA, are 
comparable. However, when irradiated in the presence of CRE DNA a much larger 
reduction is seen via these two techniques. This extra reduction is proposed to be 
due to photodimer formation, and illustrates that photodimer formation only 
occurs when the anthracene moieties are pre-organised in close proximity to one 
another. In addition to this, the CRE system is the only system that displays a 
change in α-helical content upon irradiation. This increase in the folding is 
proposed to be due to an increase in binding affinity associated with the dimer 
peptide. 
 
4.7.3 Thermal Melting Analysis After Irradiation 
Following from the Tm analysis reported in Section 4.5.3, the values were record 
after irradiation with 365 nm light for 10 minutes, Table 4.5. Results of the 
irradiated samples were within error of those determined for samples prior to 
irradiation. This indicates the thermal stability of the DNA duplex has not been 
effected by the formation of the photodimer peptide species or by the irradiation 
process. 
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Table 4.5 Tm values obtained for CRE and NS DNA (1 µM) in the absence and presence of anthracene tagged 
peptide (2 µM) before and after irradiation for 10 minutes with 365 nm light. All performed in 100 mM NaCl 
and 10 mM sodium phosphate buffer pH 7. All values are average of 2 repeat runs and are reported to the 
closest 0.5 °C due to the limits of experimental error. 
Sample Tm before irradiation (°C) Tm after irradiation (°C) 
CRE 65.5 66.0 
CRE + Peptide 68.0 68.5 
NS 65.5 66.0 
NS + Peptide 69.0 68.5 
 
 
4.8 Confirmation of Photodimer formation 
4.8.1 SDS-PAGE 
In order to confirm that the reduction seen in the anthracene signals (Figures 4.25 
and 4.26) is accompanied by photodimer formation, the samples were analysed by 
SDS-PAGE, Figure 4.28. As described previously, a control of covalently linked 
peptide (GCN4bd1)2Pyr was also run to allow for comparison. It can be seen that 
the only sample to display a higher molecular weight species, is that for the peptide 
irradiated in the presence of CRE DNA. The new species formed shows the same 
mobility through the gel as that of the covalently linked dimer control, indicating 
that the species have similar mass and confirming that photodimer has been 
formed. The presence of the photodimer band is accompanied by a reduction in the 
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monomer species, as would be expected due to it being converted to the photodimer 
species. The other irradiated samples show no new bands.  
 
It is known that SDS-PAGE with Coomassie brilliant blue R-250 protein staining 
cannot be used as a way to quantify the amount of protein present,66 therefore 
HPLC analysis was performed on the samples in an effort to determine a yield of 
dimer formation. However, the resultant chromatogram displayed poor separation 
and the technique was not pursued any further. 
 
4.8.2 Mass Spectrometry Studies on Short Irradiated Samples 
Several attempts were made to obtain mass spectra of peptide irradiated in the 
absence and presence of DNA strands after short irradiations, for comparison with 
those obtained in Section 4.6.3. It was proposed that the shorter irradiation times 
would limit the amount of degradation and oxidation occurring. Despite utilising 
several desalting methods and performing irradiations in water, suitable spectra 
could not be obtained. 
 
Figure 4.28 SDS-PAGE showing photodimer formation of 2 µM anthracene tagged peptide with 1 µM DNA where 
applicable. Lane 1 – anthracene tagged peptide, 2-(GCN4bd1)2Pyr covalent dimer control, 3 – peptide irradiated 
alone, 4 – with NS DNA, 5 – with half CRE DNA and 6 – with CRE DNA. Gel visualised using Coomassie brilliant 
blue R-250 protein stain. 
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4.9 Effect of Photodimer Formation on DNA Binding 
4.9.1 Gel EMSA Tracked DNA Binding 
Although photodimer formation has been proved, the increased binding affinity 
that this offers had yet to be assessed. Gel EMSA studies were performed which 
indicate that anthracene tagged peptide shows weak binding affinity to NS, half 
CRE and CRE DNA strands, Figure 4.29A. This is shown in the gel by smudging 
of the bands and would be expected due to the various interactions the peptide 
could have with the DNA, such as electrostatics and anthracene intercalation. 
After irradiation, gel EMSA images of NS and half CRE DNA samples are similar 
to those run prior to irradiation. Once again this is as would be hypothesised as 
there has been no evidence of dimer formation within these systems. In stark 
difference, with irradiated in the presence of CRE DNA (Figure 4.29B, lanes 13-
18), a new band of higher molecular weight corresponding to the photodimer 
peptide bound to the DNA strand can be observed. Due to the relative strength of 
this binding, this complex remains intact during the running of the gel. 
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Figure 4.29 Gel EMSA of DNA (100 nM) with increasing anthracene tagged peptide concentrations (0, 100, 200, 
400, 600 and 1000 nM) performed prior to irradiation (A) and after 10 minute irradiation with 365 nm light (B) 
for NS (lanes 1-6), half CRE (7-12) and CRE (13-18) DNA. Gel visualised using SYBR Gold® nucleic acid stain. 
 
4.10 Thermal Reversion Studies 
Anthracene dimerisation is known to be a reversible process upon heating and 
irradiation with lower wavelength light (Chapter 1.5). Samples of anthracene 
tagged peptide irradiated in the absence of DNA, and with NS and CRE DNA, were 
heated to 90°C for 10 hours. They were subsequently analysed via SDS-PAGE, 
Figure 4.30. It can be seen that there is no change in the peptide irradiated in the 
absence of DNA or the peptide irradiated with NS DNA samples, as would be 
expected. However, there is also no evidence of reversion within the peptide 
irradiated with CRE DNA samples, shown by retention of the higher molecular 
weight species (Figure 4.30). 
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It is unknown why this species does not revert upon heating. Previous systems 
within DNA have been shown to readily revert, and are accompanied by similar 
trends presented in Chapter 5.64 It would be interesting to analyse if reversion was 
achieved with irradiation of a higher energy light. Reversion would increase the 
useability of this system as it would allow for the development of a fully 
controllable system. 
 
4.11 Conclusions and Future Work 
Within this work the photodimerisation of anthracene has been investigated 
within a peptide structure for the first time. This has been used to demonstrate a 
light-triggered, highly specific dimerisation event which occurs at low, biologically 
relevant micromolar concentrations. It relies upon the preorganisation of the 
anthracene moieties, adding to the specificity of dimer formation. In addition, 
photodimers only form between anthracene sub units, allowing for site specific 
photodimerisation, a property which is not common in current commercially 
available methods. Studies previously performed on the GCN4 motif have used 
Figure 4.30 SDS-PAGE tracking photodimer reversion. Lane 1 – peptide, 2 – (GCN4bd1)2Pyr control, lanes 3-8 
show irradiated samples (30 minutes with 365 nm light) and heated samples (10 hours 90 °C) 3-4 – peptide in 
the absence of DNA, 5-6 – peptide with CRE DNA and 7-8 – peptide with NS DNA. Visualised using Coomassie 
brilliant blue R-250 protein stain. 
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photoisomerisation to control binding to DNA. Within the system used in this 
study, the change in binding affinities between the monomer and photodimer 
species, is expected to be much larger, although this is yet to be assessed. In the 
future it is hoped that this technology could be used to control a variety of protein 
processes, such as the transcription process. 
 
Although shorter irradiation times have been shown to produce the desired 
photodimer, the products of longer irradiation times are yet to be fully 
characterised. Further studies on model systems should be performed to allow for 
NMR and MS characterisation of the products. Deduction of the degradation 
pathway, could allow for a system to be developed that could prevent such 
degradation and increase the photodimerisation efficiency. Furthermore, 
incorporation into different systems would allow the analysis of the dependence 
this process has on the amino acid sequence, as well as evaluating the 
photodimerisation process using a different process. 
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Photo-Triggered Release of DNA 
 
5.1 Introduction 
This chapter focuses on efforts to achieve the photo-triggered release of single 
stranded DNA, from an assembly that contains a region of duplex DNA. The 
strategy adopted will use anthracene photodimerisation to “lock” DNA into a 
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5.1.1 DNA as a Therapeutic 
In recent years the use of nucleic acids as therapeutic agents has been explored.1,2 
These drugs have the potential to silence genes and insert new genetic material 
into a person’s DNA, and hence supress or completely remove symptoms of 
particular diseases.1,2  The nature of DNA makes these therapeutics extremely 
specific, but due to the body’s natural ability to destroy foreign DNA, hard to 
deliver.3 Several approaches to overcome this have been developed using a variety 
of different delivery and targeting mechanisms.1 
 
Of particular note is the field of antisense RNA research, an area of nucleic acid 
therapeutics which has progressed more rapidly than others. This technique takes 
advantage of the propensity of nucleic acids to form duplexes with complementary 
strands. During the gene expression process, messenger RNA (mRNA) is formed 
(transcription) and it is this which is “read” to create proteins in the translation 
process (Chapter 1.2.2). This process only occurs when the mRNA is single 
stranded and hence binding a complementary strand to the region of interest 
prevents its expression. Fomivirsen was the first such drug to make it to market 
in 1998, although it has since been removed due to poor demand.4 A recent article 
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5.1.2 DNA Origami and Machines 
In addition to its obvious biological applications, DNA has also proved to be a useful 
tool in the development of molecular machines. Due to the specific and predictable 
nature of its binding and folding, elaborate structures can be produced from DNA. 
In 2006 Rothemund reported on the use of a relative simple system formed from 
combining a single stranded DNA scaffold (obtained from the M13 bacteriophage) 
with several short oligonucleotide staples. The staples link the scaffold at 
particular locations via H-bonded base-pairing, which folds the DNA into a variety 
of 2-dimensional structures, Figure 5.1.6 More complex 3D structures which can be 
manipulated using external stimuli, have since been developed and are 
summarised in a recent review by Saccà and Niemeyer.7 
Figure 5.1 2D structures made from DNA strands in a technique known as DNA origami. Top two rows show the 
designs of the DNA strands; the second row shows this with the sequence colour coded from red to purple to 
visualise the folding. Bottom two rows are AFM images of the annealed complexes. Reprinted with permission 
from Rothemund et al., Nature, 2006, 440, 297-302. Copyright 2006 Nature Publishing Group. 
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It is anticipated that coupling this predictable folding and structure with the 
ability of DNA to be programmed to perform various tasks upon addition of an 
external stimulus, would allow molecular machines to be made. These properties 
have led to extensive research in the area of DNA-based devices, research which is 
vast and beyond the scope of this thesis. In 2011 Krishnan and Simmel published 
a comprehensive review into work that had been completed so far.8 Of particular 
note is the work by Turberfield and co-workers who have developed molecular 
machines fuelled by DNA strands.9 These include DNA walkers that can be 
programmed to follow a set route,10,11 and reversible, shape changing DNA 
nanostructures.12  
 
5.1.3 Use of Photo-Triggered Release 
Much research has focussed on releasing a single stranded oligonucleotide (ssDNA) 
from a duplex, which could then be used as an antisense strand or as a stimulus to 
control a molecular machine. Aside from the traditional ways to denature the DNA 
duplex and release ssDNA, such as increasing temperature or altering the pH, 
release can be controlled electrochemically.13 This work incorporated a 
daunomysin group into the DNA structure, the oxidised form of which intercalates 
in the DNA structure giving a stable duplex. However, the reduced form 
significantly lowers the Tm of the duplex and, at particular temperatures, ssDNA 
is formed. 
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Of interest to this work, is the ability to trigger the release of an oligonucleotide in 
situ utilising light. Groups have made efforts towards this goal utilising photo-
cross-linked hydrogels14 and photoresponsive catanionic vesicle complexes, which 
contain the ssDNA of interest.15 
 
Many other groups have focused on releasing a complementary strand from duplex 
DNA using light, and work in this area has been summarised in a recent review, 
below follows highlights from this.16 Asanuma and co-workers incorporated 
azobenzene derivatives into DNA to replace one base. Upon irradiation with light, 
azobenzene undergoes a cis-trans isomerisation. In the trans form the derivative 
can intercalate with surrounding bases and a duplex is formed. However, upon 
isomerisation the duplex is disrupted, releasing the complementary strand.17 This 
technique has since been utilised in many molecular devices.18–22 This method, as 
with the electrochemical technique described above, relies upon the change in Tm 
afforded, by the reduced ability of the modification to intercalate into the duplex of 
DNA. In order for complete release to be achieved, several azobenzene 
modifications are required. A recent study investigated various duplexes of the cis 
and trans isomers and showed that both incorporations distorted the B-DNA fold.23 
The authors commented that they were analysing the melting of DNA-azobenzene 
derivatives, but this work is yet to be published. 
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Spiropyran24–26 and diarylethene27 derivatives have also been incorporated into 
DNA. Although both these groups display photoisomerisation properties that are 
maintained once incorporated into the DNA structure, they induce minimal effects 
on the stability of DNA duplexes. 
 
In addition to the work performed using azobenzene, Asanuma and colleagues 
have also reported on the irreversibe photocrosslinking of duplex DNA. The group 
incorporated p-stilbazole derivatives into each of the DNA strands and showed that 
the duplex structure could still form with these modifications. Upon irradiation 
with 340 nm light, an irreversible crosslink was formed, Figure 5.2.28 
 
 
In 2012, Tucker and co-workers reported on the photocontrolled binding of DNA 
strands using anthracene photodimerisation. It was demonstrated that when two 
anthracene moieties within the same sequence of DNA were photodimerised, a 
Figure 5.2 Schematic representation of the photocrosslinking of DNA using p-stilbazole derivatives. Incorporation 
to replace one base on each of the complementary strands results in stacking of the p-stilbazole units. 
Subsequent irradiation with 340 nm light crosslinks the moieties and hence the DNA. Reprinted with permission 
from Kashida et al., J. Am. Chem. Soc., 2013, 135, 7960-6. Copyright 2013 American Chemical Society. 
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duplex with the complementary strand could not be formed. However, duplex 
formation followed by irradiation prevented the anthracene photodimer from 
forming, Figure 5.3.29  
 
It was anticipated that adding to the existing tools, a photo-activated reagent that 
could crosslink a specific duplex of DNA and hence release a complementary 
strand, would allow for more complex DNA machines to be made.  
 
5.1.4 Previous Efforts Towards Photo-Triggered Release 
Previously within the Tucker group, research was directed towards achieving the 
photo-triggered release of a short oligonucleotide strand by building on the work 
described above.30 Two anthracene moieties, as described in Chapter 2.3, were 
incorporated into one DNA sequence to allow for photodimerisation, with the 
hypothesis that the oligonucleotides could be “locked” into a conformation, and 
release the complementary strand. The initial system consisted of an 
Figure 5.3 Anthracene moieties have been incorporated into an oligonucleotide to replace one base. Upon 
irradiation with 365 nm light, the anthracene photodimer product can be formed, folding the DNA and 
preventing duplex formation. However, if the anthracene modified oligonucleotide forms a duplex prior to 
irradiation, no photodimer product is observed. Adapted with permission from Manchester et al., J. Am. Chem. 
Soc., 2012, 134, 10791-4. Copyright 2012 American Chemical Society. 
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oligonucleotide with anthracene attached to either end. Upon irradiation it was 
hypothesised that the tagged oligonucleotide would form a loop and the 
complementary strand would be displaced (Figure 5.4 A). However, very little or 
no photodimer formation was observed within this system, presumably due to the 
base pairing preventing the anthracene units from coming into close proximity. In 
an effort to overcome this, the anthracene tagged strand was extended to 
incorporate extra bases between the anthracene tags and the duplex region, using 
so-called “floppy ends” (Figure 5.4 B). However, upon irradiation, if anything this 
modification made the situation worse, with now no photodimer formed at all.  
Figure 5.4 Designs previously studied within the Tucker group for photo-triggered release of an oligonucleotide. 
A) A duplex system with anthracene incorporated at the ends. It was hypothesised that, upon irradiation this 
would form a loop, displacing the complementary sequence. B) “Floppy ends” modification with extra bases 
between the anthracene and the duplex DNA (red and blue) was shown to not form photodimers. C) A stem loop 
system with complementary overhangs (red), to help force the system into a folded conformation, to aid 
photodimer formation. It was found that, although photodimer did form in this case, the complementary strand 
remained bound in the loop. 
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A third generation system utilised a stem loop system. Within this the “floppy 
ends” were designed to be complementary to one another, with the aim to push the 
equilibrium towards the loop folded system and increase the extent of photodimer 
formation (Figure 5.4 C). This modification proved successful and yielded 
photodimer species. However, further analysis utilising fluorescence tagged 
systems indicated that, although the photodimer stem loop had been formed, the 
complementary strand was not displaced by this process, and in fact remained 
bound to the stem loop, Figure 5.4 C. 
 
5.2 Project Aims 
Within this project, the stem loop system will be taken and extra bases will be 
added to the complementary strand to form an overlapping region. It is 
hypothesised that this will allow for the photodimer stem loop to still form, but due 
to the overlapping bases, the complementary strand will now be displaced. This 
will be assessed using optical techniques along with gel electrophoresis. The 
reversibility of the system will also be assessed. 
 
5.3 Stem Loop System 
5.3.1 Design of Stem Loop Release System 
It had been previously suggested that incorporating additional bases into the 
complementary strand, which overlapped with the stem loop, may allow for the 
release of the strand.30 Therefore a sequence was designed which incorporated two 
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extra bases, overhanging on each end of the release strand (OH1), which were 
complementary to the stem sequence, Figure 5.5. No changes were made to the 
stem loop sequence (SL), which utilised anthracene units with D stereochemistry 
and a carbon linker length of 7, which had previously been shown to form 
photodimer products. The sequences synthesised are shown in Table 5.1. 
 
Figure 5.5 Design of extended complementary system, which incorporates complementary bases to the stem 
loop (red). It is hypothesised that the stem loop will form and become locked in this conformation by 
photodimerisation, which is expected to displace the complementary strand.  
 
 
Table 5.1 Oligonucleotide sequences used within this study. The stem loop sequence (SL) has anthracene 
moieties identified as “X” (carbon linker of 7, D stereochemistry) incorporated on the ends. The extended ends 
of the SL sequence (underlined, bold) are complementary to one another to promote stem loop formation. 
Additional bases (underlined, bold) were added to the complementary strand, OH1. 
Name Sequence 
SL 5′- XGCGACTGGACTCTCTCAATGGTCGCX -3′ 
OH1 3′- TGACCTGAGAGAGTTACCA -5′ 
 
5.3.2 Thermal Melting Studies 
The Tm values of the sequences were measured as described in Chapter 2.7.3. A Tm 
of 66 °C was recorded for the SL sequence alone, and 65 °C for SL duplex with 
OH1. The high Tm for the hairpin SL, despite having only five complementary 
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bases pairs, is thought to be due to the two anthracene units stacking with one 
another and hence increasing its stability. The Tm for the duplex of SL and OH1 is 
higher than the previous target (the duplex without the extended bases, as used in 
previous studies, gave a Tm of 54 °C).30 This would be expected due to the extra 
base pairs now available and theoretical calculations predicted a Tm of 62 °C. The 
increase in relation to this prediction can be rationalised by stabilising interactions 
provided by the anthracene modifications. This was also observed in the original 
system which had a predicted Tm of 53 °C and has also been seen in other duplex 
systems.30,31 The two systems, duplex (SL:OH1) and stem loop (SL), have Tm values 
within error of one another, suggesting they have very similar stabilities. This 
should allow for a dynamic equilibrium between the two conformations and 
therefore photodimer formation is expected to be possible. 
 
5.3.3 Photodimerisation Studies 
Initial irradiation studies were performed on SL in the absence of target to ensure 
photodimer formation was possible, and to confirm the results obtained previously 
on this strand, Figure 5.6.30 
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Over the course of an hour, the majority of the anthracene signal had disappeared 
at a rate that was comparable to that seen previously, and attributed to the 
conversion to photodimerised species, SL-D. 
 
Subsequently, the SL:OH1 duplex (1:1 ratio) was irradiated and the anthracene 
signal tracked as before, Figure 5.7.  
Figure 5.6 UV-Vis spectra tracking photodimerisation of SL. Performed with 20 µM SL in 100 mM NaCl and 10 
mM sodium phosphate buffer pH 7 at 293 K. Sample irradiated with 365 nm light after 10 minutes degassing with 
argon. Scans recorded every 10 minutes for 30 minutes (black to grey) followed by a further 30 minute irradiation 
(dotted). 
 
Figure 5.7 UV-Vis spectra tracking photodimerisation of SL:OH1 duplex. Performed with 20 µM SL and 20 µM 
OH1 in 100 mM NaCl and 10 mM sodium phosphate buffer pH 7 at 293 K. Sample irradiated with 365 nm light 
after 10 minutes degassing with argon. Scans recorded every 10 minutes for 60 minutes (black to grey) followed 
by a further 30 minute irradiation (dotted). 
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However, despite an extended irradiation period of 90 minutes, there was no 
decrease in the anthracene signal, indicating that no photodimer had been formed. 
This was consistent with duplex formation dominating the equilibrium and 
restricting the folding of the stem loop, despite the Tm values being similar. In this 
conformation, the anthracene moieties would be held far apart (approximately 60 
Å), preventing the photodimer forming. 
 
5.3.4 New Reduced Length Targets 
In an attempt to overcome this issue, further target strands were synthesised, with 
fewer complementary bases within the stem region of the stem loop sequence, 
Table 5.2. It was hypothesised that these sequences would still allow for 
photodimer formation as seen in previous work (Figure 5.4),30 whilst also resulting 
in the displacement of the complementary sequence by virtue of the photodimer 
not binding the dimerised stem loop strand. 
 
Table 5.2 New oligonucleotide sequences compared to those previously used (Table 5.1). Bases complementary 
to the stem region of SL (underlined, bold) are varied between sequences. 
Name Sequence (5′  3′) 
SL 5′- XGCGACTGGACTCTCTCAATGGTCGCX -3′ 
OH1 3′- TGACCTGAGAGAGTTACCA -5′ 
OH2 3′- TGACCTGAGAGAGTTAC -5′ t 
OH3 t 3′- ACCTGAGAGAGTTACCA -5′ 
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5.3.5 Photodimerisation with Reduced Length Targets 
SL:OH2 and SL:OH3 duplexes were irradiated with 365 nm light and UV-Vis 
spectra recorded at set time intervals, Figure 5.8. 
However, once again it was found that, despite the reduced length of the target 
strands, no reduction in the anthracene band was observed, indicating a lack of 
photodimerisation under these conditions. Subsequent analysis of the samples by 
native gel electrophoresis confirmed this, Figure 5.9. Upon irradiation of SL alone, 
a slight shift in the mobility of the band in the gel is observed, as SL-D is formed 
(Figure 5.9 Lanes 1 and 2). Upon addition of target sequence (OH1, OH2 and OH3), 
a duplex is formed which shows a slower mobility through the gel due its increased 
molecular mass. However, upon photoirradiation, there is no change in the 
intensity of the band, and no development of bands corresponding to those of free 
OHX sequences or SL-D. This is further confirmation that the photodimer species 
cannot form once the stem loop is duplexed with a target strand. 
Figure 5.8 UV-Vis spectra tracking photodimer formation of 5 µM A) SL:OH2 duplex and B) SL:OH3 in 100 mM 
NaCl and 10 mM sodium phosphate buffer pH 7 at 293 K. Sample irradiated with 365 nm light after 10 minutes 
degassing with argon. Scans recorded every 10 minutes for 30 minutes (black to grey) followed by a further 60 
minute irradiation (dotted). 
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5.3.6 Binding of Overhang Strands to Locked Stem Loop 
One question that remained was whether, if the stem loop (SL) was photodimerised 
in the absence of a complementary strand, would the target be able to bind the 
photoproduct (SL-D). In previous studies it was found that a shorter length target 
could still bind, despite the system being folded and locked in the stem loop 
conformation (Figure 5.4C).30 In order to assess this, samples of SL-D in the 
presence of complementary OHX sequences, were analysed by native gel 
electrophoresis, Figure 5.10. 
Figure 5.9 Native polyacrylamide gel of SL and target strands performed in 25 mM NaCl and 1 × tris borate EDTA 
running and sample buffer with 500 nM DNA. Lane: 1 SL, 2 SL-D, 3 OH1, 4 SL:OH1, 5 SL:OH1 irradiated, 6 OH2, 7 
SL:OH2, 8 SL:OH2 irradiated, 9 OH3, 10 SL:OH3, 11 SL:OH3 irradiated. Irradiated samples are taken after final 
UV-Vis spectra recorded (see Figures 5.7 and 5.8). Visualised with SYBR Gold® nucleic acid stain. 
Figure 5.10 Native polyacrylamide gel of SL-D and target strand strands performed in 25 mM NaCl and 1 × tris 
borate EDTA running and sample buffer with 500 nM DNA at 293 K. Lane: 1 SL, 2 SL-D, 3 OH1, 4 SL-D:OH1, 5 
OH2, 6 SL-D:OH2, 7 OH3, 8 SL-D:OH3. Visualised with SYBR Gold® nucleic acid stain. 
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Upon addition of the complementary OHX sequences, a new band of higher 
molecular weight was present, which corresponds to the OHX sequences bound to 
SL-D. However, the intensity of these bands were weak, and there was little 
change in the intensity of the SL-D and OHX bands in the gel. This suggests that, 
although there is evidence of binding, only a small proportion was now bound, and 
far less than previously observed with the earlier system containing no overlap 
with the stem, Figure 5.4C.30 
 
Although this work showed some improvements to the previous systems, it was 
clear that, without developing a more complex system, for example through 
incorporating mismatches within sequences or competing strands, the intended 
photorelease mechanism was not going to work and a new design was needed. 
 
5.4 Toe-Hold System 
5.4.1 Current Uses of Toe-Hold Systems 
In recent years, complex systems of oligonucleotides have been developed, that 
allow for the displacement of complementary strands by the addition of a 
competing strand (Figure 5.11). The displacement relies upon a section of a 
template strand (shown in black) being single stranded, to allow the competing 
strand (shown in blue) to be able to get a “toe-hold” (Figure 5.11, Step 2). The 
competing toe-hold strand can then “zip up” with the target strand, displacing the 
original duplexed strand (shown in red). 
Chapter 5 – Photo-Triggered Release of DNA 
 165 
 
In the last few years this approach has been used for several applications in both 
medical assays and DNA machines.32,33 Of particular interest to the projects 
presented in this thesis is the use of toe-hold strands to deduce the genotype of a 
subject32 and detect base mutations within DNA.33 Within the genotyping assay, a 
simple system using a FRET pair is utilised, Figure 5.12. The PCR product, 
containing a toe-hold region and a fluorophore, is mixed with a strand 
complementary to the target and labelled with the FRET partner. If the target is 
present, this strand can bind in the toe-hold region, displacing the other strand 
and quenching the fluorescence. The authors also trialled the use of this assay to 
detect SNP sites, however, they concluded that the efficiency was not sufficient 
and required additional investigations. 
 
 
Figure 5.12 Genotyping assay developed using the toe-hold method. PCR is performed on the DNA sample, the 
primer used has a fluorophore attached to it. A competing toe-hold strand is added to the reaction which is 
tagged with a quencher molecule. If the fully complementary sequence from the PCR is present, the template 
strand is displaced and the quencher is brought into close proximity of the fluorophore, reducing the 
fluorescence signal. If there is a mismatch in the sequence, displacement does not take place and fluorescence 
is observed. Adapted with permission from Khodakov et al., J. Am. Chem. Soc., 2013, 135, 5612-9. Copyright 2013 
American Chemical Society. 
 
Figure 5.11 Schematic of the toe-hold system. 1) A duplex of DNA is taken which contains a region of single 
stranded DNA on the template strand (black). 2) Upon addition of a strand which has a region complementary 
to the single stranded section (blue), the new strand binds to the template. 3) If this new sequence displays a 
higher binding affinity for the template strand than that which is currently duplexed, the original strand is 
displaced (red). 4) The new duplex is formed between the template strand and the toe-hold strand. 
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Work published by Jiang and co-workers to detect base modifications utilises a 
much more complex system in which the toe-hold method is used in combination 
with DNA splicing. Upon fully complementary DNA binding to the toe-hold region, 
the DNA is extended to incorporate a splicing site, which is subsequently “cut” to 
release a strand that can fold into a G-quadruplex. A fluorescent dye that shows 
selectivity for G-quadruplexes is then added to the system and fluorescence is 
observed.33 
 
The toe-hold system has also been utilised to make DNA machine components. 
Winfree and colleagues developed a variety of complex systems that work as logic 
gates and other circuit components, all relying on the recognition and strand 
displacement of oligonucleotides.34 Deng et al. also reported on the development of 
AND and OR logic gates which rely upon the presence of the toe-hold strand, as 
well as a metal which enhances the toe-hold strand binding through dative bond 
formation.35 
 
5.4.2 Design of a Toe-Hold System for Photo-Triggered Release 
It was proposed that a toe-hold system could be exploited to achieve photo-
triggered release of an oligonucleotide. Rather than utilising strands with different 
affinities for the release, if strands were designed with similar affinities, an 
equilibrium between the two duplexes would be expected to be achieved (if all were 
present in solution at the same concentration). Tagging both the template strand 
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and one of the complementary strands with anthracene moieties could then allow 
for the photodimerisation of the anthracene as a crosslink, locking the duplex 
together and preventing the other strand from binding (an effect that has been 
demonstrated in work previously performed in the group30). This would result in 
an effective “release” of the second strand, Figure 5.13. 
 
Sequences for oligonucleotides used within this study were derived from work by 
Winfree and Zhang;36 a schematic of these is shown in Figure 5.14. The toe-hold 
systems are made of three strands, a target (T), a photo-trigger (PT) and a 
complementary (C). The target and photo-trigger strands contain anthracene 
moieties placed opposite one another in the duplex; these were expected to 
photodimerise upon irradiation and “lock” the duplex, preventing the 
complementary strand binding. Four systems have been developed, T1:PT1:C1-S, 
T1:PT2:C2, T2:PT3:C1-S and T2:PT4:C2, the C1-S strand can be interchanged 
Figure 5.13 A) A duplex is formed between the template strand and a complementary sequence. B) A competing 
strand is able to get a “toe-hold” (through the bases shown in blue) on the target strand and displaces the original 
strand. C) The new duplex is formed. D) The new duplex can readily revert to the original duplex if the first 
complementary strand gets a “toe-hold” (through the bases shown in red). E) Irradiation of the system will 
photodimerise anthracene moieties in close proximity, locking the duplex of the two anthracene containing 
strands and releasing the unmodified strand. 
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with the C1-M and C1-L sequences. These systems were expected to produce the 
equilibrium mixture depicted in Figure 5.13. 
 
Figure 5.14 Sequences developed for photo-triggered toe-hold release. Photo-trigger (PT) and Template (T) 
strands contain anthracene (A) opposite one another in the duplex to allow for the photodimerisation and 
“locking” of the duplex. Complementary (C) strands contain a region of bases that are identical to those in the 
PT strands (shown in black) and compete for binding to the T strand. Each system will be comprised of three 
strands in which the PT and C strands form duplexes with the T stand (T1:PT1:C1, T1:PT2:C2, T2:PT3:C1 and 
T2:PT4:C2). The C1 strand is made with various lengths (C1-S, C1-M and C1-L) to allow for the analysis of the 
change in complementary bases. In addition to this, the longer strands (C1-M and C1-L) are labelled with a 
fluorescent dye, TAMRA (R). 
 
The parent duplexes (T1:PT1, T1:PT2, T2:PT3, T2:PT4, T1:C1-S, T1:C2, T2:C1-S 
and T2:C2) all had predicted Tm values of 63 °C, and all contained toe-hold regions 
(shown in blue or red in Figure 5.14) of 6 bases in length. Anthracene moieties 
were placed towards the ends of the complementary section (shown in black in 
Figure 5.14) since it was considered that a run of unmodified bases would allow for 
displacement by the competing strand. However, on the other hand substitution 
on the end base could result in a disruption in the duplex folding, or the 
photodimerisation being affected by the ends of the DNA “fraying”. They were 
therefore moved to a site a few bases from the end of the sequence. The 
incorporation was made at an A-T base pair site, as this was expected to give the 
least change to the Tm. 
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In order to assess the impact that the length of the competing strand had on the 
release, C1-S was extended by 1 (C1-M) and 2 (C1-L) base pairs. In addition to this, 
the two longer strands were labelled with a fluorescent dye (TAMRA), to allow for 
easier differentiation in gels. The dye was separated from the complementary 
region of the sequence by two bases, to prevent any interference with binding. The 
sequences of all the strands are shown in Table 5.3. 
Table 5.3 Oligonucleotide sequences used for toe-hold photo-triggered release. Anthracene units (shown as X) 
were used with D stereochemistry and a 6 carbon linker as this has been shown previously to form photodimer 
products in similar systems. Extra bases on the longer C1 strands (C1-M and C1-L) are shown underlined. 
Name Sequence 
TCon 5′- TGG AGA CGT AGG GTA TTG AAT GAG GG -3′ 
C1-S         3′- GCA TCC CAT AAC TTA CTC CC -5′ 
C1-M       3′- T GCA TCC CAT AAC TTA CTC CCT T(TAMRA) -5′ 
C1-L      3′- CT GCA TCC CAT AAC TTA CTC CCT T(TAMRA) -5′ 
C2 3′- ACC TCT GCA TCC CAT AAC TT -5′         . 
T1 5′- TGG AGA CGX AGG GTA TTG AAT GAG GG -3′ 
T2 5′- TGG AGA CGT AGG GTA TXG AAT GAG GG -3′ 
PT1 3′- ACC TCT GCX TCC CAT AAC TT -5′        .          
PT2         3′- GCX TCC CAT AAC TTA CTC CC -5′ 
PT3 3′- ACC TCT GCA TCC CAT AXC TT -5′         
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5.4.3 Thermal Melting Studies 
All possible duplex combinations were analysed by variable temperature UV-Vis 
spectroscopy to obtain Tm values, as a measure of the duplex stability, Table 5.4. 
Table 5.4 Tm data for all duplex combinations. Recorded at 5 µM duplex DNA in 100 mM NaCl, 10 mM sodium 
phosphate buffer pH 7. All values are average of at least 3 repeat runs and are reported to the closest 0.5 °C due 
to the limits of instrument error. 
Duplex Tm (°C) Duplex Tm (°C) 
TCon:C1-S 64.0 TCon:C2 62.5 
T1:PT1 63.0 T1:PT2 66.0 
T2:PT3 65.5 T2:PT4 65.0 
T1:C1-S 63.0 T1:C2 59.0 
T2:C1-S 61.5 T2:C2 61.5 
T1:C1-M 64.0 T2:C1-M 63.0 
T1:C1-L 64.5 T2:C1-L 64.5 
 
The control systems, TCon:C1 and TCon:C2, have Tm values close to the predicted 
Tm of 63 °C (predictions are performed as described in Chapter 2.7.3). However, 
substitution of the anthracene moieties was found to make varying contributions 
to the Tm. In all cases, the duplexes containing two anthracene moieties (duplexes 
formed between T and PT strands) display higher Tm values than those with one 
modification (duplexes formed between T and C strands). In particular T1:PT2 and 
T2:PT3 displayed a significant increased stability. It is likely that these sequences 
allow for the anthracene moieties to stack, resulting in a relative increase in Tm. 
This could be aided by the incorporation of anthracene close to the end of the duplex 
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in these systems. Due to the space required by stacking, it would be expected that 
bases surrounding the substitution site would be disrupted. However, being closer 
to the end of the duplex would allow for greater flexibility and therefore a relative 
increase in stability would be observed. 
 
In contrast, a marked destabilisation is seen for duplex T1:C2. A possible 
explanation for this, is that the anthracene moiety is incorporated into a C-G rich 
region. The anthracene is expected to intercalate in the DNA duplex and could 
disrupt the bases surrounding the substitution site. As the C-G base pairing offers 
the greatest affinity (containing three hydrogen bonds compared to two in A-T base 
pairs), a disruption to these would have a greater destabilisation effect on the 
duplex. Within the T1:PT2 system, this effect could be countered by the stacking 
of the anthracene moieties, as hypothesised above. 
 
A requirement for the toe-hold design to work is that the duplexes within the 
system have similar affinities, so that the strands can displace one another. The 
T1:PT2:C2 system displays the highest variation in Tm at 7 °C. The only system in 
which both duplexes have similar stabilities is within the T1:PT1:C1 system. Upon 
increasing the length of C1-S in sequences C1-M and C1-L, an increase in the Tm 
values was observed. In the case of the T1:PT1:C1-M and T1:PT1:C1-L systems, 
the Tm values with the CX strands exceeded that of the duplex between T1:PT1. 
However it was considered that this should allow for more of the complementary 
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strand to bind, and therefore leaves the potential for a higher amount of photo-
triggered release. Within the T2:PT3:C1-M and T2:PT3:C1-L systems, the Tm 
values with the CX strands were higher compared to that recorded for T2:C1-S, 
however, the melting temperatures were still below that of T2:PT3. 
 
5.4.4 Photodimerisation Studies 
Prior to analysing whether the systems could be used for photo-triggered release, 
it needed to be confirmed that the anthracene containing duplexes could form 
crosslinked photodimers. All four combinations, T1:PT1, T1:PT2, T2:PT3 and 
T2:PT4, were irradiated with 365 nm light and changes to the anthracene signal 
monitored using UV-Vis spectroscopy, Figure 5.15.  
 
All combinations showed a significant decrease within 10 minutes of irradiation, 
with little change thereafter. This is a comparable rate of reaction as that seen 
with similar systems in the group,29,30 and is also comparative to the work by 
Asanuma and co-workers utilising a p-stilbazole photocrosslink.28 As expected, 
Figure 5.15 UV-Vis spectra of anthracene containing duplexes. All performed at 5 µM duplex in 100 mM NaCl 
and 10 mM sodium phosphate buffer pH 7 at 293 K. Samples were recorded at 0 minutes (black) following 
degassing with argon for 10 minutes. They were then irradiated with 365 nm light for 10 (dark grey) and 20 (light 
grey) minutes. 
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control systems with T1 and T2 duplexed with C1-S and C2, as well as the PTX 
strands duplexed with TCon, showed no change in absorbance upon irradiation 
(see appendix 8.3). 
 
The photodimerised samples were subsequently analysed using a denaturing gel 
(this type of gel disrupts interactions between DNA strands and allows for 
covalently linked species to be analysed, Chapter 2.10.1), to confirm the presence 
of photodimer species, Figure 5.16. All samples contained a band consistent with 
a higher molecular weight than the ssDNA controls, indicating that 
photodimerisation had been successful.  
UV-Vis analysis performed on the photodimer species, showed that no Tm value 
could be obtained in all cases, it being higher than the bounds of the experiment 
(85 °C). The stabilisation afforded by the photodimerisation of anthracene to form 
Figure 5.16 Denaturing polyacrylamide gel of toe-hold duplex dimers performed in 1 × tris borate EDTA running 
buffer with 500 nM DNA in 50% formamide. Lane: 1 PT2, 2 T1, 3 PT2:T1, lanes 4-7 duplexes were degassed and 
irradiated for 20 minutes lane: 4 T1:PT2, 5 T1:PT1, 6 T2:PT4, 7 T2:PT3. Visualised using SYBR Gold® nucleic acid 
stain. 
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a crosslink has been explored previously, and this result correlates well with the 
trends observed.30 
 
5.4.5 Photodimer Binding Studies 
A prerequisite of this toe-hold system is that anthracene photodimerisation blocks 
the binding of the CX strands, as it has previously been shown to do.30 Native gel 
electrophoresis was performed on the crosslinked photodimer species (formed in 
Figure 5.15) and the complementary strand (CX), which was to be used in the toe-
hold system (Figure 5.14), to ensure that photodimerisation inhibits binding to the 
template strand, Figures 5.17 (C1-S and C2) and 5.18 (C1-M and C1-L). It would 
be expected that samples of photodimer would have a band at high molecular 
weight from the photodimer linked duplex and CX strands remain unbound and 
be seen as a low molecular weight band.  
Figure 5.17 Top: Schematic representation of photodimer formation with subsequent binding to competing 
complementary strand assessed. Bottom: Native polyacrylamide gel of toe-hold control strands performed in 25 
mM NaCl and 1 × tris borate EDTA running and sample buffer with 500 nM DNA, 293 K. Lane: 1 C1-S, 2 T1:PT1 
photodimer, 3 T1:PT1 photodimer with C1-S, 4 C1-S, 5 T2:PT3 photodimer, 6 T2:PT3 photodimer with C1-S, 7 
C2, 8 T1:PT2 photodimer, 9 T1:PT2 photodimer with C2, 10 C2, 11 T2:PT4 photodimer, 12 T2:PT4 photodimer 
with C2. Visualised using SYBR Gold® nucleic acid stain. 
 




In all cases no significantly higher molecular weight species were found which 
would be seen at a higher position in the gel, above the duplexes. This confirms 
that no three stranded systems could be detected. In lane 1 of Figure 5.17, it 
appears that the control C1-S has not been loaded or prepared correctly. An 
Figure 5.18 Top: Schematic representation of photodimer formation with subsequent binding to competing 
complementary strand assessed. Bottom: Native polyacrylamide gel of new complementary strands binding to 
photodimer performed in 25 mM NaCl and 1 × tris borate EDTA running and sample buffer with 500 nM DNA, 
293 K. A) Lane: 1 T1, 2 PT1, 3 C1-L, 4 C1-M, 5-7 with T1:PT1 photodimer alone and with C1-L and C1-M 
respectively. B) Lane: 1 PT3, 2 T2, 3 C1-L, 4 C1-M, 5-7 with T2:PT3 photodimer alone and with C1-L and C1-M 
respectively. Visualised using SYBR Gold® nucleic acid stain (left) and TAMRA fluorescence (right). 
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“identical” sample is also in lane 4 which does display the expected band. When 
using the TAMRA tagged sequences, Figure 5.18, a new duplex can be seen which 
is also visible in the TAMRA image of the gel. This indicates that some duplex is 
forming with both the C1-M and C1-L strands. This is thought to be due to 
incomplete photodimerisation of the TX and PTX systems, allowing for the 
undimerised T strand to form duplexes with the CX strands. This is supported by 
the weak band corresponding to the TX strand, in the TX:PTX photodimer samples 
(Figure 5.18, Lane 5), which disappears on addition of the CX strands (Lanes 6 and 
7). It is therefore concluded, that the photodimerisation has successfully blocked 
duplex formation between the TX and CX strands under these conditions. 
 
5.4.6 Binding Studies of Toe-Hold Systems 
Initial binding studies were performed using the control sequences, Figure 5.19, to 
assess if both competing strands (CX) could bind to the target (T) strand. If this is 
the case, when all three strands are mixed, a duplex band containing duplexes of 
both TCon:C1-S and TCon:C2 is expected along with a band at lower molecular 
weight from the excess C1-S and C2 strands. There should be no excess TCon and 
therefore no band for this when all three strands are present. The same is true for 
the strands containing anthracene, although the trends will be more easily 
distinguished utilising the anthracene fluorescence to assign which bands contain 
anthracene tagged strands. Likewise, the TAMRA tagged systems can also be 
identified by using the TAMRA fluorescence. 
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It was observed that both TCon:C1-S and TCon:C2 (Figure 5.19, Lanes 4 and 5, 
respectively) formed duplexes. The control toe-hold system containing equimolar 
amounts of all three strands, TCon:C1-S:C2, contained two bands, one 
corresponding to duplex species and one to single stranded DNA (this band is 
expected to contain both single stranded C1-S and C2). It should be noted that the 
SYBR Gold® nucleic acid stain used, exhibits weaker bind to ssDNA than dsDNA, 
as well as a reduced fluorescence output with ssDNA.37 The intensity between the 
bands can therefore not be taken as an indication of quantities present. It can be 
seen that the ssDNA bands are very weak and it is therefore hard to distinguish 
them. It was decided that for future gels, analysing strands which do not contain 
a TAMRA label, more material would be loaded to allow for the ssDNA bands to be 
more clearly seen. In addition to this, anthracene fluorescence was to be utilised to 
image the gels, allowing for the identification of any ssDNA. However, this 
approach was found to result in some overloading of the dsDNA band. 
 
Figure 5.19 Native polyacrylamide gel of toe-hold control strands performed in 25 mM NaCl and 1 × tris borate 
EDTA running and sample buffer with 500 nM DNA at 293 K. Lane: 1 C1-S, 2 C2, 3 TCon, 4 TCon:C1-S, 5 TCon:C2, 
6 TCon:C1-S:C2. Visualised using SYBR Gold® nucleic acid stain. 
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Analysis of all toe-hold combinations (Figure 5.14) was performed using native gel 
electrophoresis, Figures 5.20 and 5.21. It was expected that all TX:CX and TX:PTX 
combinations would form duplexes and be identified as a higher molecular weight 
band. In systems containing all three strands (TX:CX:PTX) an equilibrium of 
duplexes would be expected and as such a mixture of PTX and CX would be in 
single stranded form and observed as a lower molecular weight species in the gel. 
The bands containing anthracene (both duplexes and single stranded) will be 
identified using the anthracene fluorescence. It would be expected that in the 
TX:CX:PTX mixture, anthracene will be present in the duplex and single stranded 
bands. 
Figure 5.20 Top: Schematic representation of toe-hold system. Bottom: Native polyacrylamide gel of toe-hold 
systems performed in 25 mM NaCl and 1 × tris borate EDTA running and sample buffer with 10 µM DNA at 293 
K. A) Lane: 1 T1, 2 C2, 3 PT2, 4 C1-S, 5 PT1, 6 T1:C2, 7 T1:PT2, 8 T1:C1-S, 9 T1:PT1, 10 T1:C2:PT1, 11 T1:C1-S:PT1. 
B) Lane: 1 T2, 2 C2, 3 PT4, 4 C1-S, 5 PT3, 6 T2:C2, 7 T2:PT4, 8 T2:C1-S, 9 T2:PT3, 10 T2:C2:PT4, 11 T2:C1-S:PT3. 
Visualised using SYBR Gold® nucleic acid stain (left) and anthracene fluorescence (right). 
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Using the anthracene fluorescence (Figure 5.20, right), the strands containing 
anthracene are definitively identified. It can be seen that a significant amount of 
T1 remains unbound, when expected to be in a 1:1 duplex with PTX and CX strands 
(Figure 5.20 Lanes 6-9). This will obviously hinder the toe-hold ability, as an excess 
of this strand will allow for additional binding to the PTX and CX strands. 
 
Within the SYBR Gold® nucleic acid stain images of the gels, it can be seen that 
when all three strands are present (Figure 5.20, Gel A and B, lanes 10 and 11), 
there is dsDNA and ssDNA within the samples. However, correlating this with the 
anthracene fluorescence image shows anthracene to mainly be present in the 
dsDNA band, indicating that all of the PTX strands are bound and that the ssDNA 
must be due to the CX strands. This was not the planned scenario, since the CX 
strand had been released before any irradiation. It is thought that this is due to 
the higher Tm values associated with the TX:PTX duplexes, compared to those 
formed with C1-S and C2. However, the T1:PT1:C1 system displayed no 
differentiation between the two strands via Tm and is accompanied by a very weak 
band corresponding to PT1 in the anthracene fluorescence image of the gel (Figure 
5.20, Gel A, Lane 11). This was therefore deemed the most promising system. 
 
Using the TAMRA fluorescence (Figure 5.21, right) also allows for definitive 
identification of the CX strands. However, due to the increased length of C1-M and 
C1-L, their mobility through the gel has also been slowed, allowing for more 
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conclusive assignment of these bands, as they no longer overlap with those from 
the PTX strands. This trend is also seen in the duplexes formed with them, 
resulting in two bands being seen for the toe-hold system. Lanes 8 and 9 (Figure 
5.21) show that duplexes are formed with both stands, and that some of each 
strand (PTX and CX) are present in their single stranded forms. The TAMRA 
image identifies that the slowest moving duplexes, are those which contains the 
C1-M and C1-L strands. 
Figure 5.21 Top: Schematic representation of toe-hold system. Bottom: Native polyacrylamide gel of toe-hold 
system performed in 25 mM NaCl and 1 × tris borate EDTA running and sample buffer with 500 nM DNA at 293 
K. A) Lane: 1 T1, 2 PT1, 3 C1-L, 4 C1-M, 5 T1:PT1, 6 T1:C1-L, 7 T1:C1-M, 8 T1:PT1:C1-L, 9 T1:PT1:C1-M. B) Lane: 1 
T2, 2 PT3, 3 C1-L, 4 C1-M, 5 T2:PT3, 6 T2:C1-L, 7 T2:C1-M, 8 T2:PT3:C1-L, 9 T2:PT3:C1-M. Visualised using SYBR 
Gold® nucleic acid stain (left) and TAMRA fluorescence (right).  
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The system now displays the desired balance between binding to the PTX and CX 
strands, which has the potential to be manipulated using the photodimerisation of 
the TX and PTX strands. Therefore, only the systems using C1-M and C1-L were 
used for further studies. 
 
5.4.7 Release by Addition of Competing Strand 
Aside from the release by photodimerisation, as is being studied herein, the release 
by addition of the PTX strand itself needed to be addressed. Due to the two 
duplexes having similar Tm values and both binding to the template strand, an 
equilibrium is formed when all three are in solution and hence some of the CX 
strands are displaced by the PTX strands. In order to evaluate this, native gel 
electrophoresis studies were performed in the presence of increasing 
concentrations of PTX strands, Figure 5.22. It would be expected that as the 
amount of PTX strand is increased, the amount of single stranded CX strand would 
increase. This would be seen as a lower molecular weight band and will increase 
in intensity as the concentration of PTX increases. This will be identified using the 
TAMRA fluorescence associated with the CX strand. In addition to this, the 
amount of TX:PTX duplex will also increase as the PTX concentration is increased. 
This will be observed as a duplex band of slightly lower molecular weight (and 
therefore lower on the gel) than the TX:CX duplex. 
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The release of the CX strand was shown to be dependent on the concentration of 
PTX strand and can be clearly seen in the TAMRA fluorescence image of the gels 
(Figure 5.22, right), as the intensity of the single stranded CX oligonucleotides 
increases across the gels (lanes 5-8 and 9-12). The T2:PT3 system is shown to be 
more susceptible to release in this manner with the single stranded C1-M and C1-
L being visible at lower concentrations of PT3 (Figure 5.22, gel B, lanes 5-8 and 9-
12). This is due to the T2:PT3 duplex having a higher Tm than either the T2:C1-L 
and T2:C1-M duplexes. 
Figure 5.22 Top: Schematic representation of toe-hold system with displacement by competing strand. Bottom: 
Native gel electrophoresis performed in 25 mM NaCl and 1 × tris borate EDTA running and sample buffer with 
500 nM at 293 K. DNA visualised using SYBR Gold® nucleic acid stain (left) and TAMRA fluorescence (right). Gel 
A lane: 1 T1, 2 PT1, 3 C1-L, 4 C1-M, 5-8 T1:C1-L with 0, 250, 500 and 1000 nM PT1 respectively, 9-12 T1:C1-M 
with 0, 250, 500 and 1000 nM PT1 respectively. Gel B lane: 1 T2, 2 PT3, 3 C1-L, 4 C1-M, 5-8 T2:C1-L with 0, 250, 
500 and 1000 nM PT3 respectively, 9-12 T2:C1-M with 0, 250, 500 and 1000 nM PT3 respectively. 
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5.4.8 Photodimerisation with TAMRA Release Strands 
These new systems, containing all three components, were subsequently exposed 
to irradiation and changes to the anthracene region of the UV-Vis spectrum 
tracked, Figure 5.23. Upon irradiation, all samples showed a decrease in 
absorbance between 320-420 nm, which could be attributed to anthracene 
photodimerisation. The reductions in signal are lower than would have been 
expected, with approximately 20% reduction in the cases with C1-L and 40% 
reduction in the samples with C1-M. If this results in a proportional amount of 
photodimer formation and therefore release of the complementary strand, then not 
even half of the complementary strands are being released upon irradiation. 
However, this is a marked improvement on previous efforts, which did not generate 
any release. 
The samples containing C1-M displayed a greater decrease, suggesting more 
photodimer species is formed in these cases than with C1-L. This would be 
expected due to the lower Tm of C1-M with the TX strands, due its shorter length. 
This would allow for a greater amount of PTX:TX duplex to form, and therefore a 
higher amount of photodimerisation. 
Figure 5.23 UV-Vis spectra of 1 µM of each oligonucleotide strand in 100 mM NaCl and 10 mM sodium phosphate 
buffer pH 7 at 293 K. Sample irradiated with 365 nm light after 10 minutes degassing with argon at 293 K. Scans 
recorded every 30 minutes until no further change observed (black to grey). A) T1:PT1:C1-L, B) T1:PT1:C1-M, C) 
T2:PT3:C1-L, D) T2:PT3:C1-M. 
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5.4.9 Monitoring Photodimer Formation 
Aliquots of sample, at the irradiation time steps used for the UV-Vis monitoring 
(Figure 5.23), were analysed using denaturing gel electrophoresis, to assess if 
photodimers were forming and to qualitatively analyse the change in amount over 
time, Figure 5.24. The photodimer would be shown as a higher molecular weight 
band, with any non-covalently linked species dissociating under the gel conditions 
and therefore being observed as low molecular weight, single stranded DNA. 
Figure 5.24 Top: Schematic representation of toe-hold system and expected photorelease. Bottom: Denaturing 
polyacrylamide gel of TAMRA release strand irradiated samples performed in 1 × tris borate EDTA running buffer 
with 500 nM DNA in 50% formamide at 293 K. Irradiation performed with 365 nm light after 10 minutes degassing 
with argon at 293 K.  A) Lane: 1 T1, 2 PT1, 3 C1-L, 4 C1-M, 5 – 7 T1:PT1:C1-L at 0, 30 and 60 minutes irradiation 
respectively, 8-12 T1:PT1:C1-M at 0, 30, 60, 90 and 120 minutes irradiation respectively, 13 T1:PT1 control. B) 
Lane: 1 T2, 2 PT3, 3 C1-L, 4 C1-M, 5 – 8 T2:PT3:C1-L at 0, 30, 60 and 90 minutes irradiation respectively, 9-12 
T1:PT1:C1-M at 0, 30, 60 and 90 minutes irradiation respectively, 13 T2:PT3 control. Visualised using SYBR Gold® 
nucleic acid stain (left) and TAMRA fluorescence (right). 
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Evidence of photodimer formation was observed within the first time frame of 
irradiation. The TAMRA image of the gels (Figure 5.24, right) confirms that the 
photodimer species does not contain C1-L or C1-M oligonucleotides. Interestingly, 
the amount of photodimer formed appears not to change over the course of further 
irradiation, as would have been expected from the UV-Vis spectra in Figure 5.23. 
This could be due to the camera being saturated at the first timeframe and 
therefore subsequent increases in the intensity of the band are not observed. 
Alternative techniques to quantify the amount of photodimer would need to be 
undertaken to confirm this, for example, HPLC separation followed by 
quantification, or the use of 31P labelled oligonucleotides for quantitative detection 
in the gels. 
 
5.4.10 Monitoring the Photo-Triggered Release 
The aliquots used in the denaturing gel were also analysed using native gel 
conditions, in order to monitor the amount of photo-triggered release achieved, 
Figure 5.25. It would be expected that as the photodimer species forms, the CX 
strand will be released and therefore an increase in intensity of this band will be 
observed over the irradiation time. In addition to this the amount of TX:PTX 
duplex is also expected to increase. 
 
Over the course of irradiation, the intensity of the duplex bands appears not to 
change, consistent with the observations made with the denaturing gel. However, 
the intensity of the C1-L and C1-M band does increase with irradiation time. This 
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is most prominent in the T1:PT1:C1-M sample (Figure 5.25, gel A, lanes 8-12) and 
is accompanied by a decrease in intensity of the single stranded PT1 species. This 
result is very promising and confirms that photo-triggered release using the toe-
hold system, is possible. Although changes in the T2:PT3 system (Figure 5.25, gel 
B) are observed, these are not as prominent as the T1:PT1 system. It is thought 
this could be due to the Tm of the T2:PT3 duplex exceeding that of the T2:C1-L and 
T2:C1-M duplexes (Section 5.4.3). This limits the binding of C1-L and C1-M prior 
to irradiation and therefore limits the extent of release that can be achieved. 
 
Figure 5.25 Top: Schematic representation of toe-hold system and expected photorelease. Bottom: Native 
polyacrylamide gel of TAMRA release strand irradiated samples performed in 25 mM NaCl and 1 × tris borate 
EDTA running and sample buffer with 500 nM DNA at 293 K. Irradiation performed with 365 nm light after 10 
minutes degassing with argon at 293 K.  A) Lane: 1 T1, 2 PT1, 3 C1-L, 4 C1-M, 5 – 7 T1:PT1:C1-L at 0, 30 and 60 
minutes irradiation respectively, 8-12 T1:PT1:C1-M at 0, 30, 60, 90 and 120 minutes irradiation respectively. B) 
Lane: 1 T2, 2 PT3, 3 C1-L, 4 C1-M, 5 – 8 T2:PT3:C1-L at 0, 30, 60 and 90 minutes irradiation respectively, 9-12 
T1:PT1:C1-M at 0, 30, 60 and 90 minutes irradiation respectively. Visualised using SYBR Gold® nucleic acid stain 
(left) and TAMRA fluorescence (right). 
Chapter 5 – Photo-Triggered Release of DNA 
 187 
5.4.11 Efforts to Quantify Photo-Triggered Release 
Due to the limitations associated with quantifying the amount of DNA within the 
gel, using the imaging techniques described above, alternative methods were 
needed. A potential technique to quantify the amount of C1-L and C1-M, bound to 
the duplex, was to utilise the fluorescence of the TAMRA tag. Within this thesis 
the changes in fluorescence output of a fluorophore upon incorporation into DNA, 
have been explored and this could also be utilised here. In order to evaluate the 
feasibility of this method, titrations of T1 into C1-L and C1-M were performed, 
Figure 5.26. The intensity of the TAMRA fluorescence was shown to vary between 
C1-L and C1-M, which was expected to be a result of differences in their sequences. 
Upon addition of T1, a steady decrease in the intensity was observed in both cases, 
levelling off at a 1:1 ratio of C1-M to T1, consistent with the formation of a 1:1 
duplex. The C1-L:T1 system levels off earlier, suggesting errors in the 
concentration of the C1-L strand. However, the data presented is from one 
experiment and therefore repeats would be needed in order to confirm the results 
obtained. 
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Subsequent fluorescent analysis of the toe-hold system T1:PT1:C1-L was 
performed (Figure 5.27), to determine if fluorescence could be used to quantify the 
amount of TAMRA tagged strand in the duplex. The system containing all three 
oligonucleotides gave an intensity similar to that of the C1-L:T1 duplex, suggesting 
that all C1-L was duplexed. However, this observation does not agree with the gel 
studies performed above, which suggested an equilibrium of binding between the 
T1:PT1 and T1:C1-L duplexes. 
Figure 5.26 Fluorescence spectra (left) of titration of A) T1 into C1-L and B) T1 into C1-M with 1 µM C1-L or C1-
M and plot of equivalents of target against change in fluorescence intensity (right). in 100 mM NaCl and 10 mM 
sodium phosphate buffer pH 7 at 293 K. T1 added in 0.25 µM steps (black to grey). λex = 556 nm.  
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Further to this unexpected observation, a reduction in fluorescence intensity was 
observed upon irradiation of the C1-L oligonucleotide alone, Figure 5.28. 
Subsequent MS analysis of the sample showed no change in the molecular mass. 
It is not known what is causing this decrease, but it may be as a result of 
photobleaching, although the fluorescence signal did not reappear over time. 
Future attempts to quantify photo-triggered release utilising this method, were 
not explored further. 
 
Figure 5.27 Fluorescence spectra of toe-hold system C1-L (black solid), C1-L:T1 (black dot) and C1-L:T1:PT1 (grey 
solid) all at 1:1 molar equivalents at 1 µM in 100 mM NaCl and 10 mM sodium phosphate buffer pH 7 at 293 K. 
λex = 556 nm. 
 
Figure 5.28 Fluorescence spectra of 1 µM C1-L prior to irradiation (black) and after 1 hour irradiation with 365 
nm light (grey) in 100 mM NaCl and 10 mM sodium phosphate buffer pH 7 at 293 K. λex = 556 nm 
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Qualitative analysis of the amount of photo-release achieved can be inferred from 
the native gels shown in Figure 5.25. It can be seen that with the C1-L 
complementary system, a modest release is achieved. This is more pronounced 
with the C1-M system, particularly T1:PT1:C1-M in which a significant amount is 
released. This level of release falls short of that observed in the azobenzene 
examples in the literature in which complete release is observed.17 However, it 
should be noted that, at particular temperatures, the azobenzene system fails to 
work. This is due to binding to the complementary strand not being blocked, but 
only destabilised. Therefore, lowering the temperature would allow for the strand 
to still form a duplex. Within the system presented herein, the complementary 
strand would be unable to bind at these temperatures, due to the PTX strand being 
bound.  
 
5.4.12 Thermal Reversion of Photodimerisation 
It is known that anthracene photodimerisation can be reversed upon the 
application of heat. The reversibility of the system was assessed by taking the 
irradiated samples (Figure 5.23) and heating to 90 °C for 13 hours. A denaturing 
gel was then performed to compare before and after heat treatment, Figure 5.29. 
It would be expected that a high molecular weight species would be present from 
the photodimerised duplex (as in Figure 5.24). Upon heating, the photodimer 
would be expected to revert to the monomer species and therefore this high 
molecular weight band would reduce in intensity (or disappear completely) and the 
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amount of low molecular weight (single stranded DNA) would increase. It was 
observed that, although a small proportion of photodimer did remain, the majority 
had reverted to single stranded species as was expected. This reversibility is 
extremely promising and would allow the photo-triggered release to be reverted. 
 
 
5.4.13 Cycling of Photo-Triggered Release 
The thermal reversion of the photodimers could allow for the system to be cycled 
and reused, as shown in the schematic in Figure 5.29. This was assessed using 
cycles of 90 minutes irradiation, followed by 13 hours heating at 90 °C with aliquots 
Figure 5.29 Top: Schematic representation of toe-hold system showing expected photorelease and reversion 
upon heating. Bottom: Denaturing polyacrylamide gel of toe-hold systems following irradiation with 365 nm light 
until no further change in absorbance was observed. Samples then heated to 90 °C for 13 hours and analysed. 
Gel performed in 1 × tris borate EDTA running buffer with 500 nM DNA in 50% formamide at 293 K. Lanes shows 
irradiated sample and heat treated sample respectively. Lane 1-2 T1:PT1:C1-L, 3-4 T1:PT1:C1-M, 5-6 T2:PT3:C1-
L and 7-8 T2:PT3:C1-M. Visualised using SYBR Gold® nucleic acid stain. 
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taken at each point. The aliquots were then analysed by denaturing (Figure 5.30) 
and native (Figure 5.31) gel electrophoresis. In the denaturing gel it would be 
expected that the amount of photodimer (shown as a high molecular weight band) 
would alternate between being high concentration (an intense band at high 
molecular weight) after irradiation and lower (and therefore a weaker band) after 
heating. This will be accompanied by weak single stranded (low molecular weight) 
bands from the PTX and TX strands when photodimerised and strong single 
stranded bands when the anthracene photodimer is reversed to monomers. In all 
cases the bands from the CX strands is expected to remain constant as in no cases 
is this band covalently linked to another strand. 
 
Within the native gel an increase in the intensity of the CX strand is expected after 
irradiation (and associated photorelease). Upon heating, the photorelease will be 
reversed and the intensity of the single stranded CX band will decrease as it forms 
duplexes with the TX strand. In accordance with this, the amount of TX:CX duplex 
will be higher after heating. 
 
There is some photodimer present in the pre-irradiated systems, which have not 
been purposely exposed to light (lane 5). This suggests that the samples have been 
subject to photodimer inducing conditions prior to running the gel. Despite this 
slight amount of photodimer formation, the increase and decrease in the amount 
of photodimer present can clearly be seen in the denaturing gels (Figure 5.30) 
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suggesting that cycling of the system was indeed possible. Changes in the intensity 
of the CX strands can also be seen in the native gel (Figure 5.31). In the third cycle, 
fatigue of the system is more apparent. This level of fatigue is much higher that is 
seen in the azobenzene systems used by Asanuma and co-workers.17 More detailed 
analysis on any side product formation which may be causing the fatigue is needed. 
This could allow for the degradation route to be blocked and therefore the cycling 
ability of the system improved.  
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Figure 5.30 Denaturing gel electrophoresis to monitor cycling of photodimerisation with 90 minute irradiation 
with 365 nm light followed by heating to 90 °C for 13 hours. All performed in 1 × tris borate EDTA running buffer 
with 500 nM DNA in 50% formamide at 293 K and visualised using TAMRA fluorescence (right) and SYBR Gold® 
nucleic acid stain (left). Gel A Lane: 1 PT1, 2 T1, 3 C1-L, 4 T1:PT1, 5 T1:PT1:C1-L, 6-11 cycles of irradiated (even 
lanes) and heated (odd lanes) samples of T1:PT1:C1-L over 3 cycles. Gel B Lane: 1 PT1, 2 T1, 3 C1-M, 4 T1:PT1, 5 
T1:PT1:C1-M, 6-11 cycles of irradiated (even lanes) and heated (odd lanes) samples of T1:PT1:C1-M over 3 cycles. 
Gel C Lane: 1 PT3, 2 T2, 3 C1-L, 4 T2:PT3, 5 T2:PT3:C1-L, 6-11 cycles of irradiated (even lanes) and heated (odd 
lanes) samples of T2:PT3:C1-L over 3 cycles. Gel D Lane: 1 PT3, 2 T2, 3 C1-M, 4 T2:PT3, 5 T2:PT3:C1-M, 6-11 cycles 
of irradiated (even lanes) and heated (odd lanes) samples of T2:PT3:C1-M over 3 cycles. 
 




Figure 5.31 Native gel electrophoresis to monitor cycling of photodimerisation with 90 minute irradiation with 
365 nm light followed by heating to 90 °C for 13 hours. All performed in 25 mM NaCl and 1 × tris borate EDTA 
running and sample buffer with 500 nM DNA at 293 K and visualised using TAMRA fluorescence (right) and SYBR 
Gold® nucleic acid stain (left). Gel A Lane: 1 PT1, 2 T1, 3 C1-L, 4 T1:PT1, 5 T1:PT1:C1-L, 6-11 cycles of irradiated 
(even lanes) and heated (odd lanes) samples of T1:PT1:C1-L over 3 cycles. Gel B Lane: 1 PT1, 2 T1, 3 C1-M, 4 
T1:PT1, 5 T1:PT1:C1-M, 6-11 cycles of irradiated (even lanes) and heated (odd lanes) samples of T1:PT1:C1-M 
over 3 cycles. Gel C Lane: 1 PT3, 2 T2, 3 C1-L, 4 T2:PT3, 5 T2:PT3:C1-L, 6-11 cycles of irradiated (even lanes) and 
heated (odd lanes) samples of T2:PT3:C1-L over 3 cycles. Gel D Lane: 1 PT3, 2 T2, 3 C1-M, 4 T2:PT3, 5 T2:PT3:C1-
M, 6-11 cycles of irradiated (even lanes) and heated (odd lanes) samples of T2:PT3:C1-M over 3 cycles. 
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5.5 Conclusions and Future Work 
Within this chapter a photo-triggered oligonucleotide release system has been 
designed and evaluated. The initial stem-loop system was shown to either not 
photodimerise with long “release” sequences, or to photodimerise and still allow 
the binding of the “release” sequence with shorter versions. A new design was 
subsequently used, which made use of a toe-hold system and was shown to display 
promising traits. This system was able to form a photodimerised duplex upon 
irradiation, which blocked the binding to the unmodified strand and therefore 
resulted in an increase in the free single stranded complementary oligonucleotide. 
In addition to this, the system was shown to be reversible and reusable, although 
the cycling ability of the system needs to be improved. This is the first example of 
the use of anthracene photodimerisation to trigger the release of DNA strands. 
 
Future studies should focus on optimising the toe-hold system. Utilising a FRET 
pair of fluorophores could allow for the quantification of release, assuming those 
fluorophores are not affected by the irradiation process as the TAMRA label 
appeared to be. The system could then be optimised by varying the ratios of each 
strand present to create conditions where the optimum amount of complementary 
strand can be released. It is expected that this would never be able to reach 100% 
release due to the equilibrium shifting as more strand is released. However, more 
significant release efficiencies would need to be achieved than those presented 
herein in order to make the system a useful tool. It is anticipated that this could 
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be achieved by altering the length of the PTX strands. This would increase the 
number of hydrogen bond pairs and therefore the Tm of the strand, which should 
displace the competing strand more effectively. However, this may result in the 
displacement of the strand prior to irradiation. 
 
An alternative approach, would be to consider altering the ratios of the three 
strands used. Within this chapter all irradiation studies were performed on 
systems containing equimolar amounts of PTX, TX and CX strands. Figure 5.22 
shows that by altering the ratios of this strands, differing ratios of duplexes can be 
formed. By performing irradiation on these samples, a more effective release may 
be achieved. However, it is expected that there will be a fine balance, between 
achieving the release upon irradiation and the release being a prerequisite of the 
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Within this chapter anthracene photodimerisation is used to control the folding of 
a G-quadruplex structure, and efforts towards evaluating the binding of this 
moiety to a natural enzyme, are assessed. This work is a continuation of the 
studies previously performed within the group.1 
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6.1.1 The G-Quadruplex Structure 
The most common structure found within DNA is the B-DNA double helix as 
discussed in Chapter 1.2.1. However, several other folding conformations are now 
known to be naturally present, such as the i-motif and the G-quadruplex.2 In 
recent years, the biological relevance of these structures has begun to be 
understood.2 The G-quadruplex structure arises in guanine rich sequences. The 
DNA strand folds to allow four guanine bases to form Hoogsteen base pairs, with 
a monovalent cation in the centre of the cavity, Figure 6.1.3 The fold that is 
adopted by the DNA strand is highly dependent upon the DNA sequence and the 
spacing between the guanine repeating units; this has been studied in detail and 
summarised in recent reviews.4,5 Circular dichroism (CD) spectroscopy can be 
used to study the G-quadruplex structure, and the characteristic signals of the 
various conformations are now well documented.6 The expected CD spectrum of 
the anti-parallel conformation is shown in Figure 6.2.  
  
Figure 6.1 Hoogsteen bonded guanine bases form a quadruplex with a monovalent cation in the central cavity 
(left). The DNA strand can fold in various conformations to allow for this interaction, four of the most common 
are shown (right). Reprinted with permission from Ma et al., Oncogene and Cancer – From Bench to Clinic, 
2013, Chapter 6. Copyright 2013 InTech. 
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6.1.2 Biological Relevance 
In recent years, the study of the G-quadruplex system has increased significantly 
as the biological relevance of the conformation becomes more understood.7 It is 
now known that the structure is one of the main components of telomeres8 and 
also plays a role, along with the i-motif, in the regulation of the transcription, 
translation and replication processes.9–12 As such these structures have become 
interesting targets to understand and treat diseases. Research is now progressing 
to allow for the control of these stuctures.13 
 
6.1.3 Controlling the G-Quadruplex 
One potential way to control the formation of the G-quadruplex, is to use ligands 
that stabilise the structure. Many ligands have been developed and are now 
being explored as potential anti-cancer therapies.14 The G4 ligand database 
Figure 6.2 Circular Dichroism signal expected for the chair conformation of the G-quadruplex. Adapted with 
permission from Paramasivan et al., Methods, 2007, 43, 324-31. Copyright 2007 Elsevier Inc. and Ma et al., 
Oncogene and Cancer – From Bench to Clinic, 2013, Chapter 6. Copyright 2013 InTech. 
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details the reported ligands that are known to bind to the G-quadruplex.15 It also 
incorporates a tool to help design and target molecules to bind to specific G-
quadruplex sequences and structures. The majority of G-quadruplex ligands 
exploit two modes of binding, a π-π stacking interaction with the guanine bases, 
and electrostatic interactions with the DNA backbone. The most promising of 
these molecules (the only one to make phase II clinical trials) utilises groove 
binding in addition to π-π stacking, Figure 6.3.16,17 
Alternative approaches aim to induce the quadruplex folding. This is known to be 
aided by metal ions (particularly potassium), but recently ligands that induce a 
particular conformation of G-quadruplex have been discovered. Figure 6.4 shows 
two of these structures. Binding to A has been shown to induce an antiparallel 
quadruplex, where the DNA strands align 5′-3′ with 3′-5′ (Figure 6.1, top right), 
whilst binding to B leads to the formation of a parallel quadruplex, where the 
DNA strands align 5′-3′ with 5′-3′ (Figure 6.1, bottom left). The authors do not 
suggest reasons for this differentiation, although they do observe that the 
Figure 6.3 Structure of a G-quadruplex stabilising ligand, fluoroquinolone quarfloxin, comprised of an electron 
rich unit which forms π- π stacking interactions with the guanine bases, and side chains which form van der 
Waals interactions with the quadruplex grooves. 
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polyamine of B threads through the quadruplex core, a significantly different 
binding mode to molecule A.18,19 
In addition to these, ligands that disrupt the quadruplex structure have also been 
developed.20,21 These typically contain regions which are able to form π-π 
stacking interactions, coupled with large groups, which prevent the DNA folding 
into the quadruplex structure due to the formation of unfavourable steric 
interactions.14  An example of this is the triarylpyridine shown in Figure 6.5 
developed by Waller and co-workers.20 
Figure 6.4 Structures of G-quadruplex inducing ligands. Binding of ligand A forms an antiparallel quadruplex, 
whilst binding of B induces the formation of a parallel quadruplex. 
Figure 6.5 The triarylpyridine derivative developed by Waller and co-workers has been shown to disrupt G-
quadruplex formation. 
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6.1.4 Using Light to Control the G-Quadruplex 
Of particular interest to the studies presented herein, is using light to control G-
quadruplex folding. Maeda and co-workers were the first to demonstrate this 
using a photo-regulated guanine nucleobase that underwent cis-trans 
isomerisation upon light irradiation. The researchers incorporated the 
nucleobase, at various positions within the thrombin binding aptamer sequence, 
a well-known G-quadruplex forming aptamer. Upon isomerisation to the cis form, 
it was shown that the quadruplex unfolded, leading to reduced binding to 
thrombin, Figure 6.6.21 
Figure 6.6 Photo-regulated nucleobase used to control G-quadruplex formation. In the trans form the 
quadruplex can form and binding to thrombin is observed. Isomerisation to the cis form disrupts the 
quadruplex and hence the thrombin binding. Adapted with permission from Ogasawara et al., Angew. Chem. 
Int. Ed. Engl., 2009, 48, 6671-4. Copyright 2009 WILEY-WCH Verlag GmbH & Co. 
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Zhou and co-workers have utilised an azobenzene derivative to control the folding 
of a G-quadruplex sequence found within telomeres. They showed that the trans 
form of the molecule interacted with the G-quadruplex structure. Upon 
isomerisation, the cis form could not maintain the same stabilising interactions 
and the quadruplex unfolded, Figure 6.7.22,23  
 
 
Research into the photo crosslinking of G-quadruplex structures, in order to lock 
DNA into a particular conformation, has also been conducted. Verga et al. 
attached two photoactive molecules to bases within the quadruplex structure, one 
being an azide derivative the other a benzophenone. Upon irradiation, the 
molecules reacted to crosslink the DNA and lock it into the quadruplex structure. 
This technique was also shown to work within cells.24 It is hoped that this type of 
Figure 6.7 Schematic representation of the light controlled folding of a G-quadruplex structure utilising an 
azobenzene ligand. In the cis form the ligand interacts and stabilises the quadruplex structure (left). Upon 
isomerisation to the trans conformation (right), the ligand can no longer bind and the quadruplex does not 
form. Reprinted with permission from Wang et al., Angew. Chem. Int. Ed. Engl., 2010, 49, 5305-9. Copyright 
2010 WILEY-WCH Verlag GmbH & Co. 
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approach will allow for the trapping of quadruplexes within natural systems, so 
further studies can be conducted on the biological relevance of such structures. 
 
6.1.5 Thrombin Binding Aptamer 
The thrombin binding aptamer (TBA), 5′-GGTTGGTGTGGTTGG-3′, has been 
utilised to interrogate quadruplex binding in several studies, due to its relatively 
short sequence, classical anti-parallel folded G-quadruplex structure and well 
understood binding to thrombin. Within this study, the TBA sequence is adapted 
to evaluate the ability of anthracene photodimerisation, to control the G-
quadruplex fold. 
 
Thrombin is a protease enzyme essential to the coagulation cascade. Its primary 
function is to convert the soluble protein fibrinogen, into insoluble, clot-forming 
fibrin, so as to reduce blood loss. The TBA was first discovered in 1992, using the 
systematic evolution of ligands by exponential enrichment (SELEX) technique.25 
It has been shown to bind strongly to thrombin in exosite I, the natural binding 
site of the fibrinogen substrate, inhibiting the coagulation pathway. Other 
aptamers that bind to thrombin are known and vary considerably in their 
structure, conformation and binding site.26 These aptamers are generally referred 
to by alternative names to avoid confusion with the original TBA sequence. 
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The TBA folds into a chair conformation (Figure 6.8) with a monovalent cation, 
typically potassium, in the centre. The sequence is comprised of repeated guanine 
bases, separated by loops containing thymine and a guanine base. In recent 
studies it has been identified that TBA actually binds to two thrombin entities 
(Figure 6.9), with one side binding in exosite I and the other to exosite II.27,28 The 
binding is found to be highly dependent upon the cations that are present, as 
these are known to affect not only the folding of TBA, but also the folding of 
thrombin itself. It has been established that the presence of potassium enables 
the strongest binding between TBA and thrombin.29,30 
 
Figure 6.8 Thrombin binding aptamer sequence and folded conformation when bound to potassium. Loop 
regions are shown in red in the sequence. Adapted from Manchester, PhD Thesis, University of Birmingham, 
2013. 
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The work presented herein utilises the TBA sequence, to assess the ability of 
anthracene photodimerisation to control the folding of the quadruplex structure. 
 
6.1.6 Previous Work 
Previously within the Tucker group, several systems incorporating anthracene at 
various points within the TBA sequence have been developed.1 Subsequent 
photodimerisation of the anthracene moieties was found to progress at differing 
rates, depending upon the position of these and the stereochemistry and linker 
length used to attach the anthracene. Some combinations were found to display 
Figure 6.9 Model structure of thrombin binding aptamer (yellow) bound to two thrombin proteins. One 
through exosite I (green) and the other through exosite II (blue). Reprinted with permission from Gonçalves et 
al., Chem. Commun., 2006, 4685-7. Copyright 2006 Royal Society of Chemistry. 
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no photodimer formation. Photodimers that did form were purified using RP-
HPLC and variable temperature analysis identified that head-to-head (H-H) and 
head-to-tail (H-T) photodimers were present. Due to the instability of the H-H 
photodimers and their rapid reversion to monomer species, only the H-T 
photodimers were subjected to further analysis.1 
 
It was established that, upon photodimerisation, the thermal melting (Tm) 
temperatures of the G-quadruplexes in the presence of K+, were dramatically 
reduced, with some displaying no transition suggesting the complete disruption 
of the structure. This hypothesis was confirmed using CD analysis on two 
systems, but the full series of sequences was not completed. Thermal reversion of 
the photodimer species was performed by heating the sample to 80°C for 16 
hours. Upon cooling to room temperature, it was observed by CD that the 
complex had reverted to the original quadruplex fold. Initial studies to assess the 
effect of anthracene incorporation and photodimerisation on binding to thrombin, 
using isothermal calorimetry and gel electrophoresis studies, proved 
inconclusive.1 Therefore this area of the project is re-addressed herein. 
 
6.2 Project Aims 
Within this project, four anthracene tagged, G-quadruplex forming sequences are 
analysed to monitor their folding dependence on the monovalent cations present. 
The sequences are then subjected to irradiation conditions to form photodimer 
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species with the aim of locking, or disrupting the G-quadruplex formation. The 
structures are then re-assessed to monitor any changes and the binding of the 
aptamer to thrombin analysed. 
 
6.3 Anthracene Tagged Thrombin Binding Aptamer 
6.3.1 Anthracene Tagged Thrombin Binding Aptamer Sequences 
Within this thesis the most promising sequences identified by previous work, are 
assessed, Table 6.1. 
Table 6.1 Sequences used for thrombin binding aptamer where X denotes anthracene moiety with a 6 carbon 
linker length and D stereochemistry. Loop assignments are shown in Figure 6.8. 
Name Sequence (5′ – 3′) Placement of Modification 
TBA    GG TTG GTG TGG TTG G N/A 
M1-TBA XTGG TTG GTG TGG TTG GTX Ends 
M2-TBA    GG TTG GXG XGG TTG G Both in Loop B 
M3-TBA    GG TTG GTG XGG XTG G Loops B and C 
 
These incorporate anthracene at various positions within the G-quadruplex, 
along with an unmodified TBA for direct comparison. All incorporations are made 
within the loop regions, or at the ends of the aptamer (Figure 6.8), so as to 
minimise the disruption to the hydrogen bonding regions and folding, prior to 
photodimerisation. 
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Previous work has shown that, upon photodimerisation in the presence of K+, 
aptamer M1-TBA no longer displays a transition by Tm analysis, suggesting that 
it no longer has a quadruplex structure. M2-TBA and M3-TBA display reduced 
Tm values which would be consistent with a less stable quadruplex structure. CD 
studies had only been performed on the photodimer of M3-TBA, which displayed 
weak signals characteristic of a G-quadruplex structure.1 
 
6.3.2 Circular Dichroism Studies 
CD analysis was performed on the unmodified and anthracene tagged samples in 
various buffers, to assess the effect of cations on the folding. As discussed in 
Section 6.1.4, TBA folding is stabilised by the presence of potassium, however, it 
is also known that sodium can infer a degree of stability. As such the folding was 
analysed in Tris HCl buffer and sodium phosphate buffer, both in the presence 
and absence of potassium ions, Figure 6.10. The sequence used within this study 
is expected to fold into a chair like structure (Figure 6.8). 
 
Samples of TBA and M1-TBA (Figure 6.10A and B, respectively) display similar 
properties. When performed in Tris HCl buffer, the aptamers are unfolded and in 
the presence of just sodium, signals characteristic of a weak chair G-quadruplex 
are observed which are slightly more pronounced for M1-TBA. It is only upon 
addition of potassium that strong anti-parallel G-quadruplex signals are 
observed, with little change between the Tris HCl and sodium phosphate 
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samples. These observations suggest that when the anthracene modifications are 
incorporated at the ends of the aptamer, there is little change to the folding 
behaviour of the sequence. 
Aptamer M2-TBA is the only sample which does not display a folding dependence 
in the presence of cation (Figure 6.10 C). With this aptamer, all signals are very 
similar between the different buffer conditions used, with an anti-parallel 
conformation displayed. Additionally, all spectra display a strong anthracene 
Figure 6.10 CD analysis of TBA derivatives. A) TBA, B) M1-TBA, C) M2-TBA and D) M3-TBA. Performed at 1 µM 
oligonucleotide in 10 mM Tris HCl pH 7 (black solid) and with 100 mM KCl added (black dash) and in 10 mM 
sodium phosphate buffer pH 7 (grey solid) and with 100 mM KCl added (grey dash). All performed in 1 cm 
pathlength cuvette at 293 K. 
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induced peak at 265 nm. This strongly suggests that the anthracene is 
intercalating, which could increase the stability of the folded conformation. 
Interestingly, the negative band centred around 250 nm is much stronger than 
would be expected from the chair G-quadruplex, and far more characteristic of a 
B-DNA structure. This could indicate that the anthracene incorporation at the 
centre of the sequence has completely disrupted the fold, and could account for 
the reduced folding dependence upon the presence of a cation. 
 
Aptamer M3-TBA in Tris HCl buffer displays a positive band at around 255 nm, 
this could be due to an anthracene induced peak, or a parallel G-quadruplex 
structure as both display signals in this region. In the presence of sodium ions, 
weak signals characteristic of a quadruplex structure are observed with a 
positive band at ~290 nm and a negative band ~260 nm. The addition of 
potassium enhances the signals expected for an anti-parallel G-quadruplex.  
 
The above results show that strong anti-parallel G-quadruplex signals are 
observed in the presence of potassium ions. Subsequently, analysis of the H-T 
photodimer species was performed in sodium phosphate buffer in the presence 
and absence of potassium, Figure 6.11, to establish the effect photodimerisation 
has on the folding. 
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In all cases the H-T photodimer species display a reduction in the signals 
observed, suggesting the structures are less well folded. In addition to this, 
addition of potassium has little effect on the photodimerised structure. Although 
samples M1-TBA and M3-TBA are observed to have transitions in the regions 
expected for a G-quadruplex fold, these are considerably weaker, suggesting that 
the secondary structure is less well formed, and resembles that of the 
unirradiated sample in the absence of potassium. Aptamer M2-TBA appears to 
display a shift in the negative band upon photodimerisation. It is possible that 
Figure 6.11 CD analysis of TBA derivatives. A) TBA, B) M1-TBA, C) M2-TBA and D) M3-TBA unirradiated samples 
(black) and H-T photodimers isolated from HPLC (grey). Performed at 1 µM oligonucleotide in 10 mM sodium 
phosphate buffer pH 7 (solid) and with 100 mM KCl added (dashed). All performed in 1 cm pathlength cuvette 
at 293 K. 
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this is due to the eradication of the induced positive anthracene band at 265 nm 
upon photodimerisation, giving a resultant spectrum that is similar to those 
observed for the other modified aptamers. These results confirm that anthracene 
photodimerisation can impart a degree of control over the G-quadruplex fold and 
the signals obtained for the photodimerised product are similar to those found in 
the work of Maeda and co-workers.21 
 
6.3.3 Gel Electromobility Shift Assay 
An important aspect of this work was to establish the effect of the anthracene 
moieties on the binding to thrombin. It was thought that this incorporation would 
disrupt the binding to thrombin to some extent due to the proximity of their 
attachments to the binding region of the aptamer. Upon photodimerisation, it 
was expected that the disruption to the folding would inhibit the thrombin 
binding further. Previous work using ITC to assess the binding was inconclusive.1 
Within this study it was initially decided that gel EMSA would be an ideal 
technique to qualitatively determine the binding affinities of the aptamers to 
thrombin. Initial studies were performed on TBA, Figure 6.12.  
 
It can be observed that the intact protein-aptamer species is visible at 50 nM of 
thrombin (Figure 6.12, Lane 5), however, the TBA is not fully bound until 1000 
nM (Figure 6.12, Lane 12), a much higher concentration than expected compared 
to previous studies.31 This is potentially due to errors in the concentration of 
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thrombin present. The protein is supplied as a lyophilised powder that is 
quantified using the absorbance of the sample in solution. This method does not 
account for any impurities that could also absorb at the monitored wavelength 
(280 nm), such as other proteins, making the solution seem more concentrated 
than it is. In order to make this method more viable, the protein would need to be 
purified and re-quantified.  
Although this technique looked promising, it was not used in subsequent studies, 
as it was found that anthracene incorporation inhibited the fluorescence output 
of the SYBR Gold® nucleic acid stain. It was not clear whether this was a result 
of the anthracene inhibiting the binding of the dye to the DNA strands, or if the 
anthracene moiety was interfering with the fluorescence of the dye. It was found 
Figure 6.12 Gel EMSA of TBA (100 nM) with increasing thrombin concentrations (0, 12.5, 16.67, 25, 50, 75, 100, 
150, 200, 250, 500 and 1000 nM). Gel visualised using SYBR Gold® nucleic acid stain. 
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that the amount of DNA needed to analyse the strands was five times the 
amount of unmodified TBA, i.e. 500 nM rather than 100 nM (see Figure 6.12). 
This increase would need to be matched by the same relative increase in protein 
concentration for the assay to work, an amount of protein that was deemed too 
excessive. 
 
6.3.4 Binding assay 
An alternative approach to monitor the binding is to exploit the natural clotting 
pathway that thrombin displays. It is known that fibrinogen is converted to fibrin 
by thrombin, Section 6.1.2. The fibrin then forms a clot, reducing the flow of the 
liquid and increasing the optical density of the sample. This clot formation is 
routinely used to measure fibrinogen concentrations within medical samples, and 
is referred to as the Clauss assay.32 
 
Upon binding of TBA to thrombin, the exosite is blocked, and hence the time it 
takes for a clot to form is either slowed or halted completely. A measurement of 
the clot time, can therefore be used to infer the binding affinity of the inhibitor, 
as long as all other variables are kept constant. These type of experiment have 
been reported in the literature.25,33–36 Thorough analysis of the clotting curves 
has also been reported and the elucidation of binding constants from the curves 
has been achieved.37 
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The aptamers used herein were analysed using the clotting time of fibrinogen 
when in the presence of thrombin, Figure 6.13. The thrombin, salts and aptamers 
were mixed prior to addition to the fibrinogen, to ensure they had reached a 
binding equilibrium. 
 
Figure 6.13 Two identical repeats of the clotting time assays performed using 3 µM fibrinogen with 0.1 NIH 
units of thrombin and 37 nM of aptamer in 50 mM Tris HCl pH 7 with 100 mM KCl, all performed at 25 °C. No 
aptamer (black), TBA (blue), M1-TBA (red), M2-TBA (yellow), M3-TBA (green) with isolated H-T photodimers of 
anthracene modified sequences shown as the corresponding dashed line. 
 
Initial studies looked promising, with all aptamers displaying clotting times that 
fell in between the two expected extremes of no aptamer present and TBA 
present. From the CD results (Section 6.3.1) it would have been hypothesised 
that M1-TBA would display the closest resemblance to TBA, due to the extremely 
similar folding. The experiment is consistent with the hypothesis, with M1-TBA 
displaying the slowest clotting time of all the modified aptamers. Similarly, all 
the H-T photodimers, which were shown to have poor folding, display limited 
inhibition and have fast clotting times. Aptamer M3-TBA contains anthracene 
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modifications in both of the thrombin binding sites, and would hence be predicted 
to display the weakest binding of all the modified aptamers. Once again this 
trend is observed within the clotting times, with this sequence displaying the 
closest clotting curve to the sample containing no TBA.  
 
Despite the trends being as one would have predicted, the results should not be 
over interpreted. This assay was repeated several times using several different 
stocks and suppliers of both fibrinogen and thrombin. Each time unmodified 
aptamer was used first, but unfortunately consistent results could not be 
obtained. In addition to this all buffers, cuvettes and preparation equipment was 
also changed, but the source of the true discrepancy could not be identified. 
 
6.4 Conclusions and Future Work 
This study has focussed on gaining a deeper understanding on the use of 
anthracene photodimerisation to control the folding of oligonucleotides. It has 
been shown by CD studies, that photodimerisation can reduce the folding of the 
TBA G-quadruplex. Different methods were then used in an attempt to assess 
the effect of photodimerisation on thrombin binding and activity. However, 
further studies would be required to verify initial results which indicate an effect 
on clotting time in the Clauss assay. 
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It is hoped that future work will allow for further experiments towards 
determining and quantifying the binding affinities of the aptamers. This could 
potentially be performed by optimising methods such as ITC, gel EMSA and the 
Clauss assay. Confirmation of the successful application of anthracene 
photodimerisation to control aptamer folding and therefore function, would 
eventually allow for other more advanced photocontrollable biological systems to 
be developed.  
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Within this thesis the use of anthracene incorporation into biomolecules has been 
assessed, utilising the photodimerisation and fluorescence properties that 
anthracene possess to monitor, and control, the biomolecules. 
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7.1.1 SNP Detection using an Anthracene Probe 
In the first project presented herein, anthracene was used as a fluorescent 
reporter molecule to establish the base present on a complementary strand of 
DNA. Several linker lengths and stereochemistry combinations of the anthracene 
were used and the fluorescent properties of each was assessed in the probe 
system. A linker length of 5 carbons and L stereochemistry was shown to give the 
greatest differentiation between the A and C bases that needed to be 
distinguished in the complementary sequence. Further to this, the probe was 
shown to be able to quantitatively determine the ratio of the two bases on the 
complementary strand by the relative intensity of fluorescence. This is an 
advancement on the currently available methods as this assay is able to be 
performed at room and biological temperatures. 
 
 
Future work should focus on reducing the amounts of material needed to perform 
the assay, making it more biologically relevant. This could be done by reducing 
the concentrations and volumes required, although studies presented herein have 
shown that this increases the error of the assay. Alternatively, an additional 
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In addition to SNP sensing, the base modification 8-oxoG was also shown to be 
distinguished by the anthracene probe. This was assessed in two sequences of 
DNA and the fluorescent output was shown to be highly dependent on the bases 
surrounding the fluorophore. Future work should address this with more detailed 
studies on the origin of this effect. The probe could also be developed into a 
quantitative system as with the SNP sensing.  
 
 
7.1.2 Controlling DNA Binding using an Anthracene Tagged Peptide 
A DNA binding, homodimer peptide was taken and the coiled coil dimerisation 
region removed and replaced with anthracene. Studies showed that this 
incorporation did not disrupt the DNA binding or selectivity of the peptide. The 
anthracene was used as a fluorescent output to assess the DNA binding of the 
system. Subsequent irradiation to form photodimer species showed that the 
photodimer only forms when target DNA is present. This is due to the peptide 
units binding in a specific fashion and pre-organising the anthracene moieties 
into close proximity. With the other DNA sequences, the anthracene moieties are 
too far apart to form photodimers. The formation of a covalently linked 
homodimer peptide was shown to increase the binding affinity for target DNA. 
This project is the first example of the use of anthracene photodimerisation 
within a protein structure. 
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Despite the positive outcomes of these project, several questions remain 
unanswered, such as why the system is not reversible and the products that are 
formed from extensive irradiation. Future work should focus on these areas 
potentially using a different amino acid sequence to monitor the effect of the 
individual amino acids on the process, such as methionine oxidation. 
 
 
7.1.3 Photo-Triggered Release of DNA 
The use of anthracene to force the release of a segment of single stranded DNA 
was also assessed. This started by focussing on a stem loop system with 
anthracene moieties incorporated on the ends of the sequence. This system was 
shown to be difficult to optimise and a new toe-hold system was used as an 
alternative. Within this system three strands of DNA were used that were in an 
equilibrium mixture. Upon irradiation, two of the strands which incorporated an 
anthracene unit, were “locked” together, shifting the equilibrium and releasing 
the third strand. Initial results from this project are promising with a degree of 
release shown by gel electrophoresis analysis. 
 
 
Further optimisation of the toe-hold system is needed to quantify the release of 
the single stranded oligonucleotide. This information could then be used to help 
optimise the system and increase the amount of release. 
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7.1.4 Controlling DNA Folding using Anthracene Photodimerisation 
The final project presented herein places an anthracene monomer at various 
locations on a G-quadruplex aptamer. Photodimerisation was shown to alter the 
folding of the systems, dependent upon where the anthracene incorporations 
were made. The systems were then studied to monitor the effect of the 
incorporation and subsequent dimerisation, on the binding of the aptamer to its 
target, thrombin. These studies were hindered by error and, although initially 
promising, the results cannot be used to draw any conclusions on the effects this 
incorporation has had on the binding. 
 
 
Further studies should focus on assessing the binding of the aptamer utilising gel 
electromobility shift assays. Alternative DNA folds could also be analysed in 














Potassium phosphate dibasic, potassium phosphate monobasic, sodium chloride, 
acrylamide, tetramethylethylenediamine (TEMED), ammonium persulphate 
(APS), tris base, hydrochloric acid 32%, sodium dodecyl sulphate (SDS), sodium 
hydroxide, magnesium chloride, potassium chloride, potassium carbonate, sodium 
carbonate, trifluoroacetic acid (TFA), glacial acetic acid, ethyl acetate, 
ethylenediaminetetraacetic acid (EDTA), methanol, acetone, dichloromethane, 
ethanol and triethyl amine (TEA) were all purchased from Fisher Scientific Ltd, 
Loughborough UK. Tricine, anthrone, and 4,4’-dimethyoxytrityl chloride was 
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obtained from Alfa Aesar, Massachusetts, USA; anisole, thioanisole and 1,2-
ethanedithiol were purchased from Merck Millipore, Darmstadt, Germany. Sigma 
Aldrich Ltd., Missouri, USA were used to supply glycerol, Igpeal CA 630, bovine 
serum albumin, ethyl bromoacetate, Ethyl-4-bromobutyrate, Ethyl-5-
bromovalerate, Ethyl-6-bromohexanoate, Ethyl-7-bromoheptanoate, magnesium 
sulphate, silica, L-threoninol, D-threoninol, dimethylformamide (DMF), alumina, 
solid supported benzyl alcohol, HBTU, DIPEA, 4-dimethylaminopyridine and 9-
anthracenecarboxylic acid. SYBR Gold was sourced from Life Technologies Ltd., 
Paisley, UK; hexane from VWR, Lutterworth, UK and Coomassie brilliant blue 
stain R-250 protein stain from AppliChem GmbH, Darmstadt, Germany. 
 
Fmoc-Arg(Pbf)-OH, Fmoc-Leu-OH, Fmoc-Met-OH, Fmoc-Ser(tBu)-OH, Fmoc-
Thr(tBu)-OH, HBTU, DIPEA and rink amide MBHA resin were purchased from 
AGTC Bioproducts Ltd. Fmoc-Ala-OH, Fmoc-Asn(Trt)-OH, Fmoc-Gln(Trt)-OH, 
Fmoc-Glu(OtBu)-OH, Fmoc-Lys(Boc)-OH, 20% piperidine in DMF and peptide 
synthesis grade DMF were purchased from Pepceuticals Ltd, Leicester, UK. Fmoc-
Lys(Mtt)-OH was obtained from Merck Millipore, Darmstadt, Germany. All 
oligonucleotide synthesis reagents were purchased from Link Technologies Ltd., 
Bellshill, UK, including 2-cyanethyl-diisopropylchlorophosphoramidite, potassium 
carbonate in anhydrous methanol and TAMRA-dT-CE phosphoramidite. 
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Thrombin and Fibrinogen were obtained from Sigma Aldrich Ltd., Missouri, USA 
and Merck Millipore Darmstadt, Germany. An assay kit “Clauss Fibrinogen Assay” 
from Helena Laboratories (UK) Ltd. was also used. 
 
Unless otherwise stated, all reagents were used as per the manufacturer’s 
instructions without further purification. All water was ultrapure grade obtained 
from a Millipore Elix-Gradient A10 system (resistivity > 18 µΩ cm toc ≤ 5 ppb, 
Millipore, France). 
 
1H and 31P NMR were performed on a Bruker AV300 spectrometer, 13C NMR was 
performed on a Bruker AV400 spectrometer. MALDI-TOF mass spectrometry was 
performed on a Water Synapt G2-Si Mass Spectrometer. Electrospray-TOF mass 
spectrometry was performed on a Waters LCT Premier or a Water Synapt G2-Si 
Mass Spectrometer. 
 
8.2 Anthracene Monomer Synthesis 
The synthesis of anthracene phosphoramidites to allow for incorporation into 
oligonucleotides was performed as previously reported.1 Herein follows the 
characterisation of anthracene linkers 1 and 3-6 with both L and D 
stereochemistries. 7L and 7D versions were synthesised by Jack Manchester.2 A 
reaction scheme for these can be found in Chapter 2.2.1. 
Chapter 8 – Experimental 
 
 232 
8.2.1 General Synthesis Procedure 
Anthrone was refluxed in degassed acetone in the dark overnight with 1 molar 
equivalent of potassium carbonate and 1 molar equivalent of the bromoethyl ester 
of the desired length:  
n=1  Ethyl bromoacetate 
n=3  Ethyl-4-bromobutyrate 
n=4  Ethyl-5-bromovalerate 
n=5  Ethyl-6-bromohexanoate 
n=6  Ethyl-7-bromoheptanoate 
The solution was then filtered and acetone removed in vacuo to afford an orange 
oil. The solid was re-suspended in dichloromethane (DCM), washed with water, 
dried with magnesium sulphate and the solvent removed in vacuo. The crude 
product was then purified on silica using column chromatography in 10% hexane 
in DCM. 
 
The ester product was then hydrolysed by refluxing overnight in the dark in a 1:1 
degassed solution of 10% sodium hydroxide and ethanol to produce the carboxylic 
acid. The ethanol was then removed in vacuo and the solution diluted to 3 times 
the volume with water. Concentrated hydrochloric acid was added dropwise to 
produce a cream precipitate which was collected by suction filtration. 
 
The stereochemistry was introduced using L- or D-threoninol. The carboxylic acid 
was dissolved in degassed dimethylforamide (DMF) and 1 molar equivalent of O-
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(benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate (HBTU) 
was added and the solution stirred for 15 minutes. 1 molar equivalent of threoninol 
with 1 molar equivalent of N,N-diisopropylethylamine (DIPEA) was then added 
and the reaction stirred at 40ºC for 40 hours. The solution was diluted with 
methanol and DCM and washed with water before the solvent was removed under 
vacuum. The crude product was column purified on silica using a gradient of 1-5% 
methanol in DCM to afford an orange oil. 
 
The primary alcohol of the threoninol was then protected with a dimethyloxytrityl 
(DMT) group. The threoninol derivatised anthracene was dissolved in pyridine and 
1 molar equivalent of dimethoxytrityl chloride was added with 0.15 molar 
equivalents of 4-dimethylaminopyridine. The solution was stirred in the dark 
overnight under argon. Water was added to dilute the solution and the product 
was extracted with DCM and dried over magnesium sulphate. The crude product 
was purified using a silica column with 40% hexane, 59% ethyl acetate and 1% 
triethylamine as an eluent. 
 
Finally the phosphoramidite group was added by dissolving the DMT protected 
alcohol in dry DCM with 1 molar equivalent DIPEA and 1 molar equivalent 2-
cyanethyl-diisopropylchlorophosphoramidite and stirring for 2 hours. 1 molar 
equivalent of solid supported benzyl alcohol was then added and stirred for a 
further hour. The solution was filtered and rinsed with ethyl acetate, washed with 
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sodium carbonate, water and brine before being dried with magnesium sulphate. 
The solvent was removed in vacuo and the crude product purified on activated 
alumina using an eluent of 40% hexane, 59% ethyl acetate and 1% triethylamine. 
 
The below compounds have been previously synthesised.1,2 
 
8.2.2. Characterisation of n=1L and 1D 




1H NMR (300 MHz, Chloroform-d) δ 8.36 (d, J = 7.7 Hz, 2H, H6), 8.27 (s, 1H, H1), 
8.01 (d, J = 7.5 Hz, 2H, H3), 7.53 – 7.46 (m, 4H, H4 and H5), 4.81 (s, 2H, H9), 4.38 
(q, J = 7.1 Hz, 2H, H11), 1.38 (t, J = 7.2 Hz, 3H, H12); 13C NMR (100 MHz, 
Chloroform-d) δ 169.1 (C10), 149.5 (C8), 132.3 (C2), 128.4 (C3), 125.6 (C5), 125.6 (C4), 
124.3 (C7), 123.1 (C1), 122.2 (C6), 72.1 (C9), 61.4 (C11), 14.3 (C12); m/z (ES+) 
calculated for C18H16O3Na 303, found 303. Yield: 28%, Rf = 0.59 in CH2Cl2. 
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8.2.2.2. n=1 Carboxylic Acid 
2-(Anthracen-9-yloxy)acetic acid 
 
1H NMR (300 MHz, Chloroform-d) δ 8.30 (s, 1H, H1), 8.26 (d, J = 8.1 Hz, 2H, H6), 
8.02 (d, J = 8.2, 2H, H3), 7.56 – 7.45 (m, 4H, H4 and H5), 4.85 (s, 1H, H9); 13C (100 
MHz, Chloroform-d) δ 172.4 (C10), 149.5 (C8), 132.3 (C2), 128.6 (C3), 126.0 (C5), 
125.7 (C4), 124.2 (C7), 123.5 (C1), 121.7 (C6), 71.3 (C9); m/z (ES+) calculated for 
C16H12O3Na 275, found 275. Yield: 90%. 
 
8.2.2.3. n=1L Diol 
2-(Anthracen-9-yloxy)-N-((2R,3R)-1,3-dihydroxybutan-2-yl)acetamide 
 
1H NMR (300 MHz, Chloroform-d) δ 8.29 (s, 1H, H1), 8.22 – 8.17 (m, 2H, H6), 8.05 
– 7.98 (m, 2H, H3), 8.02 (s, 1H, NH), 7.49 (m, 4H, H5 and H4), 4.75 (s, 2H, H9), 4.42 
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– 4.33 (m, 1H, H12), 4.21 – 3.90 (m, 3H, H11 and H14), 1.42 (d, J = 6.4 Hz, 3H, H13); 
13C NMR (100 MHz, Chloroform-d) δ 169.5 (C10), 162.7 (C8), 132.3 (C2), 128.7 (C3) 
125.8 (C5), 125.7 (C4), 124.2 (C7), 123.4 (C1), 121.4 (C6), 73.6 (C9), 69.0 (C12), 65.2 
(C14), 54.8 (C11), 20.9 (C13); m/z (ES+) calculated for C20H21NO4Na 362, found 362. 
Yield: 28%, Rf = 0.57 in CH2Cl2 with 10% MeOH. 
 




1H NMR (300 MHz, Acetonitrile-d3) δ 8.30 (s, 1H, H1), 8.23 – 8.10 (m, 2H, H6), 7.99 
(d, J = 8.5 Hz, 2H, H3), 7.79 (d, J = 5.8 Hz, 1H, NH), 7.46 – 7.41 (m, 4H, H4 and 
H22), 7.36 – 7.28 (m, 2H, H5), 7.25 – 7.12 (m, 6H, H17 and H23), 7.09 – 6.96 (m, 1H, 
H24), 6.83 – 6.64 (m, 4H, H18), 4.61 (s, 2H, H9), 4.14 – 3.96 (m, 2H, H11 and H12), 
3.68 (s, 6H, H20), 3.33 – 3.04 (m, 2H, H14), 1.12 (d, J = 5.0 Hz, 3H, H13); 13C NMR 
(100 MHz, Acetonitrile-d3) δ 158.5 (C10), 145.2 (C19), 139.9 (C8), 136.1 (C21), 129.7 
(C16), 128.5 (C2), 128.0 (C17), 127.8 (C3), 127.6 (C22), 126.8 (C23), 126.7 (C24), 126.0 
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(C5), 125.8 (C4), 123.2 (C7) 121.6 (C1), 117.5 (C6), 112.8 (C18), 96.3 (C15), 74.7 (C9), 
66.2 (C12), 63.4 (C14), 54.9 (C20), 51.1 (C11), 19.8 (C13); m/z (ES+) calculated for 
C41H39NO6Na 664, found 664. Yield: 50%, Rf = 0.39 in CH2Cl2 with 5% MeOH. 
 




1H NMR (300 MHz, Acetonitrile-d3) δ 8.31 (s, 1H H1), 8.22 – 8.18 (m, 2H, H6), 8.00 
(d, J = 8.5 Hz, 2H, H3), 7.80 (d, J = 5.8 Hz, 1H, NH), 7.48 – 7.38 (m, 4H, H4 and 
H22), 7.38 – 7.28 (m, 2H, H5), 7.24 – 7.19 (m, 6H, H17 and H23), 7.09 – 7.01 (m, 1H, 
H24), 6.78 (d, J = 2.2 Hz, 4H, H18), 4.59 – 4.67 (m, 2H, H11 and H12), 4.07 (s, 2H, H9), 
3.68 (s, 6H, H20), 3.67 – 3.10 (m, 6H, H14, H25 and H28), 2.88 – 2.34 (m, 2H, H26), 
1.28 – 0.90 (m, 12H, H29), 0.71 (d, J = 6.8 Hz, 3H, H13); 31P NMR (121 MHz, 
Acetonitrile-d3) δ 148.4, 146.0; m/z (ES+) calculated for C50H56N3O7PNa 864, found 
864. Yield: 65%, Rf = 0.74 in 50% hexane, 50% ethyl acetate. 
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8.2.2.6. n=1D Diol 
2-(Anthracen-9-yloxy)-N-((2S,3S)-1,3-dihydroxybutan-2-yl)acetamide 
 
1H NMR (300 MHz, Chloroform-d) δ 8.28 (s, 1H, H1), 8.21 – 8.06 (m, 2H, H6), 8.05 
– 7.96 (m, 2H, H3), 7.75 (d, J = 3.9 Hz, 1H, NH), 7.62 – 7.42 (m, 4H, H5 and H4), 
4.73 (s, 2H, H9), 4.84 – 4.55 (m, 1H, H12), 4.37 (dd, J = 6.4, 2.4 Hz, 1H, H11), 4.05 
(d, J = 3.5 Hz, 2H, H14), 1.40 (d, J = 6.4 Hz, 3H, H13); 13C NMR (100 MHz, 
Chloroform-d) δ 169.3 (C10), 162.7 (C8), 132.4 (C2), 128.7 (C3) 125.8 (C5), 125.7 
(C4), 124.2 (C7), 123.4 (C1), 121.4 (C6), 73.6 (C9), 68.8 (C12), 65.2 (C14), 54.8 (C11), 
21.1 (C13); m/z (ES+) calculated for C20H21NO4Na 362, found 362. Yield: 40%, Rf = 
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1H NMR (300 MHz, Acetonitrile-d3) δ 8.37 (s, 1H, H1), 8.21 – 8.27 (m, 2H, H6), 8.06 
(d J  = 8.4 Hz, 2H, H3), 7.50 (d, J = 6.9 Hz, 1H, NH), 7.48 – 7.40 (m, 2H, H4), 7.37 
(d, J = 8.9 Hz, 2H, H22), 7.32 – 7.25 (m, 2H, H5), 7.25 – 7.15 (m, 6H, H17 and H23), 
7.13 – 7.08 (m, 1H, H24), 6.80 – 6.87 (m, 4H, H18), 4.68 (s, 2H, H9), 4.36 – 3.91 (m, 
2H, H11 and H12), 3.71 (s, 6H, H20), 3.25 – 2.71 (m, 2H, H14), 1.19 (d, J = 6.2 Hz, 3H, 
H13); 13C NMR (100 MHz, Acetonitrile-d3) δ 158.6 (C10), 145.2 (C19), 139.9 (C8), 132.1 
(C21), 130.0 (C16), 128.5 (C2), 128.0 (C17), 127.8 (C3 andC22), 126.9 (C23 and C24), 
126.0 (C5), 125.8 (C4), 123.2 (C7) 121.7 (C1), 117.5 (C6), 113.1 (C18), 96.3 (C15), 74.7 
(C9), 66.2 (C12), 63.4 (C14), 54.9 (C20), 51.1 (C11), 19.8 (C13); m/z (ES+) calculated for 
C41H39NO6Na 664, found 664. Yield: 48%, Rf = 0.39 in CH2Cl2 with 5% MeOH. 
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1H NMR (300 MHz, Acetonitrile-d3) δ 8.42 (s, 1H, H1), 8.24 (d, J = 8.7 Hz, 2H, H6), 
8.11 (d, J = 8.4 Hz, 2H, H3), 7.59 – 7.47 (m, 5H, NH, H4 and H22), 7.47 – 7.38 (m, 
6H, H5 and H17), 7.37 – 7.29 (m, 2H, H23), 7.28 – 7.21 (m, 1H, H24), 6.93 – 6.85 (m, 
4H, H18), 4.84 – 4.64 (m, 2H, H9), 4.45 – 4.25 (m, 2H, H11 and H12), 3.79 – 3.71 (m, 
6H, H20), 3.70 – 3.20 (m, 6H, H14, H25 and H28), 2.89 – 2.62 (m, 2H, H26), 1.45 – 0.95 
(m, 12H, H29), 0.81 (d, J = 6.8 Hz, 3H, H13); 31P NMR (121 MHz, Acetonitrile-d3) δ 
147.5, 144.5; m/z (ES+) calculated for C50H56N3O7PNa 864, found 864. Yield: 30%, 





Chapter 8 – Experimental 
 
 241 
8.2.3. Characterisation of n=3L and 3D 
8.2.3.1. n=3 Ester 
Ethyl 4-(anthracen-9-yloxy)butanoate 
 
1H NMR (300 MHz, Chloroform-d) δ 8.31 – 8.14 (m, 3H, H1 and H6), 7.99 (d, J = 9.7 
Hz, 2H, H3), 7.56 – 7.40 (m, 4H, H4 and H5), 4.26 – 4.16 (m, 4H, H13 and H9), 2.79 
(t, J = 7.4 Hz, 2H, H11), 2.48 – 2.33 (m, 2H, H10), 1.31 (t, J = 7.1 Hz, 3H, H14); 13C 
NMR (100 MHz, Chloroform-d) δ 173.3 (C12), 151.0 (C8), 132.4 (C2), 128.5 (C3), 125.5 
(C5), 125.2 (C4), 124.7 (C7), 122.2 (C1), 122.2 (C6), 74.6 (C9), 60.6 (C13), 31.2 (C11), 
26.1 (C10), 14.3 (C14); m/z (ES+) calculated for C20H20O3Na 331, found 332. Yield: 
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8.2.3.2. n=3 Carboxylic Acid 
4-(Anthracen-9-yloxy)butanoic acid 
 
1H NMR (300 MHz, Chloroform-d) δ 8.36 – 8.13 (m, 3H, H1 and H6), 8.03 – 7.96 (m, 
2H, H3), 7.63 – 7.37 (m, 4H, H4 and H5), 4.25 (t, J = 6.2 Hz, 2H, H9), 2.88 (t, J = 7.4 
Hz, 2H, H11), 2.52 – 2.28 (m, 2H, H10); ); 13C NMR (100 MHz, Chloroform-d) δ 178.8 
(C12), 150.9 (C8), 132.4 (C2), 128.5 (C3), 125.5 (C5), 125.3 (C4), 124.6 (C7), 122.3 (C1), 
122.2 (C6), 74.3 (C9), 30.8 (C11), 25.7 (C10); m/z (ES+) calculated for C18H16O3Na 
303, found 303. Yield: 93%. 
 
8.2.3.3. n=3L Diol 
4-(Anthracen-9-yloxy)-N-((2R,3R)-1,3-dihydroxybutan-2-yl)butanamide 
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1H NMR (300 MHz, Chloroform-d) δ 8.38 – 8.11 (m, 3H, H1 and H6), 8.05 – 7.88 (m, 
2H, H3), 7.57 – 7.34 (m, 4H, H4 and H5), 6.67 (d, J = 8.4 Hz, 1H, NH), 4.37 – 4.04 
(m, 3H, H14 and H9), 3.94 – 3.86 (m, 1H, H13), 3.83 (d, J = 3.6 Hz, 2H, H16), 2.73 (t, 
J = 8.4 Hz, 2H, H11), 2.46 – 2.22 (m, 2H, H10), 1.20 (d, J = 6.3 Hz, 3H, H15); 13C NMR 
(100 MHz, Chloroform-d) δ 173.6 (C12), 150.9 (C8), 132.4 (C2), 128.5 (C3) 125.9 (C5), 
125.5 (C4), 125.3 (C7), 122.2 (C1), 122.2 (C6), 74.9 (C9), 68.8 (C14), 65.0 (C16), 54.8 
(C13), 31.5 (C11), 26.7 (C10), 20.5(C15); m/z (ES+) calculated for C22H25NO4Na 390, 
found 390. Yield: 73%, Rf = 0.25 in CH2Cl2 with 5% MeOH. 
 




1H NMR (300 MHz, Acetonitrile-d3) δ 8.36 – 8.21 (m, 3H, H1 and H6), 8.14 – 7.91 
(m, 2H, H3), 7.44 – 7.34 (m, 4H, H4 and H24), 7.24 – 7.13 (m, 9H, H5, H19, H25 and 
H26), 6.93 – 6.68 (m, 4H, H20), 4.30 – 4.14 (m, 2H, H9), 4.10 – 3.97 (m, 2H, H14 and 
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H13), 3.70 (s, 6H, H22), 3.14 (d, J = 9.1 Hz, 2H, H16), 2.61 (t, J = 7.3 Hz, 2H, H11), 
2.31 (m, 2H, H10), 1.05 (d, J = 6.3 Hz, 3H, H15); 13C NMR (100 MHz, Acetonitrile-
d3) δ 173.5 (C12), 159.4 (C21) 149.9 (C8), 146.3 (C23), 133.0 (C18), 132.4 (C2), 130.8 
(C19), 128.7 (C3), 128.9 (C24), 128.7 (C25), 127.6 (C26), 125.8 (C5), 125.5 (C4), 125.3 
(C7), 122.3 (C1), 122.2 (C6), 113.0 (C20), 87.1 (C17) 75.2 (C9), 66.2 (C14), 63.5 (C16), 
55.9 (C22), 54.8 (C13), 31.4 (C11), 26.4 (C10), 19.6 (C15); m/z (ES+) calculated for 
C43H43NO6Na 693, found 693. Yield: 35%, Rf = 0.48 in CH2Cl2 with 5% MeOH. 
 





1H NMR (300 MHz, Acetonitrile-d3) δ 8.34 (s, 1H, H1), 8.30 (d, J = 8.4 Hz, 2H, H6), 
8.16 – 8.00 (m, 2H, H3), 7.57 – 7.38 (m, 4H, H4 and H24), 7.37 – 7.24 (m, 6H, H5 and 
H19), 6.91 – 6.75 (m, 3H, H25 and H26), 6.39 (d, J = 9.1 Hz, 4H, H20), 6.32 (d, J = 9.3 
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Hz, 1H, NH), 4.30 – 4.15 (m, 2H, H9), 3.73 (s, 6H, H22), 3.79 – 3.70 (m, 2H, H13 and 
H14), 3.59 – 3.43 (m, 4H, H27 and H30), 3.20 – 3.05 (m, 2H, H16), 2.70 – 2.55 (m, 4H, 
H11 and H28), 2.47 (p, J = 5.9 Hz, 2H, H10), 1.35 – 1.12 (m, 12H, H31), 0.99 (d, J = 
6.8 Hz, 3H, H15); 31P NMR (121 MHz, Acetonitrile-d3) δ 147.6, 147.0; m/z (ES+) 
calculated for C52H60N3O7PNa 893, found 893. Yield: 38%, Rf = 0.66 in 50% hexane, 
50% ethyl acetate. 
 





1H NMR (300 MHz, Chloroform-d) δ 8.28 – 8.20 (m, 2H, H6), 8.22 (s, 1H, H1), 8.03 
– 7.95 (m, 2H, H3), 7.53 – 7.4. (m, 4H, H4 and H5), 6.45 (d, J = 10.5 Hz, 1H, NH), 
4.28 – 4.15 (m, 3H, H9 and H14), 3.95 – 3.84 (m, 1H, H13), 3.86 (d, J  = 4.5 Hz, 2H, 
H16), 2.80 – 2.72 (m, 2H, H11), 2.48 – 2.36 (m, 2H, H10), 1.22 (d, J = 6.4 Hz, 3H, H15); 
13C NMR (100 MHz, Chloroform-d) δ 173.4 (C12), 150.9 (C8), 132.4 (C2), 128.5 (C3) 
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125.5 (C5), 125.3 (C4), 124.6 (C7), 122.3 (C1), 122.1 (C6), 74.9 (C9), 69.3 (C14), 65.4 
(C16), 54.6 (C13), 33.6 (C11), 26.7 (C10), 20.7 (C15); m/z (ES+) calculated for 
C22H25NO4Na 390, found 390. Yield: 78%, Rf = 0.25 in CH2Cl2 with 5% MeOH. 
 




1H NMR (300 MHz, Acetonitrile-d3) δ 8.34 (s, 1H, H1), 8.34 – 8.23 (m, 2H, H6), 8.18 
– 8.02 (m, 2H, H3), 7.47 – 7.37 (m, 4H, H4 and H24), 7.31 – 7.26 (m, 6H, H5 and H19), 
7.25 – 7.09 (m, 3H, H25 and H26), 6.85 – 6.76 (m, 4H, H20), 6.54 (d, J = 8.9 Hz, 1H, 
NH), 4.21 (d, J = 6.4 Hz, 2H, H9), 4.06 – 3.89 (m, 1H, H14), 3.83 – 3.75 (m, 1H, H13), 
3.73 (s, 6H, H22), 3.17 (d, J = 9.1, 2H, H16), 2.64 (t, J = 7.3 Hz, 2H, H11), 2.39 – 2.28 
(m, 2H, H10), 1.07 (d, J = 6.3 Hz, 3H, H15); 13C NMR (100 MHz, Chloroform-d) δ 
173.5 (C12), 159.4 (C21) 149.9 (C8), 146.3 (C23), 133.0 (C18), 132.4 (C2), 129.7 (C19), 
128.7 (C3), 128.9 (C24), 128.7 (C25), 127.6 (C26), 125.8 (C5), 125.5 (C4), 125.3 (C7), 
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122.3 (C1), 122.2 (C6), 112.7 (C20), 87.1 (C17) 75.0 (C9), 66.3 (C14), 63.2 (C16), 55.9 
(C22), 54.3 (C13), 31.4 (C11), 26.4 (C10), 19.6 (C15); m/z (ES+) calculated for 
C43H43NO6Na 693, found 693. Yield: 52%, Rf = 0.53 in CH2Cl2 with 5% MeOH. 
 





1H NMR (300 MHz, Acetonitrile-d3) δ 8.42 (s, 1H, H1), 8.24 (d, J = 8.7 Hz, 2H, H6), 
8.11 (d, J = 8.4 Hz, 2H, H3), 7.59 – 7.38 (m, 4H, H4 and H24), 7.38 – 7.29 (m, 6H, H5 
and H19), 7.28 – 7.23 (m, 3H, H25 and H26), 6.99 – 6.81 (m, 5H, H20 and NH), 4.84 –
4.21 (m, 2H, H9), 3.80 – 3.70 (m, 2H, H13 and H14), 3.74 (s, 6H, H22), 3.57 – 3.29 (m, 
4H, H27 and H30), 3.28 – 3.19 (m, 2H, H16), 2.89 – 2.58 (m, 4H, H11 and H28), 2.47 –
2.40 (m, 2H, H10), 1.45 – 0.95 (m, 12H, H31), 0.81 (d, J = 6.8 Hz, 3H, H15); 31P NMR 
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(121 MHz, Acetonitrile-d3) δ 147.6, 147.0; m/z (ES+) calculated for C52H60N3O7PNa 
893, found 893. Yield: 52%, Rf = 0.67 in 50% hexane, 50% ethyl acetate. 
 
8.2.4. Characterisation of n=4L and 4D 
8.2.4.1. n=4 Ester 
Ethyl 5-(anthracen-9-yloxy)pentanoate 
 
1H NMR (300 MHz, Chloroform-d) δ 8.45 – 8.20 (m, 3H, H1 and H6), 8.02 – 7.95 (m, 
2H, H3), 7.53 – 7.41 (m, 4H, H4 and H5), 4.50 – 4.00 (m, 4H, H9 and H14), 2.50 (t, J 
= 7.0 Hz, 2H, H12), 2.18 – 1.99 (m, 4H, H10 and H11), 1.29 (t, J = 7.2 Hz, 3H, H15); 
13C NMR (100 MHz, Chloroform-d) δ 173.5 (C13), 151.3 (C8), 132.8 (C2), 128.5 (C3), 
125.5 (C5), 125.1 (C4), 124.7 (C7), 122.4 (C1), 122.1 (C6), 75.5 (C9), 60.4 (C14), 34.2 
(C12), 30.1 (C10), 21.9 (C11), 14.3 (C15); m/z (ES+) calculated for C21H22O3 322, found 
322. Yield: 42%, Rf = 0.56 in CH2Cl2. 
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8.2.4.2. n=4 Carboxylic Acid 
5-(Anthracen-9-yloxy)pentanoic acid 
 
1H NMR (300 MHz, Chloroform-d) δ 8.40 – 8.11 (m, 3H, H1 and H6), 8.06 – 7.93 (m, 
2H, H3), 7.55 – 7.33 (m, 4H, H4 and H5), 4.22 (t, J  = 6.0 Hz, 2H, H9), 2.59 (t, J = 6.0 
Hz, 2H, H12), 2.18 – 1.99 (m, 4H, H10 and H11); 13C NMR (100 MHz, Chloroform-d) 
δ 179.1 (C13), 151.2 (C8), 132.4 (C2), 128.5 (C3), 125.5 (C5), 125.2 (C4), 124.7 (C7), 
122.3 (C1), 122.2 (C6), 75.4 (C9), 33.8 (C12), 30.1 (C10), 21.6 (C11); m/z (ES+) 
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8.2.4.3. n=4L Diol 
5-(Anthracen-9-yloxy)-N-((2R,3R)-1,3-dihydroxybutan-2-yl)pentanamide 
 
1H NMR (300 MHz, Chloroform-d) δ 8.39 – 8.11 (m, 3H, H1 and H6), 8.07 – 7.83 (m, 
2H, H3), 7.70 – 7.35 (m, 4H, H4 and H5), 6.41 (d, J = 8.3 Hz, 1H, NH), 4.23 – 4.13 
(m, 3H, H15 and H9), 3.93 – 3.66 (m, 3H, H14 and H17), 2.73 (t, J = 8.4 Hz, 2H, H12), 
2.48 – 2.40 (m, 2H, H11), 2.12 – 2.03 (m, 2H, H10), 1.20 (d, J = 6.3 Hz, 3H, H16); 13C 
NMR (100 MHz, Chloroform-d) δ 173.7 (C13), 151.2 (C8), 132.4 (C2), 128.5 (C3) 125.5 
(C5), 125.2 (C4), 124.7 (C7), 122.3 (C1), 122.1 (C6), 75.6 (C9), 68.9 (C15), 65.2 (C17), 
54.6 (C14), 36.5 (C12), 31.5 (C10), 22.7 (C11), 20.6(C16); m/z (ES+) calculated for 
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1H NMR (300 MHz, Acetonitrile-d3) δ 8.36 – 8.20 (m, 3H, H1 and H6), 8.02 – 7.85 
(m, 2H, H3), 7.48 – 7.35 (m, 4H, H4 and H25), 7.34 – 7.15 (m, 9H, H5, H20, H26 and 
H27), 6.84 – 6.78 (m, 4H, H21), 6.16 (d, J = 9.0 Hz, 1H, NH), 4.30 – 4.10 (m, 2H, H9), 
4.03 – 3.94 (m, 2H, H15 and H14), 3.70 (s, 6H, H23), 3.14 (d, J = 9.1 Hz, 2H, H17), 2.43 
(t, J = 6.0 Hz, 2H, H12), 2.17 – 2.01 (m, 4H, H10 and H11), 1.15 (d, J = 6.3 Hz, 3H, 
H16); 13C NMR (100 MHz, Acetonitrile-d3) δ 173.0 (C13), 158.7 (C22) 144.3 (C8), 144.2 
(C24), 135.5 (C19), 135.3 (C2), 132.2 (C20), 129.9 (C3), 128.4 (C25), 128.1 (C26), 127.9 
(C27), 125.5 (C5), 125.2 (C4), 124.7 (C7), 122.3 (C1), 122.1 (C6), 113.0 (C21), 87.3 (C18) 
75.6 (C9), 68.9 (C15), 65.5 (C17), 55.2 (C23), 53.3 (C14), 36.7 (C12), 31.4 (C10), 26.4 (C11), 
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20.0 (C16); m/z (ES+) calculated for C44H44NO6Na 706, found 706. Yield: 38%, Rf = 
0.50 in CH2Cl2 with 5% MeOH. 
 






1H NMR (300 MHz, Acetonitrile-d3) δ 8.17 – 8.11 (m, 3H, 8.14, H1 and H6), 7.95 – 
7.84 (m, 2H, H3), 7.40 – 7.30 (m, 10H, H4, H5, H20, and H25), 7.19 (m, 3H, H26 and 
H27), 6.78 – 6.62 (m, 4H, H21), 6.20 (d, J = 8.9 Hz, 1H, NH), 4.05 (t, J = 5.9 Hz, 2H, 
H9), 3.60 – 3.55 (m, 2H, H14 and H15), 3.58 (s, 6H, H23), 3.48 – 3.19 (m, 4H, H28 and 
H31), 3.11 – 2.97 (m, 2H, H17), 2.60 – 2.53 (m, 2H, H29), 2.47 (t, J = 5.9 Hz, 2H, H12), 
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2.32 – 2.24 (m, 4H, H10 and H11), 1.12 – 0.94 (m, 12H, H32), 0.86 (d, J = 6.8 Hz, 3H, 
H16). 31P NMR (121 MHz, Acetonitrile-d3) δ 147.5, 147.0; m/z (ES+) calculated for 
C53H62N3O7PNa 906, found 906. Yield: 61%, Rf = 0.70 in 50% hexane, 50% ethyl 
acetate. 
 
8.2.4.6. n=4D Diol 
5-(Anthracen-9-yloxy)-N-((2S,3S)-1,3-dihydroxybutan-2-yl)pentanamide 
 
1H NMR (300 MHz, Chloroform-d) δ 8.35 – 8.13 (m, 3H, H1 and H6), 8.07 – 7.85 (m, 
2H, H3), 7.54 – 7.33 (m, 4H, H4 and H5), 6.37 (d, J = 8.3 Hz, 1H, NH), 4.37 – 4.06 
(m, 3H, H15 and H9), 3.95 – 3.69 (m, 3H, H14 and H17), 2.87 (t, J = 8.4 Hz, 2H, H12), 
2.53 – 2.32 (m, 2H, H11), 2.26 – 1.96 (m, 2H, H10), 1.21 (d, J = 6.4 Hz, 3H, H16); 13C 
NMR (100 MHz, Chloroform-d) δ 173.6 (C13), 151.2 (C8), 132.4 (C2), 128.5 (C3) 125.5 
(C5), 125.2 (C4), 124.7 (C7), 122.3 (C1), 122.1 (C6), 75.6 (C9), 69.1 (C15), 65.4 (C17), 
54.5 (C14), 36.6 (C12) 30.1 (C10), 22.7 (C11), 20.6 (C16); m/z (ES+) calculated for 
C23H27NO4Na 404, found 404. Yield: 78%, Rf = 0.46 in CH2Cl2 with 5% MeOH. 
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1H NMR (300 MHz, Acetonitrile-d3) δ 8.47 – 8.23 (m, 3H, H1 and H6), 8.12 – 8.03 
(m, 2H, H3), 7.57 – 7.41 (m, 4H, H4 and H25), 7.37 – 7.17 (m, 9H, H5, H20, H26 and 
H27), 6.94 – 6.81 (m, 4H, H21), 6.46 (d, J = 9.0 Hz, 1H, NH), 4.19 – 4.08 (m, 2H, H9), 
4.02 – 3.93 (m, 2H, H15 and H14), 3.72 (s, 6H, H23), 3.17 (d, J = 9.1 Hz, 2H, H17), 2.40 
(t, J = 6.9 Hz, 2H, H12), 2.18 – 2.00 (m, 4H, H10 and H11), 1.07 (d, J = 6.1 Hz, 3H, 
H16); 13C NMR (100 MHz, Acetonitrile-d3) δ 173.0 (C13), 158.3 (C22) 145.3 (C8), 145.2 
(C24), 136.0 (C19), 135.9 (C2), 132.2 (C20), 129.6 (C3), 128.0 (C25), 127.7 (C26), 127.5 
(C27), 126.4 (C5), 125.3 (C4), 125.0 (C7), 121.9 (C1), 117.0 (C6), 112.7 (C21), 75.4 (C18) 
65.5 (C9), 63.3 (C15), 60.0 (C17), 54.8(C23), 54.5 (C14), 35.2 (C12), 31.4 (C10), 25.5 (C11), 
20.0 (C16); m/z (ES+) calculated for C44H45NO6Na 706, found 706. Yield: 32%, Rf = 
0.50 in CH2Cl2 with 5% MeOH. 
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1H NMR (300 MHz, Acetonitrile-d3) δ 8.41 – 8.20 (m, 3H, 8.14, H1 and H6), 8.09 – 
7.95 (m, 2H, H3), 7.53 – 7.41 (m, 10H, H4, H5, H20, and H25), 7.21 (m, 3H, H26 and 
H27), 6.86 – 6.78 (m, 4H, H21), 6.31 (d, J = 8.9 Hz, 1H, NH), 4.08 (m, J = 7.1 Hz, 2H, 
H9), 3.72 – 3.64 (m, 2H, H14 and H15), 3.70 (s, 6H, H23), 3.60 – 3.42 (m, 4H, H28 and 
H31), 3.23 – 3.05 (m, 2H, H17), 2.73 – 2.40 (m, 2H, H29), 2.48 (t, J = 6.0 Hz, 2H, H12), 
2.43 – 2.34 (m, 4H, H10 and H11), 1.27 – 1.08 (m, 12H, H32), 0.98 (d, J = 6.1 Hz, 3H, 
H16). 31P NMR (121 MHz, Acetonitrile-d3) δ 147.5, 147.0; m/z (ES+) calculated for 
C53H62N3O7PNa 906, found 906. Yield: 43%, Rf = 0.63 in 50% hexane, 50% ethyl 
acetate. 
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8.2.5. Characterisation of n=5L and 5D 
8.2.5.1. n=5 Ester 
Ethyl 6-(anthracen-9-yloxy)hexanoate 
 
1H NMR (300 MHz, Chloroform-d) δ 8.39 – 8.13 (m, 3H, H1 and H6), 8.06 – 7.88 (m, 
2H, H3), 7.53 – 7.35 (m, 4H, H4 and H5), 4.33 – 4.03 (m, 4H, H9 and H15), 2.42 (t, J 
= 7.0 Hz, 2H, H13), 2.18 – 1.94 (m, 4H, H10 and H11), 1.87 – 1.77 (m, 2H, H12), 1.28 
(t, J = 7.2 Hz, 3H, H16); 13C NMR (100 MHz, Chloroform-d) δ 173.7 (C14), 151.4 (C8), 
134.1 (C2), 128.4 (C3), 125.5 (C5), 125.1 (C4), 124.7 (C7), 122.4 (C1), 122.0 (C6), 75.8 
(C9), 60.3 (C15), 34.3 (C13), 30.4 (C10), 25.9 (C12), 25.0 (C11), 14.3 (C16); m/z (ES+) 
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8.2.5.2. n=5 Carboxylic Acid 
6-(Anthracen-9-yloxy)hexanoic acid 
 
1H NMR (300 MHz, Chloroform-d) δ 8.42 – 8.10 (m, 3H, H1 and H6), 8.06 – 7.89 (m, 
2H, H3), 7.52 – 7.34 (m, 4H, H4 and H5), 4.24 – 4.08 (m, 2H, H9), 2.48 (t, J = 7.2 Hz, 
2H, H13), 2.16 – 2.04 (m, 4H, H10 and H11), 1.89 – 1.70 (m, 2H, H12); 13C NMR (100 
MHz, Chloroform-d) δ 179.5 (C14), 151.3 (C8), 132.5 (C2), 128.4 (C3), 125.5 (C5), 
125.1 (C4), 124.7 (C7), 122.4 (C1), 122.1 (C6), 75.7 (C9), 33.9 (C13) 30.4 (C10), 25.8 
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8.2.5.3. n=5L Diol 
6-(Anthracen-9-yloxy)-N-((2R,3R)-1,3-dihydroxybutan-2-yl)hexanamide 
 
1H NMR (300 MHz, Chloroform-d) δ 8.36 – 8.12 (m, 3H, H1 and H6), 8.13 – 7.90 (m, 
2H, H3), 7.60 – 7.27 (m, 4H, H4 and H5), 6.38 (d, J = 7.5 Hz, 1H, NH), 4.23 – 4.14 
(m, 2H, H9), 3.90 – 3.73 (m, 2H, H15 and H16), 2.96 – 2.78 (m, 2H, H18), 2.41 – 2.34 
(m, 2H, H13), 2.10 – 1.94 (m, 2H, H10), 1.95 – 1.58 (m, 4H, H11 and H12), 1.20 (d, J 
= 6.4 Hz, 3H, H17); 13C NMR (100 MHz, Chloroform-d) δ 174.3 (C14), 151.2 (C8), 
132.4 (C2), 128.4 (C3), 125.5 (C5), 125.3 (C4), 125.2 (C7), 122.3 (C1), 122.1 (C6), 75.8 
(C9), 69.0 (C16), 65.3 (C17), 54.6 (C15), 36.6 (C13), 30.4 (C10), 25.9 (C11), 25.7 (C12), 
20.5 (C18); m/z (ES+) calculated for C24H29NO4Na 418, found 418. Yield: 79%, Rf = 
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1H NMR (300 MHz, Acetonitrile-d3) δ 8.36 – 8.20 (m, 3H, H1 and H6), 8.02 – 7.95 
(m, 2H, H3), 7.48 – 7.40 (m, 6H, H4, H5 and H26), 7.34 – 7.11 (m, 7H, H21, H27 and 
H28), 6.84 – 6.78 (m, 4H, H22), 6.62 (d, J = 9.0 Hz, 1H, NH), 4.15 – 3.95 (m, 4H, H9, 
H15 and H16), 3.68 (s, 6H, H24), 3.28 – 3.08 (d, J = 9.1 Hz, 2H, H18), 2.30 (t, J = 6.9 
Hz, 2H, H13), 2.07 – 1.93 (m, 4H, H10 and H11), 1.81 – 1.64 (m, 2H, H12), 1.09 (d, J 
= 6.3 Hz, 3H, H17); 13C NMR (100 MHz, Chloroform-d) δ 174.0 (C14), 159.3 (C22) 
152.3 (C8), 146.2 (C24), 137.0 (C19), 133.3 (C2), 130.7 (C20), 129.7 (C3), 128.9 (C25), 
128.7 (C26), 128.0 (C27), 125.5 (C5), 125.0 (C4), 124.7 (C7), 122.4 (C6), 122.1 (C1), 
113.0 (C21), 87.3 (C18) 75.6 (C9), 68.9 (C16), 65.5 (C28), 55.5 (C23), 55.3 (C15), 36.7 
(C13), 31.2 (C10), 26.4 (C11), 26.3 (C12), 20.5 (C17); m/z (ES+) calculated for 
C45H47NO6Na 721, found 721. Yield: 37%, Rf = 0.53 in CH2Cl2 with 5% MeOH. 
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1H NMR (300 MHz, Acetonitrile-d3) δ 8.29 – 8.21 (m, 3H, 8.14, H1 and H6), 8.08 – 
8.00 (m, 2H, H3), 7.49 – 7.41 (m, 10H, H4, H5, H21, and H26), 7.27 (m, 3H, H27 and 
H28), 6.90 – 6.73 (m, 4H, H22), 6.17 (d, J = 9.1 Hz, 1H, NH), 4.05 (m, 2H, H9), 3.73 
– 3.67 (m, 2H, H15 and H16), 3.69 (s, 6H, H24), 3.59 – 3.40 (m, 4H, H29 and H32), 3.13 
– 3.03 (m, 2H, H18), 2.60 – 2.53 (m, 2H, H30), 2.47 (t, J = 6.0 Hz, 2H, H13), 2.34 – 
2.24 (m, 6H, H10, H11 and H12), 1.22 – 1.04 (m, 12H, H33), 0.96 (d, J = 6.8 Hz, 3H, 
H17); 31P NMR (121 MHz, Acetonitrile-d3) δ 147.6, 146.9; m/z (ES+) calculated for 
C54H64N3O7PNa 920, found 920. Yield: 43%, Rf = 0.70 in 50% hexane, 50% ethyl 
acetate. 
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8.2.5.6. n=5D Diol 
6-(Anthracen-9-yloxy)-N-((2S,3S)-1,3-dihydroxybutan-2-yl)hexanamide 
 
1H NMR (300 MHz, Chloroform-d) δ 8.33 – 8.09 (m, 3H, H1 and H6), 8.09 – 7.89 (m, 
2H, H3), 7.82 – 7.37 (m, 4H, H4 and H5), 6.24 (m, 1H, NH), 4.45 – 4.05 (m, 2H, H9), 
3.88 – 3.49 (m, 2H, H15 and H16), 2.96 – 2.78 (m, 2H, H18), 2.41 – 2.34 (m, 2H, H13), 
2.10 – 1.94 (m, 2H, H10), 1.90 – 1.70 (m, 4H, H11 and H12), 1.21 (d, J = 6.4 Hz, 3H, 
H17); 13C NMR (100 MHz, Chloroform-d) δ 173.3 (C14), 150.2 (C8), 134.4 (C2), 128.3 
(C3) 125.4 (C5), 125.1 (C4), 125.0 (C7), 122.3 (C1), 122.2 (C6), 76.0 (C9), 69.2 (C16), 
65.5 (C17), 54.4 (C15), 36.4 (C13), 30.6 (C10), 25.8 (C11), 25.7 (C12), 20.5 (C18); m/z 
(ES+) calculated for C24H29NO4Na 418, found 418. Yield: 76%, Rf = 0.18 in CH2Cl2 
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1H NMR (300 MHz, Acetonitrile-d3) δ 8.35 – 8.20 (m, 3H, H1 and H6), 8.13 – 7.98 
(m, 2H, H3), 7.56 – 7.40 (m, 6H, H4, H5 and H26), 7.34 – 7.14 (m, 7H, H21, H27 and 
H28), 6.88 – 6.78 (m, 4H, H22), 6.43 (d, J = 8.9 Hz, 1H, NH), 4.15 – 3.88 (m, 4H, H9, 
H15 and H16), 3.72 (s, 6H, H24), 3.16 (d, J = 9.1 Hz, 2H, H18), 2.32 (t, J = 6.9 Hz, 2H, 
H13), 2.20 – 1.96 (m, 6H, H10, H11 and H12), 1.07 (d, J = 6.2 Hz, 3H, H17); 13C NMR 
(100 MHz, Acetonitrile-d3 δ 174.0 (C14), 158.3 (C22) 152.3 (C8), 146.2 (C24), 137.0 
(C19), 133.3 (C2), 130.7 (C20), 129.6 (C3), 128.0 (C25), 127.7 (C26), 127.4 (C27), 126.4 
(C5), 125.3 (C4), 125.0 (C7), 121.9 (C6), 121.1 (C1), 112.6 (C21), 87.3 (C18) 75.5 (C9), 
66.0 (C16), 63.3 (C28), 54.5 (C23), 53.9 (C15), 35.6 (C13), 29.8 (C10), 25.3 (C11), 25.3 
(C12), 19.3 (C17); m/z (ES+) calculated for C45H47NO6Na 721, found 721. Yield: 38%, 
Rf = 0.51 in CH2Cl2 with 5% MeOH. 
Chapter 8 – Experimental 
 
 263 






1H NMR (300 MHz, Acetonitrile-d3) δ 8.24 – 8.08 (m, 3H, 8.14, H1 and H6), 8.02 – 
7.90 (m, 2H, H3), 7.79 – 7.34 (m, 10H, H4, H5, H21, and H26), 7.19 (m, 3H, H27 and 
H28), 6.77 – 6.68 (m, 4H, H22), 6.12 (d, J = 9.1 Hz, 1H, NH), 4.20 – 3.91 (m, 2H, H9), 
3.66 – 3.61 (m, 2H, H15 and H16), 3.62 (s, 6H, H24), 3.50 – 3.28 (m, 4H, H29 and H32), 
3.10 – 3.00 (m, 2H, H18), 2.62 – 2.54 (m, 2H, H30), 2.54 (t, J = 5.9 Hz, 2H, H13), 2.43 
– 2.33 (m, 6H, H10, H11 and H12), 1.15 – 0.95 (m, 12H, H33), 0.98 (d, J = 6.8 Hz, 3H, 
H17); 31P NMR (121 MHz, Acetonitrile-d3) δ 147.6, 146.9; m/z (ES+) calculated for 
C54H64N3O7PNa 920, found 920. Yield: 74%, Rf = 0.65 in 50% hexane, 50% ethyl 
acetate. 
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8.2.6. Characterisation of n=6L and 6D 
8.2.6.1. n=6 Ester 
Ethyl 7-(anthracen-9-yloxy)heptanoate 
 
1H NMR (300 MHz, Chloroform-d) δ 8.53 – 8.15 (m, 3H, H1 and H6), 8.07 – 7.86 (m, 
6H, H3, H4 and H5), 4.24 – 4.10 (m, 4H, H9 and H16), 2.37 (t, J = 7.5 Hz, 2H, H14), 
2.17 – 1.92 (m, 4H, H10 and H11), 1.83 – 1.43 (m, 4H, H13 and H12), 1.28 (t, J = 7.1 
Hz, 3H, H17); 13C NMR (100 MHz, Chloroform-d) δ 173.8 (C15), 151.5 (C8), 134.1 
(C2), 128.5 (C3), 125.5 (C5), 125.1 (C4), 124.7 (C7), 122.4 (C1), 122.0 (C6), 76.0 (C9), 
60.3 (C16), 34.4 (C14), 30.5 (C10), 29.2 (C13), 26.0 (C12), 25.0 (C11), 14.3 (C17); m/z 
(ES+) calculated for C23H26O3Na 373, found 373. Yield: 48%, Rf = 0.17 in CH2Cl2 
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8.2.6.2. n=6 Carboxylic Acid 
7-(Anthracen-9-yloxy)heptanoic acid 
 
1H NMR (300 MHz, Chloroform-d) δ 8.37 – 8.14 (m, 3H, H1 and H6), 8.06 – 7.38 (m, 
6H, H3, H4 and H5), 4.19 (t, J = 6.6 Hz, 2H, H9), 2.43 (t, J = 7.4 Hz, 2H, H14), 2.15 – 
1.92 (m, 4H, H10 and H11), 1.83 – 1.47 (m, 4H, H13 and H12); 13C NMR (100 MHz, 
Chloroform-d) δ 173.6 (C15), 151.5 (C8), 134.0 (C2), 128.5 (C3), 125.3 (C5), 125.1 (C4), 
124.7 (C7), 122.4 (C1), 122.1 (C6), 76.0 (C9), 34.4 (C14), 30.4 (C10), 29.2 (C13), 26.0 
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8.2.6.3. n=6L Diol 
7-(Anthracen-9-yloxy)-N-((2R,3R)-1,3-dihydroxybutan-2-yl)heptanamide 
 
1H NMR (300 MHz, Chloroform-d) δ 8.38 – 8.08 (m, 3H, H1 and H6), 8.07 – 7.84 (m, 
2H, H3), 7.58 – 7.34 (m, 4H, H4 and H5), 6.25 (d, J = 7.7 Hz, 1H, NH), 4.18 (t, J = 
7.5 Hz, 2H, H9), 3.89 – 3.78 (m, 2H, H16 and H17), 2.92 – 2.80 (m, 2H, H19), 2.31 (t, 
J = 7.5 Hz, 2H, H14), 1.89 – 1.59 (m, 4H, H10 and H13), 1.59 – 1.37 (m, 4H, H11 and 
H12), 1.19 (d, J = 6.4 Hz, 3H, H17); 13C NMR (100 MHz, Chloroform-d) δ 174.3 (C15), 
151.4 (C8), 132.4 (C2), 128.5 (C3), 125.5 (C5), 125.1 (C4), 124.7 (C7), 122.4 (C1), 122.0 
(C6), 76.0 (C9), 69.0 (C17), 65.3 (C19), 54.5 (C16), 36.8 (C14), 30.6 (C10), 29.3 (C13), 26.1 
(C11), 25.8 (C12), 20.6 (C18); m/z (ES+) calculated for C25H31NO4Na 432, found 432. 
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1H NMR (300 MHz, Acetonitrile-d3) δ 8.35 – 8.16 (m, 3H, H1 and H6), 8.15 – 7.88 
(m, 2H, H3), 7.52 – 7.42 (m, 6H, H4, H5 and H27), 7.34 – 7.19 (m, 7H, H22, H28 and 
H29), 6.92 – 6.69 (m, 4H, H23), 6.40 (d, J = 9.0 Hz, 1H, NH), 4.15 (t, J = 6.5 Hz, 2H, 
H9), 4.05 – 3.90 (m, 2H, H16 and H17), 3.74 (s, 6H, H25), 3.31 – 2.90 (m, 2H, H19), 
2.24 (m, 4H, H12 and H14), 2.08 – 1.84 (m, 4H, H10 and H11), 1.82 – 1.57 (m, 2H, 
H13), 1.05 (d, J = 6.2 Hz, 3H, H18); 13C NMR (100 MHz, Acetonitrile-d3) δ 172.8 (C15), 
158.3 (C23), 145.3 (C8), 144.2 (C25), 135.7 (C20), 132.1 (C2), 129.6 (C21), 128.0 (C3), 
127.7 (C26), 127.5 (C27), 126.4 (C28), 125.3 (C5), 125.0 (C4), 124.2 (C7), 121.9 (C6), 
121.5 (C1), 112.7 (C22), 87.3 (C19), 75.6 (C9), 66.0 (C17), 63.3 (C29), 54.5 (C24), 53.9 
(C16), 35.6 (C14), 29.8 (C10), 28.6 (C13) 25.4 (C11), 25.3 (C12), 19.3 (C18); m/z (ES+) 
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calculated for C46H49NO6Na 735, found 735. Yield: 35%, Rf = 0.62 in CH2Cl2 with 
5% MeOH. 
 





1H NMR (300 MHz, Acetonitrile-d3) δ 8.23 – 8.12 (m, 3H, 8.14, H1 and H6), 7.98 – 
7.89 (m, 2H, H3), 7.77 – 7.30 (m, 10H, H4, H5, H22, and H27), 7.25 – 7.06 (m, 3H, H28 
and H29), 6.79 – 6.71 (m, 4H, H23), 6.10 (d, J = 9.1 Hz, 1H, NH), 4.07 – 3.91 (m, 2H, 
H9), 3.68 – 3.60 (m, 2H, H16 and H17), 3.63 (s, 6H, H25), 3.53 – 3.26 (m, 4H, H30 and 
H33), 3.15 – 2.92 (m, 2H, H19), 2.62 – 2.52 (m, 2H, H31), 2.49 (t, J = 5.9 Hz, 2H, H14), 
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2.21 – 2.10 (m, 6H, H10, H11 and H12), 1.45 – 1.35 (m, 2H, H13), 1.20 – 0.98 (m, 12H, 
H34), 0.87 (d, J = 6.7 Hz, 3H, H18); 31P NMR (121 MHz, Acetonitrile-d3) δ 147.6, 
146.9; m/z (ES+) calculated for C55H66N3O7PNa 935, found 935. Yield: 63%, Rf = 
0.68 in 50% hexane, 50% ethyl acetate. 
 
8.2.6.6. n=6D Diol 
7-(Anthracen-9-yloxy)-N-((2S,3S)-1,3-dihydroxybutan-2-yl)heptanamide 
 
1H NMR (300 MHz, Chloroform-d) δ 8.39 – 8.14 (m, 3H, H1 and H6), 8.07 – 7.80 (m, 
2H, H3), 7.57 – 7.33 (m, 4H, H4 and H5), 6.34 (d, J = 8.2 Hz, 1H, NH), 4.16 (t, J = 
6.5 Hz, 2H, H9), 3.93 – 3.64 (m, 2H, H16 and H17), 3.39 – 3.31 (m, 2H, H19), 2.29 (t, 
J = 7.5 Hz, 2H, H14), 1.82 – 1.57 (m, 4H, H10 and H13), 1.54 – 1.37 (m, 4H, H11 and 
H12), 1.18 (d, J = 6.3 Hz, 3H, H17); 13C NMR (100 MHz, Chloroform-d) δ 174.0 (C15), 
151.2 (C8), 132.4 (C2), 128.5 (C3) 125.5 (C5), 125.2 (C4), 124.7 (C7), 122.3 (C1), 122.1 
(C6), 75.8 (C9), 68.9 (C17), 65.2 (C19), 54.5 (C16), 36.7 (C14), 30.4 (C10), 29.3 (C13), 25.9 
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(C11), 25.7 (C12), 20.6 (C18); m/z (ES+) calculated for C25H31NO4Na 432, found 432. 
Yield: 50%, Rf = 0.38 in CH2Cl2 with 5% MeOH. 
 




1H NMR (300 MHz, Acetonitrile-d3) δ 8.35 – 8.24 (m, 3H, H1 and H6), 8.10 – 7.99 
(m, 2H, H3), 7.48 – 7.41 (m, 6H, H4, H5 and H27), 7.36 – 7.17 (m, 7H, H22, H28 and 
H29), 6.91 – 6.79 (m, 4H, H23), 6.39 (d, J =8.8 Hz, 1H, NH), 4.16 (t, J = 6.5 Hz, 2H, 
H9), 4.10 – 3.94 (m, 2H, H16 and H17), 3.75 (s, 6H, H25), 3.15 – 2.99 (m, 2H, H19), 
2.27 (m, 4H, H12 and H14), 2.19 – 1.96 (m, 4H, H10 and H11), 1.69 – 1.42 (m, 2H, 
H13), 1.05 (d, J = 6.2 Hz, 3H, H18); 13C NMR (100 MHz, Acetonitrile-d3) δ 172.8 (C15), 
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158.3 (C23) 145.3 (C8), 144.2 (C25), 135.7 (C20), 132.1 (C2), 129.7 (C21), 128.0 (C3), 
127.7 (C26), 127.5 (C27), 126.4 (C28), 125.3 (C5), 125.0 (C4), 124.2 (C7), 121.9 (C6), 
121.5 (C1), 112.7 (C22), 87.3 (C19) 75.6 (C9), 66.0 (C17), 63.3 (C29), 54.5 (C24), 53.9 
(C16), 35.6 (C14), 29.9 (C10), 28.6 (C13) 25.4 (C11), 25.3 (C12), 19.3 (C18); m/z (ES+) 
calculated for C46H49NO6Na 735, found 735. Yield: 43%, Rf = 0.48 in CH2Cl2 with 
5% MeOH. 
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1H NMR (300 MHz, Acetonitrile-d3) δ 8.35 – 8.22 (m, 3H, 8.14, H1 and H6), 8.11 – 
8.02 (m, 2H, H3), 7.57 – 7.48 (m, 10H, H4, H5, H22, and H27), 7.38 – 7.25 (m, 3H, H28 
and H29), 6.92 – 6.79 (m, 4H, H23), 6.20 (d, J = 9.1 Hz, 1H, NH), 4.27 – 3.99 (m, 2H, 
H9), 3.74 (s, 6H, H25), 3.64 – 3.38 (m, 6H, H16, H17, H30 and H33), 3.19 – 3.01 (m, 2H, 
H19), 2.78 – 2.65 (m, 2H, H31), 2.49 (t, J = 5.9 Hz, 2H, H14), 2.28 – 2.00 (m, 6H, H10, 
H11 and H12), 1.58 – 1.24 (m, 2H, H13), 1.20 – 1.06 (m, 12H, H34), 0.99 (d, J = 6.8 
Hz, 3H, H18); 31P NMR (121 MHz, Acetonitrile-d3) δ 147.6, 146.9; m/z (ES+) 
calculated for C55H66N3O7PNa 935, found 935. Yield: 55%, Rf = 0.62 in 50% hexane, 
50% ethyl acetate. 
 
8.3 Oligonucleotide Synthesis 
8.3.1 Synthesis 
All oligonucleotides were synthesised on an Applied Bioscience 394 DNA/RNA 
synthesiser on a 1 µmol scale. Controlled-pore glass (CPG) resin with the first base 
attached was used. The standard phosphoramidites used were Ac-dC-CE, iBu-dG-
CE, Bz-dA-CE and dT-CE. The resin was washed with acetonitrile prior to the first 
reaction. The trityl group was removed using 3% trichloroacetic acid in 
dichloromethane for 40 seconds. The next phosphoramidite in the sequence was 
then coupled using 0.5 M Ethylthiotetrazole (ETT) as the activator and appropriate 
phosphoramidite (0.1 M) concentration for 30 seconds for standard bases and 10 
minutes for anthracene phosphoramidites. Unreacted sequences were then capped 
using tetrahydrofuran(THF)/pyridine/acetic anhydride (70:15:15) and 10% methyl 
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imidazole in THF for 15 seconds. The phosphite group was then oxidised to a 
phosphate using 0.02 M iodine in THF/pyridine/water (70:15:15) for 15 seconds. 
The cycle was repeated until the desired sequence was completed. The resin was 
then treated with 30% ammonia hydroxide (four 15 minute cycles) to cleave the 
oligonucleotide from the resin. The solution was heated to 55°C for 6 hours to 
remove the nucleobase protecting groups and ammonia hydroxide was removed in 
vacuo to yield a clear to yellow oil. Oligonucleotides were redissolved in water prior 
to purification. 
 
For rhodamine labelling used in Chapter 6, TAMRA-dT-CE phosphoramidite was 
used with a 6 minute coupling time. Due to the milder cleavage conditions needed 
for this modification, ultra-mild nucleotide phosphoramidites, Ac-dC-CE and dmf-
dG-CE were used. Cleavage and deprotection was performed using 0.05 M 
potassium carbonate in anhydrous methanol for 4 hours. The sample was then 
passed through a NAP-10 column to remove the potassium carbonate before the 
solvent was removed. 
 
8.3.2 Purification 
All oligonucleotides were purified using RP-HPLC on a Phenomenex Clarity 5 µm 
Oligo RP 150 x 10 mm C18 column. After purification, solvent removed in vacuo, 
and the sample was desalted on a NAP-10 G-25 sephadex column. Analytical RP-
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HPLC was then used to check purity using a Phenomenex Clarity 5 μm Oligo RP 
LC column 150 x 4.6 mm. 
 
Unmodified and TAMRA labelled oligonucleotides along with those containing an 
anthracene tag of carbon linker length 1, were purified using the “Oligo SP 60 min” 
method. Oligonucleotides containing anthracene tags with carbon linker lengths 
of 3-7 were purified with the “DMT-On” method, Figure 7.1.  
 
Figure 7.1 HPLC methods for oligonucleotide purification. Oligo SP 60 min (A) is used for unmodified and 
TAMRA labelled sequences. DMT-On (B) is used for anthracene containing sequences. The graphs (right) show 
the percentage of each solvent as a function of time where solvent A is 0.1 M TEAA in 5 % acetonitrile, 95% 
water (solid line), solvent B is 0.1 M TEAA in 5 % acetonitrile, 95% water (dotted line) and solvent C is 100% 
acetonitrile (dashed line). 
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8.3.3 Characterisation and Concentration Determination 
Oligonucleotides were characterised by negative mode electrospray mass 
spectrometry (ESI-MS) and their concentration determined using UV-Vis 
spectroscopy by measuring the absorbance at 260 nm.  
 
Molar extinction coefficients were calculated using an online oligonucleotide 
property calculator which utilised the nearest neighbour method.3,4 The 
anthracene modifications are known to absorb at 260 nm and contributes a molar 
extinction value of 51 444 M-1- cm-1.1 The TAMRA modification was used as per the 
manufacturer’s instructions with Ɛ260 nm = 32 300 M-1- cm-1.  
 
Oligonucleotides were stored at -20°C in MilliQ water. Before use they were 
defrosted, brought to room temperature and thoroughly mixed. 
 
8.4 Peptide Synthesis 
8.4.1 Synthesis 
Ac-ALKRARNTEAARRSRARKLQRMKQKG-NH2 
The peptide was synthesized using standard solid-phase peptide synthesis (SPPS) 
methods5 on rink amide MBHA resin (0.1 mM scale, 0.65 mmol/g loading) using a 
CEM Liberty 1 automated peptide synthesizer. Initial couplings (bold and 
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underlined) were performed manually to allow for the retrieval of Fmoc-Lys(Mtt)-
OH. The 4-methyltrityl (Mtt) protecting group was removed with 3% TFA in DCM 
for 10 minutes with 3 repeats. The resin was then rinsed 5 times with 10 mL DCM 
and 5 times with 10 mL DMF. A ten-fold excess of 9-anthracenecarboxylic acid was 
then coupled using SPPS synthesis methods, with a 15 hour coupling time. The 
resin was then loaded into the CEM Liberty 1 automated peptide synthesizer and 
the remaining amino acids coupled. A standard coupling programme (25 W, 75 ºC, 
300 s) was used for all amino acids except for the coupling of Fmoc-Arg(Pbf)-OH 
and Fmoc-Ser(tBu)-OH which were double coupled along with residues towards 
the N-terminus (underlined). Deprotections were performed in 20% piperidine in 
DMF (35 W, 75 ºC, 180 s). The N-terminus was manually acetylated (20% acetic 
anhydride, 20% DIPEA in DMF) before cleavage from the resin and deprotection 
of side chains (95% trifluoroacetic acid, 5% thioanisole, 3% 1, 2-ethanedithiol and 
2% anisole for 2 hours).  
 
8.4.2 Purification  
The modified peptide was purified by preparative RP-HPLC (Phenomenex Jupiter 
10 µm Proteo 90 Å Axia packed column, C12, 250 by 21.2 mm) using a flow rate of 
10 ml/min with a gradient of 0-100% solvent B (acetonitrile with 0.05 % TFA) over 
40 mins, where solvent A was 0.05% TFA in deionised water followed holding at 
100 % solvent B for 10 minutes before being retuned to 100 % solvent A (Rt = 13.73 
min). This product was further purified using a semi-preparative column 
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(Phenomenex Luna 10 µm 100 Å, C18, 250 by 4.6 mm) using a ramp of 0-20% 
solvent B over 15 minutes followed holding at 20% solvent B for 35 minutes (Rt = 
27.80 min). 
 
8.4.3 Characterisation and Concentration Determination 
The modified peptide was characterised using positive ESI-MS. Peptide 
concentrations were calculated based on the anthracene absorbance at 375 nm, Ɛ375 
nm = 6300 M-1 cm-1 in water.6  
 
8.5 UV-Vis Spectroscopy Studies 
Standard measurements (including titrations and concentration determinations) 
were performed on a Shimadzu UV-1800 UV-Vis spectrophotometer using either a 
3 mL, 1 cm pathlength or a 1 mL, 1 cm pathlength quartz cuvette. Variable 
temperature studies were performed on a Cary 5000 UV-Vis-NIR 
spectrophotometer fitted with a Peltier temperature controller. These studies were 
performed in 500 µL, 1 cm pathlength, low head space quartz cuvettes. The 
temperature was increased 0.5°C/min and held for 3 minutes at the extremes of 
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8.6 Fluorescence Spectroscopy Studies 
All measurements taken on Shimadzu RF-5301 PC Spectrofluorophotometer using 
a 1 mL, 1 cm quartz cuvette apart from those identified in Chapter 3.3.2 which 
were performed on an Edinburgh FLSP920 fluorescence spectrometer using a 50 
µL, 1 cm quartz cuvette. All concentrations, buffer conditions and fluorescence 
parameters are detailed within the main body of this thesis. 
 
8.7 Irradiation studies 
Samples were irradiated with a water cooled 125 W mercury arc lamp, purchased 
from Photochemical Reactors Ltd, Reading, UK, placed in a housing with a small 
outlet fitted with a 365 nm filter purchased from Edmunds Optics Ltd, York, UK.  
 
8.8 Circular Dichroism Spectroscopy Studies 
Circular dichroism (CD) spectroscopy studies were performed on a Jasco J-810 
spectropolarimeter using a 1 cm pathlength quartz cuvette. A data pitch of 0.2 nm 
was used at a scan rate of 200 nm/min with a response time of 1 second, with the 
signal averaged over 10 accumulations per sample. 
 





     (1) 
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where Θm is the molar ellipticity, Θ is the ellipticity, l is the pathlength in cm, c is 
the concentration of anthracene tagged peptide in mol dm-3 and Na is the number 
of amino acid residues in the peptide. Percentage folded values were calculated 
















































   (2) 
All experiments were performed in 100 mM NaCl, 10 mM sodium phosphate 
buffer pH7. DNA, peptide and any addition buffer or salt concentrations are 
detailed in the body of the thesis. For studies on the folding of peptide in the 
presence of DNA, the signals from the DNA were subtracted to give a difference 
spectrum for the peptide. 
 
8.9 Peptide Denaturing Gel Electrophoresis 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS PAGE) studies 
were performed with a 20% polyacrylamide separating gel with 0.5 M tris HCl 
buffer pH 8.8, 0.5% SDS and a 4% polyacrylamide stacking gel with 0.1 M tris HCl 
pH 6.8, 2% SDS. Samples were prepared in 250 mM Tris HCl pH 6.8, 10% glycerol 
and 2% SDS and equilibrated for 1 hour. The gel was run with 1x tris tricine 
running buffer for 15 minutes at 100V and increased to 200V for the remainder of 
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the gel running. The gels were stained with coomassie brilliant blue R-250 protein 
stain. 
 
8.10 Gel Electrophoretic Mobility Shift Assays 
Gel EMSA studies were performed using a 10% polyacrylamide gel with 0.5x TBE 
buffer. 0.5x TBE buffer was also used as a running buffer. Peptide and DNA were 
prepared in 20 mM Tris HCl pH 7.5, 2 mM MgCl2, 2 mM EDTA, 90 mM KCl, 10% 
glycerol, 2.25% Igpeal CA630 and 0.1 mg/mL BSA. Samples were then irradiated 
with 365 nm light for 10 minutes where stated, and equilibrated for 1 hour. The 
gels were run at 100V for 1 hour. Gels were visualised with SYBR Gold stain and 
imaged using an excitation wavelength of 480 nm and a camera fitted with an 
ethidium bromide filter. 
 
8.11 Native DNA Gel Electrophoresis 
Native DNA gels were performed using a 20% polyacrylamide gel  with 25 mM 
sodium chloride and 1 x TBE  and a 25 mM sodium chloride and 1 x TBE running 
buffer. Samples were also prepared in 25 mM sodium chloride and 1 x TBE. The 
gels were run at 100V for 1 hour. Gels were visualised by anthracene and TAMRA 
fluorescence as well as using SYBR gold nucleic acid stain. 
 
 
Chapter 8 – Experimental 
 
 281 
8.12 Denaturing DNA Gel Electrophoresis 
Denaturing DNA gels were performed using 20% polyacrylamide gel  with 1 x TBE  
and a 1 x TBE running buffer. Samples were prepared in 50% formamide and 
heated to 90 °C for 5 minutes before being quickly cooled on ice prior to loading the 
gel. Gels were pre-run at 15W for 10 minutes prior to loading and then at 15W for 
30 minutes with samples. Gels were visualised by anthracene and TAMRA 
fluorescence as well as using SYBR gold nucleic acid stain. 
 
8.13 Clauss Assay 
The Clauss assay was performed by monitoring the transmittance of the sample at 
450 nm on a Cary 5000 UV-Vis-NIR spectrophotometer fitted with a Peltier 
temperature controller. 3 µM fibrinogen was prepared in 50 mM tris HCl pH 7, 100 
mM KCl and equilibrated at 25 °C for 10 minutes prior to the experiment. 0.1 NIH 
units of thrombin were incubated at 25 °C for 10 minutes with 37 nM aptamer in 
50 mM tris HCl pH 7, 100 mM KCl. The two solutions were mixed and the 
measurement started with the temperature maintained at 25 °C. 
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9.1 SNP Detection Using an Anthracene Probe 
Table 9.1 MS characterisation and analytical HPLC retention times of oligonucleotides used for SNP and base 
modification studies. “Oligo Gen 60” refers to the Oligo General 60 minute method described in the experimental 









Alz-Pr(1L) 4641 4642 Oligo Gen 60  38.992 
Alz-Pr(1D) 4641 4641 Oligo Gen 60  37.003 
Alz-Pr(3L)* 4669 4669 DMT On 15.001 
Alz-Pr(3D) 4669 4669 DMT On 15.097 
Alz-Pr(4L) 4683 4683 DMT On 15.888 
Alz-Pr(4D) 4683 4683 DMT On 16.080 
Alz-Pr(5L) 4697 4697 DMT On 16.336 
Alz-Pr(5D) 4697 4697 DMT On 17.025 
Alz-Pr(6L) 4711 4710 DMT On 17.670 
Alz-Pr(6D)* 4711 4711 DMT On 17.441 
Alz-Pr(7L)* 4725 4725 DMT On 19.052 
Alz-Pr(7D)* 4725 4725 DMT On 19.130 
Alz-Pr(UM-T)* 4543 4543 Oligo Gen 60  30.092 
Alz-Pr(UM-G)* 4568 4568 Oligo Gen 60  26.721 
Alz-TarA 4578 4577 Oligo Gen 60  25.852 
Alz-TarC 4602 4601 Oligo Gen 60  24.685 
BM-Pr(1L)* 4720 4720 Oligo Gen 60 39.852 
BM-Pr(1D) 4720 4720 DMT On 37.259 
BM-Pr(3L)* 4748 4748 DMT On 15.250 
BM-Pr(3D) 4748 4748 DMT On 15.415 
BM-Pr(4L) 4762 4762 DMT On 16.215 
BM-Pr(4D) 4762 4762 DMT On 16.240 
BM-Pr(5L) 4776 4776 DMT On 16.768 
BM-Pr(5D) 4776 4776 DMT On 17.050 
BM-Pr(6L)* 4790 4790 DMT On 16.872 
BM-Pr(6D)* 4790 4790 DMT On 17.863 
BM-Pr(7L)* 4804 4805 DMT On 18.458 
BM-Pr(7D)* 4804 4804 DMT On 18.497 
BM-TarG* 4536 4536 Oligo Gen 60 33.392 






9.2 Controlling DNA Binding using an Anthracene Tagged Peptide 
 
Figure 9.1 Circular dichroism spectra of Alz-Pr(UM-G) (grey) and Alz-Pr(UM-T) (black) as ssDNA (dotted) and 
duplexed with target Alz-TarC and Alz-TarC respectively (solid). All spectra shown are recorded with 1 µM probe 
and target, where applicable, in 10 mM sodium phosphate buffer pH 7 and 100 mM NaCl at 293 K. 
 
Figure 9.2 Analytical HPLC of anthracene tagged peptide. Run using gradient of 0-100% water-MeCN with 0.1% 
TFA over 40 minutes, followed by a 10 minute hold at 100% MeCN with 0.1% TFA. Monitored at 210 nm (black) 




Table 9.2 MS characterisation and analytical HPLC retention times of oligonucleotides used for studies in 
anthracene tagged peptide binding work. “Oligo Gen 60” refers to the Oligo General 60 minute method described 









CRE 1 6086 6087 Oligo Gen 60 32.256 
CRE 2 6148 6148 Oligo Gen 60 32.779 
Half CRE 1 6179 6179 Oligo Gen 60 37.327 
Half CRE 2 6055 6055 Oligo Gen 60 36.148 
NS 1 6179 6179 Oligo Gen 60 31.775 















Figure 9.4 Job plot to deduce the stoichiometry of anthracene tagged peptide binding to CRE and NS DNA. A) CRE 
DNA, B) NS DNA. The top graphs show the theoretical absorbance at 365 nm due to the change in anthracene 
concentration (black) and the raw data from the Job Plot (grey). The bottom graphs show the raw data with the 




9.3 Photo-Triggered Release of DNA 
Table 9.3 MS characterisation and analytical HPLC retention times of oligonucleotides used for photo-triggered 
release studies. “Oligo Gen 60” refers to the Oligo General 60 minute method described in the experimental 









SL* 8685 8688 DMT On 21.201 
OH1 5836 5837 Oligo Gen 60 32.332 
OH2 5234 5235 Oligo Gen 60 25.872 
OH3 5203 5204 Oligo Gen 60 29.084 
T1 8361 8363 DMT On 16.021 
T2 8361 8363 DMT On 15.938 
PT1 6130 6129 DMT On 16.654 
PT2 6114 6114 DMT On 17.399 
PT3 6130 6129 DMT On 17.233 
PT4 6114 6114 DMT On 16.352 
C1-S 5966 5965 Oligo Gen 60 16.200 
C1-M 7739 7738 Oligo Gen 60 39.419 
C1-L 8028 8026 Oligo Gen 60 39.388 
C2 5971 5970 Oligo Gen 60 21.721 






Figure 9.5 UV-Vis spectra of anthracene containing duplexes. All performed at 1 µM duplex in 100 mM NaCl and 
10 mM sodium phosphate buffer pH 7 at 293 K. Samples were recorded at 0 minutes (solid) following degassing 
with argon for 10 minutes they were then irradiated with 365 nm light for 30 (dotted). 
 
9.4 Controlling DNA Folding using Anthracene Photodimerisation 
Table 9.4 MS characterisation and analytical HPLC retention times of oligonucleotides used for thrombin binding 
aptamer work. “Oligo Gen 60” refers to the Oligo General 60 minute method described in the experimental 









TBA 4726 4726 Oligo Gen 60 26.901 
M1-TBA 6277 6277 DMT On 22.823 
M2-TBA 5060 5060 DMT On 20.912 
M3-TBA 5060 5060 DMT On 20.513 
 
 
